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ABSTRACT
The work in this thesis can be divided into two sections, namely the study of delicious 
peptide, a food flavour and the antimicrobial peptide lactofenicin B. The main 
interest in these compounds is in teims of structure and confoimation adopted in 
solution and how this relates to their mode of action.
Delicious peptide was studied initially by NMR spectroscopy for evidence of a 
specific solution structure. Results show that delicious peptide does not adopt a 
regular confonuation in solution. Moleculai' dynamics simulations of this peptide 
show the flexibility of the peptide stiTicture in solution. Quenched molecular 
dynamics simulations were used to sear ch for low energy confoimers of the peptide. 
The results suggest that the flavour of the peptide is produced by interaction of basic 
and acidic regions in the peptide. The work was extended to examine delicious 
peptide analogues with similar flavour characteristics. The results obtained suggest 
that similar interactions of basic and acidic regions occur for these peptides to 
produce a savoury flavour.
The antimicrobial peptide Lactofenicin B was synthesised by Fmoc poly-amide 
synthesis. Problems with the synthesis occurTed due to the protecting groups used for 
the five arginine residues present in the sequence. Predictive modelling studies on 
Lactofenicin B peptide, derived from bovine lactofenin protein suggest that the 
peptide adopts a region of a-helical conformation in solution. The flexibility of the 
peptide was studied by molecular dynamics in solution and simulations of other 
environmental conditions were canied out by variation of electrostatic interactions 
using dielectric constants for membrane, TFE and water environments. The results 
suggest the a-helical conformation is most stable in an environment such as 
tr ifluoroethanol, the peptide showing more flexibility in aqueous solution.
Experimental results for the peptide confirm the flexibility of the peptide in solution. 
CD results show that lactofenicin B has no specific conformation in solution,
although an a-helical conformation is adopted in trifluoroethanol. The peptide also 
adopts a (3-sheet confonuation in low concentrations of SDS micelle and therefore its 
conformation is dependant on environmental conditions. NMR studies show that the 
peptide, although flexible in solution, shows short-range NOE interactions that 
suggest a local a-helical confonuation may be present. However tire overall 
conformation for the peptide is a flexible one.
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Chapter 1: Introduction
1.1 POLYPEPTIDE STRUCTURE
Peptides and proteins are linear polymers formed by condensation of the 20 common 
L-amino acids. There is no clear definition for distinguishing between peptides and 
proteins. A polypeptide chain consisting of 40 amino acids may well be called a large 
peptide or a small protein. Amino acids aie linked into peptides or proteins by a 
peptide bond. The polypeptide chain of a peptide or protein can be represented as 
follows :
H- (NH -CH Ri-CO -)„O H
where n is the total number of amino acids linked together and R,- is the side chain of 
the zth amino acid.
1.1.1 The Peptide Bond
The peptide bond is a relatively rigid unit due to its 40% C-N double bond character 
(Figure 1-1).
O C,--------- o" C,-
C N C :^ = N
■Cl H  H
Figure 1-1 : Partial Double Bond Character of the Peptide Bond.
Rotation about the bond is restricted due to its partial double bond nature and the CO, 
NH and both adjacent Ca atoms tend to lie in the same plane. Two planar forms aie 
possible, in which the adjacent Ca carbons are fixed in either the cis or the trans 
configuration. The trans form of the bond is intrinsically favoured 1000-fold over the 
cis form because cis peptide bonds can lead to considerable steric hindiance between 
adjacent side chains. The exception is proline however where there is little difference
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in energy between the cis and trans isomers. In folded proteins about 6% of proline 
residues are preceded by a cis peptide bond\
1.1.2 Backbone Torsion Angles
Peptide confoimation is described in teims of the backbone dihedial angles^ (|), y  and 
CO of each residue and the side chain torsion angles Xi (Figure 1.2^ Rotation about 
the peptide bond is defined by the bond angle co, which is 0° in the cis configuration 
and ±180° in the trans configuration. Only certain values of the (j) and \j/ angles aie 
allowed, the values depending on the size and shape of the side chain for a particular 
amino acid. The most flexible amino acid is glycine because of the absence of any 
side chain atoms, other residues have less confoimational flexibility. The barriers to 
rotation around the (j), y  angles are small (less than 5kcal mol'^) which provides the 
high flexibility of the peptide chain. The different side chains present are important 
for stmctural properties and stability.
H O
R2
\
H
N
R H
Figure 1-2 : The geometry of the peptide backbone.
The peimitted values of (j) and y  are usually indicated by a two-dimensional map of 
the (t)-y plane known as a Ramachandran Plot^.
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1.1.3 Polypeptide Structure
It has long been realised that proteins and peptides with sequences greater than about 
25 residues may adopt ordered thiee-dimensional structures in solution which are 
energetically stable. In contrast it is generally accepted that shorter peptides camiot 
maintain a stmcture in solution but exist in a random coil, constantly moving between 
a lar ge number of energetically allowed conformations. However in spite of the large 
number of conformations that may exist for a peptide in solution, many peptides show 
specificity of action with potential targets'*. Among the various hypotheses that have 
been proposed to explain this are : a preferred peptide shape may be induced by a 
specific receptor on binding; certain structures may be stabilised by alterations in 
solvent conditions in the environment close to the receptor; or the peptides may not 
be as mobile in aqueous conditions as first thought. Studies into the initiation of 
protein folding have found a number of peptide fragments that can adopt stable 
conformations in water^.
The random coil natural state of a polymer is favoured by conformational entropy and 
favourable interactions with solvent. Although a single favourable hydrogen bond, 
salt bridge or van der Waals interaction in a random polypeptide chain is unlikely to 
provide unique stability, multiple interactions that occur simultaneously in any 
particular conformation may assist each other to give a conformation stable enough to 
predominate in solution.
1.1.3,1 a-helix
The a-helix (Figure 1-3) is the best known polypeptide regular* structure char acterised 
by hydr ogen bonds between the backbone car bonyl oxygen atom of each residue and 
the backbone NH gr oup of the fourth residue along the chain. a-Helices ar e stabilised 
by hydr ogen bonds and van der Waals interactions between atoms of the backbone 
packed together, and by favourable (j) and \j/ angles. Hydrogen bonds point in one 
direction so that the dipoles of the individual peptide bonds are favourable. Side
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chains are staggered along the axis to minimise steric clashes, Amphipathic helices 
contain predominantly non-polai* side chains on one side of the helix and polar* side 
chains on the other*.
Figure 1-3 ; a-helical polypeptide unit. Dotted lines indicate hydrogen bonds between residnes i 
and i+4 along the chain.
LI.3,2 Çi-sheets
The second major* element of regular secondar*y structure is the ^-strand, which has 
the backbone extended. This extended structure is not stable in isolation, and is 
observed only in ^-sheets (Figure 1-4) which are aggregates of multiple (3-strands, 
r*unning in the same (parallel) or* opposite (antipaiallel directions). Strands are cross- 
linked by hydr ogen bonds between the carbonyl and NH groups that point out fr om 
the peptide chain at right angles to the side chains.
C O ------------  HN HN HN
< > > >/ \ \\ \ \
UN"\ ^ c o\ \y y y
/ \ ^ o \
\ o - - .Î 1 1
Figure 1-4 ; Antiparallel (left) and parallel (right) beta-sheet. Hydrogen bonds are shown by 
dashed lines.
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1.1.3.3 Disulphide Bonds
Pairs of cysteine residues have the potential to form disulphide bonds between them 
to give a cystine residue. These are covalent reversible cross links which are often 
important for maintaining regular* str*uctur*e in proteins. The participating Cys 
residues must be held in a closely defined conformation with respect to each other.
1.2 DETERMINATION OF PEPTIDE CONFORMATION
Several spectroscopic techniques have been utilised for* elucidating the solution 
conformations of peptides and proteins. These include Circular* Dichroism^ (CD), 
vibrational spectroscopy (Raman and Fourier* Transform infiared (FTIR)') and 
Nuclear Magnetic Resonance (NMR) spectroscopy^’^ . The different spectroscopic 
techniques have different time scales : the var ious forms of optical spectroscopy can 
distinguish between species that interconvert on a subpicosecond time scale, whereas 
for* NMR spectroscopy exchanging species are distinguishable only if they 
interconvert on a rnillisecond-to-second tirnescale. Conformational exchange on time 
scales faster tlian this ar e therefore time-averaged; this includes vir*tually all peptide 
conformational exchange processes, except for proline cis-trans isomerization*** 
which occurs at rates of 0.01 to 0.1s'*.
The three-dimensional str*uctur*e of proteins can be best determined by X-ray 
crystallography in solids and for low-molecular* weight proteins by two-dimensional 
NMR spectroscopy in solution. Crystallographic analysis has practical limitations 
such as the availability of high-quality crystals, the time required for* a structure 
determination and most impor*tantly the static nature of cr*ystallogr*aphic information 
that carmot be easily extr apolated to the dynamic properties of proteins in solution.
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1.2.1 Circular Dichroism
This is probably the most extensively used technique for exploration of peptide and 
protein conformation. Polarimetric measurements determine the extent to which a 
beam of linearly polar ised light is rotated on transmission thr ough an optically active 
medium. The polypeptide backbone of L-amino acid residues is chiral and gives an 
intense CD signal in the far-UV region (180-240nm) that is dependent on the 
conformation of the backbone. The char acteristic CD spectra of regular* elements of 
secondar*y str*ucture present in proteins are well known and the CD spectr*um of a 
protein can be deconvoluted into a-helix, P-sheet, reverse turn and random coil 
contributions**. The approximate average content of such structures in a protein can 
be estimated fr om its CD spectrum by compar ison to a database of spectra of lorown 
protein str*uctur*es.
1.2.2 Fourier Transform Infrared Spectroscopy
In the past the practical usefulness of IR methods for* structure prediction was limited 
by low sensitivity of infrared instr*uments, interfering absor*ption from surTounding 
media or solvents such as water* and by difficulties in extracting structural information 
from the conformation-sensitive infrared bands. The first two obstacles have been 
lar*gely overcome by computerised FTIR instr*umentation. The most commonly used 
spectral band in the IR spectr*um is the amide 1 stretching band ( 1600-1700cm'*)* ,^ 
which arises primarily from the stretching vibrations of the backbone carbonyl 
groups. The frequency of the vibration depends on the nature of the hydrogen 
bonding between C=0 and NH moieties at the site, which is determined by the 
secondar*y structure adopted by the polypeptide chains. In D2O the a-helical 
conformation gives a band centred between 1650 and 1658 cm'*, P-sheets between 
1625 and 1640 cm * and random coils between 1640 and 1648 cm *. These bands are 
not fully resolved and detailed analysis of the spectr*um is usually necessar y to resolve
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the components. Infrared spectroscopy is increasingly being used to probe secondary
structure elements of peptides*^.
1.2.3 NMR Spectroscopy
Nuclear- Magnetic Resonance Spectra ar e generated by placing a sample in a magnetic 
field and applying radio frequency pulses that perturb the equilibrium nuclear 
magnetisation of those atoms with nonzero spin. Transient time domain signals are 
detected as the system returns to equilibrium. Fourier transformation of the transient 
signal into the frequency domain yields a one-dimensional spectrum. The technique 
is useful because nuclei of the same element in different environments give rise to 
distinct spectral lines. Only certain nuclei which possess a magnetic moment (or 
nuclear spin) can be seen in NMR spectra, including *H, and *^ N useful in the 
study of biological compounds.
Use of NMR to study macromolecules has developed significantly in the last fifteen 
years and it is now possible to construct three dimensional structures of proteins of 
less than around 200 amino acid units long*'*. One dimensional and two-dimensional 
NMR experiments are used to determine macromolecular structure along with the 
nuclear Overhauser effect (NOE), a phenomenon that gives information on 
uncomiected spin-1/2 nuclei that are close in space and relax by dipole-dipole 
interactions. New developments in NMR spectroscopy include the introduction of 
isotope labelling that enables three and four dimensional techniques to be used. In 
addition it is possible to gain information on conformational dynamics through 
relaxation data. Solid state NMR of peptides and proteins is complimentary to X-ray 
crystallography in giving information on solid state conformation.
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1.2.4 X-Ray Crystallography
Protein ciystallography has developed into an efficient and extensively used tool 
since the 1960's. This is still the prefened method for looking at peptide and protein 
stmctures if crystals can be grown efficiently.*^ X-ray ciystallogr-aphy of proteins 
requires that the protein molecules be organised in a precise crystal lattice but the 
preparation of protein crystals of suitable quality is often a difficult task* .^ The basis 
of the X-ray diffraction technique is that electrons of atoms in the crystal scatter an 
incident X-ray beam to produce a characteristic pattern of reflections that can be 
observed with an X-ray detector*^. The intensities of the individual reflections 
depend upon whether the waves scattered by all the atoms in the crystal recombine in 
phase to reinforce each other, or out of phase to cancel each other out. Knowledge of 
the intensities and phases of individual reflections would permit reconstruction of the 
original protein molecule in the crystal lattice, but only the intensities can be 
measured directly. The phases are usually obtained indirectly by isomorphous 
replacement from the way that one or a few heavy atoms incorporated into the same 
isomorphous crystal lattice affect the diffraction pattern. Once they have been 
determined the intensities and phases of all the X-ray reflections are combined and 
Fourier transformed to produce maps of the electron density.
1.2.5 Molecular Modelling
Molecular modelling is extensively used for examining the conformations of peptides 
and proteins*^. For large peptides and proteins a large amount of time is needed for 
simulations and it is not possible to predict protein folding from the primary 
sequence. This means that other information must be used to limit tlie conformational 
space of modelling calculations. This information can be gained either by 
experimental methods such as X-ray crystallography or NMR spectroscopy or by 
similarities with known protein str*uctures* .^
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1.3 FOOD FLAVOUR PEPTIDES
The perception of flavour is a fine balance between the sensory input of both 
desirable and undesirable flavours^ **. It involves a complex series of biochemical and 
physiological reactions that occur at the cellular' and sub cellular level. Final sensory 
perception or response to food is regulated by the action and interaction of flavour 
compounds and their products on two neural networks, the olfactoi-y (smell) and 
gustatory (taste) systems. The major food flavour components involved in the 
initiation and transduction of the flavour response are the food's lipids, caibohydiates 
and proteins and their reaction products.
The contribution of amino acids and peptides to the tastes of foods has been known 
for many years^*. Amino acids aie often added to food to increase their nutritional 
value and enhance taste, the individual amino acids having distinctive flavours^^. The 
taste of traditional Japanese foods such as sake and soy sauce is assumed to be due to 
the release of amino acids fr om natural proteins during fei-mentation. The tastes of 
individual amino acids as well as some short lineal' peptides have been studied in 
detail and can be categorised as sweet, savoui-y, sour or bitter^ .^
A well Icnown example of peptides used as food flavours is the dipeptide aspaitame 
(Asp-Phe-OMe) commonly known by the brand name Nutrasweet. This has been 
used for many years as a sugar substitute in foods. Sweet molecules are known to 
contain a hydrogen bond donor (AH) and a hydrogen bond acceptor (B) with a 
distance between of about 3.1 A and potent sweet molecules also contain a 
hydrophobic group (X)^ '*. This hydi'ophobic group is drought to contribute to the 
sweetness intensity^^. Studies on sweet peptide compounds suggest that the str-ucture 
of these compounds is important to their flavour^^ and that the sweet flavour comes 
fr om the interaction of the AH and B components with receptor sites.
Bitter peptides ar e thought to contain two active sites, one made up of hydr ophobic 
units and a ‘stimulating unit’ made up of bulky basic and hydr ophobic groups with a
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distance between the two sites of 4.1 A. Some evidence has been put forward to 
suggest that sweet and bitter flavours ar e recognised at the same receptor^.
Amino acids and peptides are also known to be involved in the flavour of meat^^’"“ 
and cheese^^. A number of peptides are thought to be formed from the par ent proteins 
that contribute to the flavour characteristics of these substances. The bitterness 
present in the flavour of some cheeses is thought to be due to the formation of bitter- 
tasting peptides from casein protein. An example of this is BPI (Arg-Gly-Pro-Pro- 
Phe-Ile-Val)^** isolated from casein hydrolyzate. Studies of BPI peptides have 
suggested the importance of the amino acid composition, especially the presence of 
hydr ophobic groups and their position in the sequence to the bitter flavour. A peptide 
that has been isolated from beef gravy is ‘delicious peptide’ (Lys-Gly-Asp-Glu-Glu- 
Ser-Leu-Ala)^*. This peptide has been formd to contain the same savoury flavour as 
beef soup and its conformation is studied in detail in Chapter 3.
1.4 ANTIMICROBIAL PEPTIDES
The study of antimicrobial peptides has stemmed from the desire to find a natural 
product to kill harmful microbes without causing damage to the host^ .^ An 
asymmetric clustering of basic residues has been observed in various peptides which 
show an affinity for biological membranes. Examples of these are the magainins, 
defensins and cecropins^^. These cationic peptides have been shown to kill sensitive 
micro-organisms by inducing an increase in cell membrane permeability leading to a 
disruption of energy metabolism or other essential functions in the target organism.
1.4.1 Cationic Antimicrobial Peptides 
1.4.L I  Defensins
The defensins were first isolated in the early 1980's, with the first sequences reported 
a few years later. All defensins contain 29-34 amino acid residues, have three
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intramoleculai' disulphide bonds, one consei*ved arginine, and one conserved glycine 
residue and aie basic and relatively aiginine rich^ '*. Defensin peptides have been 
isolated from rat, guinea pig, rabbit and hyman neutrophils. Neutrophils aie 
phagocytic cells that play an active role in the mammalian defence system against 
foreign microbes. These compounds aie known to adopt antiparallel p-sheet 
conformations^ (Figure 1-5).
Figure 1-5 ; Conformation of a Defensin dimer  ^ . Dashed lines show hydrogen bonding 
interactions.
1.4.1.2 Cecropins
The cecropins were originally extracted from the cecropia moth. These peptides have 
31-39 residues with no cysteine and have a strongly basic N-teiminal region and a 
long hydrophobic stietch in the C-teiminal half The structure of cecropins 
deduced from NMR studies is two a-helices joined by a hinge region containing a 
Gly-Pro^^’'*** fragment.
1.4.1.3 Magainins
The magainins are a series of antimicrobial peptides isolated from glands found in 
frog skin. Magainins have 23 residues with no cysteine and aie known to form an 
amphipathic a-helix in a simulated membrane environment'**’'*^ . These peptides are
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believed to act as sterilising agents of the skin and this may be the reason for the 
extraordinaiy freedom from infection chaiacteristic of wound healing in these fr ogs, 
even in a microbially contaminated habitat.
1.4.2 Lactoferricin Peptides
A series of peptides have been found derived from lactofenin proteins which are very 
effective antimicrobial agents. These peptides, known as lactofenicin H and 
lactofenicin B were discovered by gastric pepsin cleavage of the lactoferrin 
protein'*^’'*'*. Peptides lactoferricin H and lactofenicin B are derived from human and 
bovine lactofenin respectively, the sequences involved coming from the N-teiminal 
region of the protein distinct from the iron binding sites. The most effective 
antimicrobial agent of the two is lactofenicin B.
These peptides have potential to be of widespread commercial use as 'natural 
antimicrobial agents’ in a variety of food product applications.
1.4.2.1 Lactoferrin Protein
Lactofenin is an iron-binding glycoprotein of the tiansfenin family present in milk, 
tears, saliva and a variety of other biological fluids. Transfenins are used to control 
iron levels in animals through the tight but reversible binding of iron'*^ . Lactofenin 
also has antimicrobial activity against bacteria and yeast’s in an iron-free state and is 
thought to be an important component of the host defence against microbial 
infections'*^. The antimicrobial domain of lactoferrin is thought to be near the N- 
terminus in a region distinct fr om the iron-binding sites.
1.4.2.2 Lactoferricin B
This is a twenty-five residue cationic peptide derived from bovine lactoferrin protein 
of which eight out of the twenty-five residues are basic. The sequence is as follows :
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PHE-LYS-CYS-ARG-ARG-TRP-GLN-TRP-ARG-MET-LYS-LYS-
LEU-GLY-ALA-PRO-SER-ILE-THR-CYS-VAL-ARG-ARG-ALA-PHE
The sequence coiTesponds to residues 17 to 41 neai’ the N-terminus of bovine 
lactofenin. The moleculai* weight of the peptide is 3125 by sequence. Lactofenicin 
B was originally isolated by cleavage of bovine lactofenin with tiypsin'* .^ The 
peptide has also been synthesised and shown to exhibit the same antimicrobial effects. 
The structure contains a loop region between the two cysteine residues, 3 and 20.
1.4.2.3 Lactoferricin H
This peptide conesponds to the N-terminus of human lactofenin and consists of 47 
amino acid residues with a molecular* weight of 5558. Lactofenicin H has a region 
analogous to that of lactofenicin B in the loop region from residue 19 to residue 36. 
Residues 19 and 36 ar e cysteine and may be joined by a disulphide bridge.
1.4.2.4 Antibacterial Activity
The peptides lactofeii'icin's H and B have been found to be 2-fold and 12-fold more 
effective antimicrobial agents than the corresponding lactofeiTin H and lactofenin B 
proteins'* .^ Lactofenicin B is a 9-fold more effective antimicrobial agent than 
lactofenicin H. The activity of bovine lactofen*in is abolished in the presence of 
ferTous sulphate, whilst that of lactoferricin B is reduced by about 2.5 fold'*^ . The 
presence or* absence of a disulphide bond has not been found to effect the activity of 
lactofen*icin B.
The two peptides both contain a relatively high proportion and asymmetric clustering 
of basic amino acid residues, with eight basic residues in lactofenicin B and seven in 
lactoferricin H. The relative antimicrobial efficacy of the peptides seems to be 
correlated with the net positive charge suggesting the basic residues may be important 
for* activity. This asymmetric clustering of basic residues has been obser*ved in other* 
peptides with antimicrobial properties (section 1.4.1).
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In lactofenin protein the antimicrobial sequence is exposed on the exterior of the 
folded protein molecule allowing its interaction with target sites on the cell surface. 
Physical studies of lactofenin have shown that a substantial conformational change in 
the N-terminus accompanies iron-binding^**. This change may in some manner reduce 
the availability of the antimicrobial domain for interaction with the microbial sur face. 
Such an hypothesis could explain why saturation of lactofenin with iron abolishes its 
bactericidal activity, although this does not explain why lactofenicin B loses activity 
when iron is bound because the iron-binding ligands ar*e not present in the peptide. 
The activity of lactoferricin B peptide is also diminished in the presence of other 
metal ions such as Calcium and Magnesium.
1.5 OUTLINE OF WORK
The work covered by this thesis can be divided into two broad areas; studies of food 
flavour peptides and studies of antimicrobial peptides, the main aim being to gain 
information on the solution conformations of these peptides. Studies of delicious 
peptide, a food flavour peptide of eight residues were canied out using two- 
dimensional *H NMR spectroscopy and molecular* modelling as outlined in chapter 3. 
Initial experimental studies showed no evidence of specific solution str*ucture and 
indicated the flexible nature of the peptide. Molecular* dynamics techniques were 
used to search for* possible low energy conformers. The modelling results obtained 
were compared to those of a series of delicious peptide analogues lorown to have 
similar flavour* properties.
The antimicrobial peptide lactofenicin B is looked at in detail in chapters 4, 5 and 6. 
The synthesis and prelirninar*y characterisation of this peptide is outlined in chapter 4. 
Lactoferricin B was synthesised by Fmoc solid phase peptide synthesis. Predictive 
modelling of the two peptides lactoferricin B and lactofenicin H are outlined in 
chapter* 5. Molecular* modelling teclmiques based on the protein crystal structure 
were used to predict conformations for the two compounds. These conformations 
were refined by molecular* dynamics simulations in a number of different
Chapter 1: Introduction 16
environments. Experimental NMR and circular* dichroism results for lactoferricin B 
ar e outlined in chapter* 6.
Chapter* 7 summarises the results obtained and gives some suggestions for future 
work in this ar ea.
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2.1 INTRODUCTION
This chapter gives a brief oveiwiew of modem two-dimensional NMR spectr oscopy, 
concentrating on the use of NMR in structure determination of macromolecules. NMR 
spectroscopy allows the détermination of structure in both solid and liquid form. Solid 
state NMR spectroscopy is important for compounds of low solubility and gives results 
complementary to X-ray crystallography. Modem solution NMR spectroscopy of 
macromolecules has undergone numerous developments in the last fifteen years and a 
brief outline of some of the basic techniques is given here. This is followed by a section 
on basic principles of molecular simulation methods including derivation of force 
fields, energy minimisation and molecular dynamics techniques. The application of 
these techniques to the specific study of peptides is discussed.
Finally basic results obtained for Met-enkephalin ft'orn NMR and simulation teclmiques 
are presented and compar ed to known results for this peptide.
2.2 TWO-DIMENSIONAL NMR SPECTROSCOPY
NMR spectroscopy is established as an alternative to X-ray crystallography for the 
determination of three-dimensional protein structure \  NMR is a unique method for 
structure determination in that it is the only method available for providing high 
resolution structural information in the solution state .^ Structural information is 
obtained mainly due to the nuclear" Overhauser effect (NOE) which can give 
information on atoms that are close in space for spin-^S nuclei such as protons that relax 
by dipole-dipole interactions.
With the advent of two-dimensional NMR techniques such as COSY and NOESY in the 
early 1980s the amount of information that could be obtained from protein NMR 
spectroscopy was dramatically increased. In 1982 Wüthrich and co-workers introduced 
a systematic method for the full assignment of the two-dimensional spectra of proteins^
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which has since been adopted by other workers in the field. The advent of three- 
dimensional NMR spectroscopy along with isotopic labelling has enabled 
confoiinational studies of larger proteins by NMR"*.
Protein NMR techniques can be applied to peptides^’^ . Although the spatial stracture 
deteimination of peptides would appear to be easier than for proteins because of their 
smaller size, this has not been found to be the case for a number of reasons^. Peptides 
aie flexible molecules that do not have such well defined stractures in solution as 
proteins. Short linear peptides aie thought to exist mainly in a random coil 
confoimation in solution, although evidence of a specific stracture has been found in a 
few cases^. It is raie for peptides to have a single rigid confoimation although NMR 
results ai*e sometimes interpreted as such and lead to a ‘time-averaged’ confonnation 
that may not exist for any reasonable period of time. Formation of constrained cyclic 
foims of linear peptides helps reduce the conformational freedom of these peptides^.
This section is designed to give a brief introduction to homonuclear two-dimensional 
NMR techniques used in stracture deteimination of peptides and is not intended to 
cover all the techniques used. Numerous texts are available which give more 
infoimation on different techniques availab le the  background theoiy of NMR^*’^ ’^^  ^
and its application to the study of biological macromolecules
2.2.1 Basic NMR spectroscopy
In NMR spectroscopy a radio fiequency pulse tips the spins of those nuclei of nonzero 
spin, and the magnetic moment aiising jfrom them, from their equilibrium position along 
the applied magnetic field (defined as tlie z direction in Figure 2-1). The magnetisation 
is disturbed fiom its orientation along the z axis and precesses in the xy plane. 
Immediately after the pulse the fiee induction decay (FID) is recorded by a receiver 
coil. The decay takes place because the individual nuclei relax through interaction with 
local fluctuating magnetic fields back to their equilibrium positions. Fourier 
transfoimation of the FID which is said to be in the time domain will convert the signal
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to a spectmm in the fi*equency domain. Sensitivity of the technique can be improved by 
recording successive FIDs which are added together in the computer before Fourier 
transfomiation.
Relaxation of the system back to equilibrium is governed by two relaxation times, 
and T2, the spin-lattice and spin-spin relaxation times. is the time constant for the 
magnetisation to return to its equilibrium value Mq along z. A period of several T, is 
left between signal acquisitions to obtain the proper amplitudes for all peaks. T2 is the 
time constant for the magnetisation to retmn to its equilibrium value of zero in the x-y 
plane.
M A n il Pulse
Relaxation T ,
Precession
Figure 2-1 ; Diagram showing the effect of application of a 90° pulse in the NMR experiment.
2.2.2 Principles of Two-dimensional NMR Spectroscopy
Two-dimensional (2D) NMR experiments can be described by the basic scheme of
preparation, evolution ( tj ,  mixing and detection (t2) (Figure 2-2^ )^.
Preparation Evolution Mixing Detection
m
Figure 2-2 : Basic pulse sequence for 2D NMR spectroscopy.
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The scheme differs from that for one dimensional spectra by the introduction of a 
second time variable ti during the evolution time which is incremented to obtain a 
second time-domain. Spectra are recorded as a function of two time variables tj and t2- 
A basic pulse sequence is repeated n times with tj being incremented each time. A free 
induction decay S(t2) is acquired for each new value of t, so that after n experiments a 
two-dimensional anny S(ti,t2) is acquired. The resulting data must be Fourier 
transformed twice over t2 and t^  to give a spectrum as a function of two frequency 
variables S(œ 1,0)2).
The spectra can be recorded with different properties for ti and t2 so that the two 
frequency dimensions contain different kinds of NMR infoimation. An important idea 
is that of coiTelation. A coherence transfer can be set up whereby some I magnetisation 
is transfeiTed to the S spins in a coupled IS system. The coherence may precess at the I 
spin 5j during ti and the S spin ôg during t2. There will therefore be a peak at (Ôi, 5s) 
reflecting the fact that I is coupled to S. This is the basis for the COSY technique. The 
usefulness of 2D experiments stems from this exchange of infoimation between spins. 
Data are usually represented as a contour plot showing the coiTelation between separate 
spin systems.
The importance of 2D NMR stems from the fact that there aie two main methods of 
coherence transfer. These aie through-bond scalar spin-spin (J) coupling (COSY and 
TOCSY) or interaction via dipolar- coupling through space (NOESY).
2.2.2.1 COSY
The simplest 2D NMR experiment is known as homonuclear Correlated SpectroscopY 
(COSY’^ ). The pulse sequence consists of two 90° pulses separated by a delay and 
gives information on directly coupled spin systems. The second pulse of the experiment 
causes magnetisation arising from one transition during tj to be redistributed amongst 
all the others with which it is associated. This means that for two spins I and S that are 
directly coupled, cross peaks will occur at (6i,5s) and (ôs,ôi). The cross peaks will be 
antiphase in character.
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The diagonal of the COSY spectmm consists of the conventional ID spectmm and the 
cross peaks on either side represent thi*ough-bond scalai* correlation’s. A sample COSY 
spectmm is shown in Figure 2-4. This shows the usefulness of the technique as an aid 
to spectral assignment of peptides. The spectmm shows the typical connectivities 
obtained for an amino acid such as Asp. Connection can be traced from the NH signal 
to aCH which in turn is connected by cross peaks to the PCH2 signals.
90 90
Figure 2-3 : Basic pulse sequence for COSY experiment.
NH HCa 
CO 2 ppm
HCP
HCa
ppm
NH
HCP
Figure 2-4 ; Diagram showing the theoretical COSY cross peaks for a simple peptide unit such as 
Asp \  Dotted lines represent connections between adjacent signals.
Problems may occur in the spectmm close to the diagonal where peaks may be lost due 
to coherence that has not been tiansferred. The COSY technique can be modified to
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select only coherence transfeiTed during the experiment by applying a double quantum
filter^
2.2.2.2 TOCSY (HOHAHA)
For lai'ger molecules chemical shift degeneracies or near degeneracies cause assignment 
problems. New techniques have been developed to overcome this. The RELAY^^ 
experiment shows COSY-type cross peaks as well as cross peaks from spins not directly 
coupled but with common coupling paitners. Extended couplings can be identified 
using TOCSY (TOtal CoiTelation SpectroscopY), also known as HOHAHA^^ 
(HOmonuclear HArtmann HAhn spectroscopy). Here the magnetisation becomes ‘spin- 
locked’ causing all spins to become equivalent, effectively averaging out chemical 
shifts. During this multiple pulse sequence the spins behave as if they are all strongly 
coupled and coherence that begins on one spin can be spread to all others that are pait 
of the coupled group. This enables all couplings in a pai'ticular amino acid residue to be 
observed.
90 SPINLOCK
Figure 2-5 : TOCSY pulse sequence.
2.2.3 The Nuclear Overhauser Effect (NOE)
Dipolai* coupling generates relaxation between spin-l/2 nuclei which aie close in space, 
via cross relaxation. This gives rise to the nuclear Overhauser effect (NOE). This is 
defined as a variation in intensity of one signal as a result of saturation of another. NOE 
effects depend on distances between cross-relaxing nuclei and can be used to deteimine
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interatomic distances between nuclei that aie close in space but not coupled. The effect 
is only noticeable over short distances of 2 to 4Â due to the rate and efficiency of 
dipole-dipole interactions and falls off rapidly to the inverse sixth power of the distance 
between nuclei.
The NOE is dependent on distance (7) and coiTelation times (r j. 
1NOE oc < > / W Eqn 2-1
accounts for the influence of motional averaging processes on the NOE. These are 
governed by overall rotational molecular' motions which depend on the size and shape 
of the protein and on intramolecular' motions. I q may vai'y in different locations in the 
protein. This means that the NOE cannot directly give a measure of distance, but a 
build-up rate must be observed^ \
ap
@
aa
Pot
Figure 2-6 : Energy level diagram for dipole-dipole relaxation in a homonuclear two-spin 
system^ .^
Consider a simple system of two dipolar isolated spin-% nuclei I and S whose atoms ar e 
close in space, a  and p are the possible orientations of the magnetisation vector of each 
spin in a magnetic field. The nuclei give rise to four populated energy levels (Figure 2- 
6). Wi^ and W / are single quantum transition probabilities that give rise to a nonnal 
NMR spectrum. W2 is a double quantum transition probability for the two spins to 
relax simultaneously in the same direction while Wq is a zero quantum transition
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probability corresponding to a mutual ring flip. The double and zero quantum processes 
are not detected directly in NMR spectra but they contribute to relaxation of the system. 
Relaxation due to the W2 pathway is stimulated by rapid tumbling of molecules with a 
molecular weight of 100 to 200. This gives rise to a positive NOE effect (or an increase 
in signal intensity). is stimulated by slower tumbling of lai'ger molecules with a 
molecular weight greater than 1000. This gives rise to a negative effect (or a decrease 
in signal intensity). For molecules of intemediate size little or no NOE effect is seen.
2.2.3.1 NOESY
The main two dimensional technique used for measuring NOE effects is known as 
NOESY (Nuclear Overhauser Enhancement SpectroscopY). The pulse sequence is 
described in Figure 2-7. The first 90° pulse creates transverse xy magnetisation and the 
second pulse rotates the components of magnetisation along the -z axis. During the 
subsequent mixing period z-magnetisation components exchange due to cross­
relaxation. The transverse components are not required and are removed by phase 
cycling. Therefore only the magnetisation vector in z remains. The third 90° pulse 
generates the observable magnetisation.
m
Figure 2-7 : Basic NOESY pulse sequence.
The time delay (T^) is of key importance. Nuclear Overhauser effects require a certain 
time to build up and the length of time chosen for the mixing period depends on the 
molecule being studied. In the NOESY the NOE is seen as a cross peak that builds up 
during the mixing time at an initial rate proportional to r’^ . However the build-up soon 
becomes non-linear paiticularly when other protons are close by. To remain in the 
lineal' region, known as the exti'eme narrowing limit, short mixing times must be used.
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The NOESY technique can be used for large macromolecules where strong negative 
effects are obseiwed and for small molecules with positive effects. Medium sized 
molecules show only small or zero NOE effects. This is the case for peptides of 5 to 12 
residues long at frequencies of 300-500MHz.
Z2.3.2 ROESY
In ROESY^^’^"^ (Rotating hame Overhauser Enhancement SpectroscopY) cross peaks 
ai e generated by cross-relaxation of transversal magnetisation. Unlike the NOE, ROE 
effects aie always positive. This is useful where NOE effects are small or zero. Cross 
peaks come from relaxation thiough dipolar couplings in the rotating frame. The pulse 
sequence is identical to that for HOHAHA except the RF power used to achieve spin 
locking is lower which helps prevent the occurrence of HOHAHA cross peaks. Cross 
relaxation occurs in the presence of a weak RF field rather than a large static magnetic 
field so the extreme naiTowing limit is maintained for all values of the coiTelation time.
90
m
Figure 2-8 ; ROESY pulse sequence.
2.2.4 Resonance Assignments
It is not possible to obtain stimctural infoimation from NMR until a frill resonance 
assignment has been made. Since many amino acids exhibit a characteristic pattern of 
proton signals, they can be detected in two-dimensional spectia by maldng use of 
conelation's via J-coupling. In general the *H resonance’s from different types of 
protons on side-chains can be roughly grouped based on chemical shift. Amide protons 
usually resonate in the region 6-1 Ippm, aH ’s in the region 3.5-6ppm and CH^’s in the
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region 0.5-2.5ppm. However the chemical shifts aie dependent on environmental 
conditions such as local conformation of the backbone and contacts with side chains.
The amide protons of solvent-exposed residues exchange fairly rapidly with protons 
fi'om solvent water. Thus, when a sample is dissolved in ^H20 solution the amide 
proton resonance’s will dis appeal'. This means experiments must be earned out in H2O 
or vital information on backbone confonnation is lost. There are a number of methods 
for suppressing the proton signal from H2O from the spectrum, the most common being 
to saturate the solvent signal during the delays in the experiment. This can also cause 
saturation of aH resonance’s that have the same chemical shift as water and a number 
of more sophisticated methods for water suppression have been developed^^. COSY 
spectra in H2O enable direct coiTelation from NH to aCH signals in each residue. 
These signals should then line up with cross peaks further thiough the residue. For 
complicated spectra residue assignments can be carried out more easily by methods 
such as TOCSY.
Amino acid sequence assignment is carried out using 2D NOE techniques. The use of 
through-space *H-*H interactions from the nucleai' Overhauser effect to identify 
sequentially neighbouring amino acid residues was first utilised by Wuthi'ich et. al.^ .^ 
Nuclei in adjacent residues will be close in space and should therefore show an NOE 
effect between backbone residues. Figure 2-9 shows the sequential NOE effects that 
should be obsei'ved in spectra of peptides and proteins^^.
CH, CH,
CiPH O
H
'i+1
>  HH ^ doN
Figure 2-9 : Diagram of sequential NOE interactions for a dipeptide unit. Standard notation 
used for NOE distances from reference 26. Arrows represent NOE effects.
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2.2.5 Determination of Three-dimensional Structure from NMR Data
The most important structure paiameter that can be utilised by NMR is the NOE. This 
has proven to be an efficient method for building up structural information in various 
macromolecules such as proteins and nucleic acids. NOE effects occurring between 
non-adjacent residues allow a build-up of secondary stiircture elements in the sequence. 
It is possible to carry out a mathematical determination of the NOE^ '^^  ^ by creating 
NOE build-up curwes which can lead to an accurate determination of interproton 
distances^^.
Refinement of experimental data obtained from NMR spectroscopy is normally canied 
out by simulation methods (section 2.4.1).
2.2.5.1 Coupling Constants
Vicinal spin-spin coupling constants provide additional information on peptide 
conformation^^. Values of main chain (|) angles can be linked to experimentally 
measured H^-H“ coupling constants^ ^  (^J^a) by a Karplus equation^^. The angular* 
dependence for J^nNa has been calibrated on several proteins. One estimate is^  ^ :
’^jHNa = 6.4 C0S2((j) -  60) -1.4 cos((|) -  60) +1.9 Eqn 2-2
This equation is represented in Figure 2-10.
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I
Figure 2-10 : Relationship between vicinal coupling constant and  ^dihedral angle.
The graph shows that for each value of coupling constant there are a number of dihedr al 
angles that are valid. The dihedr al angle range can be limited to those found in protein 
structures (from -30 to -180°). Values of coupling constants can be used to give an 
indication of secondary structure, for example values of ar ound 7Hz indicate a random 
coil conformation.
Vicinal coupling constants between a  and (3 protons ( J^p) can be linked to the 
sidechain angle %, although additional data is normally required from NOE interactions
34before applying dihedr al constraints .
2.2.5.2 Amide Proton Chemical Shifts
The change in value of the ’H amide chemical shift with increase in temperatur e has 
been used to give an indication of hydr ogen bonding in a peptide systeni^^. With 
increasing temperature, hydrogen bonds in the system will be broken. The slope of a 
graph of chemical shift against temperature gives the temperature coefficient for that 
residue. Comparison of the gradients for different residues can give an indication of 
whether a particular residue is involved in inter or intra molecular hydrogen bonding.
The information obtained from amide chemical shifts and coupling constants is best 
used in conjunction with other evidence such as NOE interactions to confirm its 
interpretation.
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2.3 MOLECULAR SIMULATIONS
For simulation studies of molecules an appropriate potential energy surface is needed 
for the molecule. This would ideally be calculated by molecular' orbital methods but 
this is not practical for molecules of greater than about 20 heavy atoms. The laws of 
classical mechanics can be applied which use an empirical function to define a 
classical potential energy surface. Molecular* mechanics represents a molecule as a 
collection of spheres joined by springs. The motions of these atoms can be described 
by the laws of classical physics and simple potential energy functions can be used to 
give a set of mathematical equations. This set of potential functions is known as a 
force field. This method allows the representation of much lar'ger molecular systems 
than molecular* orbital calculations although the results obtained will only be as good 
as the potential functions and par ameters used.
The energy of a molecule is calculated as a sum of the steric and nonbonded 
interactions present. The potential energy surface is represented by terms to describe 
bond stretch bond angle deformation {Eangu), torsional or dihedral angles
(E(ors)^nd non-bonded interactions This is illustrated in equation 2-3.
Etot — Eboud +  Eaiigla +  Etors +  Eiib EqXl 2-3
Bond stretch and angle deformation are usually described by a simple harmonic 
potential, the typical vibrational behaviour being nearly harmonic close to the 
equilibrium value. For a more accurate description Morse potentials can be used. 
Torsional rotational forces are described by a periodic Fourier series. Nonbonded 
interactions are distance dependent and are calculated as a sum over all atoms with a
1.4 or greater* separation. These interactions have two components represented by 
Lennard Jones (van der* Waals) and Coulomb (electrostatic) potentials. A pictorial 
representation of a molecular* mechanics force field is shown in Figure 2-11^ .^
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Figure 2-11 : Pictorial representation of a molecular mechanics force field. +,- represent 
electrostatic interactions.
Additional terms that effect the energy of the system may be added such as hydr ogen 
bonding terms, cross terms and constraint terms.
The force field must be parameterized with details of atom types, force constants, etc. 
Parameters can be obtained from experimental data and Ab Initio calculations^^. 
Force constants for bond, bond angle and torsional angles may be obtained from 
vibrational and other forms of spectr oscopy or from molecular orbital calculations of 
reference molecules. Lennard-Jones parameters are obtained fi'om gas-phase 
scattering and crystal packing. Partial charges can be obtained fi'om molecular orbital 
calculations.
A number of different force fields and parameter sets are available. These include
Amber^^ (Assisted Model Building with Energy Refinement), GROMOS 
(GROningen MOlecular' Simulation Package) and CHARMM^* used specifically for 
peptides and proteins and used for small organic molecules. A description of
the CHARMM force field which was used in this thesis follows.
39
2.3.1 CHARMM Force Field
The CHARMM^ ^ (Chemistry and HARvard Macromolecular* Mechanics) empirical 
energy function is based on separable interiral co-ordinate terms and pairwise 
nonbonded interaction terms. The potential energy is described by equation 2.4. The 
separ able energy terms are described in the following section.
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Potential Energy = E}^ + ^ 0  + + E^ (internal)
+ E^i + E^ ,^„ (non-bond)
+ ^cous + K th e r  (ot^er) Eqn 2-4
2.3.1.1 Internal Energy Terms
The bond potential tenu {E^ is described by a simple harmonic potential in a similar 
maimer to a stretched spring (equation 2-5). kjj is the bond stietching force constant 
describing deformation, r is the bond length and the equilibrium bond length.
E b - ^  kb{r — VoŸ Eqn 2-5
The bond angle potential (Eg) is treated in a similar- way to the bond stretch (equation 
2-6). /c0 is the force constant and the equilibrium value for the bond angle. At 
ordinary temperatures in the absence of chemical reactions changes in bonds and 
angles are sufficiently small for a harmonic approximation to apply'* .^
E %  —  ^  ] 7cq ( 0  — G o) Eqn 2-6
The dihedral angle potential term is described by a Fourier series (equation 2.7) where 
k^ is the rotational barrier height and n the periodicity of rotation. The torsion energy
ter-m is a four atom term based on the dihedral angle about an axis defined by the
middle pair of atoms.
Æ’it) = V  -  h  cos&(b) ^ ^  Eqn 2-7n = 1,2,3,4,6
The improper torsional potential { E ^  is designed to maintain chirality about a 
tetrahedral carbon such as an amino acid carbon where one hydrogen is present in a 
united atom representation (section 2.3.1.3) and to maintain planarity about sp  ^
hybridised atoms such as cartonyl carbons using a quadratic distortion potential 
(equation 2 -8 ). /c^ , represents the force constant and où the improper torsion value.
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E(ù = ^  /c(o(co — COo)^  Eqn 2-8
2.3.1.2 Non Bonded Interactions
Nonboiided interactions are distance dependent and can be calculated as a sum over 
all atoms with a 1,4 or greater separation. These have two components : van der 
Waals interactions and electrostatic energy (equation 2-9).
Enb = Evdw + Eel — \ —TT 71 + f  ^   ^ I Eqn 2-9rV  KAnZor;
Electrostatic interactions {E^^ between pairs of atoms are represented by a Coulomb 
potential. 8^  is the effective dielectric function for the medium and r the distance 
between the two charges (g^ - and ^). The CHARMM force field allows other methods 
of treating electrostatic interactions. These include application of an approximate 
screening teiin in the dielectric constant by setting the dielectric constant proportional 
to distance. This is intended to provide an approximate way of dealing with solvent 
effects without explicit inclusion of solvent.
The van der Waals energy (E’vrf^ ,) is approximated in the CHARMM energy function 
by the Lennard-Jones potential energy function often called the 6-12 potential 
(equation 2-9). The values of A and B will depend on the atoms involved and can be 
detennined from crystal data and gas-phase scattering.
In nonbonded calculations a list is created containing all pairs of interactions to be 
considered. Atom pairs are not included in the list if they are too fai' apart (beyond 
long range cut-offs) or if they are directly connected. For a typical macromolecule 
nonbonded interactions represent the bulk of the energy evaluation time. The 
efficiency of nonbonded calculations is increased by including only atom pairs that 
ai*e closer than a cut-off distance. This is computationally more efficient but includes
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the assumption that long range nonbonded interactions are negligible which may not 
always be the case"^ ’^.
A discontinuity in the energy function results at the cut-off distance which can distort 
computational results. This can be resolved by use of teclmiques that smooth the 
function around the cut-off distance'*'*. This can be done by two methods, the 
switching and shifting functions'* .^ A switching function reduces the size of the 
nonbonded list by indicating a distance to be applied beyond which no interaction is 
computed. A switching region is defined over which nonbonded interactions aie 
smoothed. This method can still result in significant energy at the cut-off distance. A 
shifted potential modifies the radial function so that energy and forces are reduced to 
zero at a cut-off distance.
2,3,1.3 Other energy terms
An explicit hydrogen bonding term can be added with a foimat similar to the 
Lennard-Jones potential. However hydiogen bond interactions should already be 
described by the combination of electrostatic and van der Waals forces.
Other energy terms include constraint tenus (Econs) to restrict changes that can occur 
in a stmcture'* .^ It is possible to ensure that bond lengths and angles stay in a 
specified region or to constrain pails of the system. This is useful for studying a 
specific pai't of a molecule only (e.g. the active site of a protein.).
For representations of laige macromolecules the large number of atoms that describe 
the system may result in slow computational times. One way of limiting the system is 
to use a united atom model potential energy function. This omits nonpolar 
hydiogen's by including these with the carbon parameters. An all-atom model 
includes all hydiogen's explicitly and is usually necessary for simulations fiom NMR 
results.
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2.3.2 Energy Minimisation
Energy minimisation is used to find a set of co-ordinates representing a molecular 
conformation such that the potential energy of the system is at a minimum. 
Depending on the starting stmcture this will probably be a local minimum. The 
lowest possible energy a molecule can have is described as the global minimum. For 
a large macromolecule the global minimum may never be found because of the 
complexity of the potential energy surface. There are a number of minimisation 
algorithms available based on first derivative and second derivative methods. The 
method used for a paiticulai' minimisation will depend on the type of simulation to be 
canied out.
2.3.2.1 Steepest Descents*^
This is a very simple first derivative method which uses only first derivative 
information and saves only the cunent location of co-ordinates from iteration to 
iteration. This method converges very slowly to a local minimum but will rapidly
I
remove a poor confonnation. |
I
I
2.3.2.2 Conjugate gradien/^, II
This exhibits better convergence than steepest descents. The method is iterative and 
makes use of the previous histoiy of minimisation steps and the cunent gradient to 
determine the next step.
2.3,2.3 Newton-Raphson
These method can recover hom some local minima due to diagonalisation of the
second derivatives matrix which can involve long computational times. The
procedure requires the computation of the derivative of the gradient which is a matrix
and requires excessive storage requirements for large molecules. j
!1
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2.3,2.4 A dopted Basis-set Newton-Raphson^
This is similar to conjugate gradients but fewer energy evaluations are usually 
necessaiy. The positions and forces from a set previous number of steps are stored. 
Minimisation is canied out using a Newton-Raphson algorithm applied to this 
subspace of the co-ordinate vector. The second derivative matrix is constmcted 
numerically fr om the change in the gradient vectors.
2.3.3 Solvation
The simplest way to account for solvation effects is to assume that the major effect is 
to screen electrostatic interactions in the solute. This can be accomplished by 
including the appropriate dielectric constant in the elecfrostatic tenu of the potential 
energy function. This method has clear limitations for example no account of 
favourable solvent-solute interactions such as hydrogen bonding with solvent are 
included. An advantage is the reduction in computational time taken to run the 
simulation.
The most accurate method of solvent simulation is the inclusion of explicit solvent 
molecules. The obvious disadvantage of this method is that the size of the calculation 
is significantly increased. For a more accurate calculation a method of simulating the 
effects of bulk solvent is also required. This can be accomplished by applying 
periodic boundary conditions (Figure 2-12). The solvent and solute ar e placed in a 
box of finite size which is suiTounded by images of itself. Molecules close to the 
edge of the real box will interact with image molecules in the surr ounding boxes 
minimising edge effects. If the motion of the molecule causes it to leave the 
simulation box an image molecule enters fr om the opposite face keeping the number 
of molecules in the system constant.
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Figure 2-12 : Au illustration of periodic boundary conditions, A molecule leaving the box is 
replaced by its image from an adjacent box.
2.3.4 Molecular Dynamics
Molecular- dynamics simulations allow atoms to move in space according to Newton’s 
laws of motion. The essence of molecular* dynamics (MD) is the numerical 
integration of Newton’s second law relating the mass and acceleration of an atom in 
the system to the gradient of the potential energy field. Given acceleration, an 
approximate velocity for the atom can be computed for a given period of time and 
changes in the atomic co-ordinates can be detennined. Newton’s second law gives :
Ft — imai Eqn 2-10
where F  is the force acting on a par*ticle, m its mass and a its acceleration. The force 
can be computed from the derivative of the potential energy E, so writing acceleration 
as the second derivative of position r gives
5£ 6 >
5r “ Eqn 2-11
The force and mass are known and therefore the acceleration can be calculated. This 
means that velocity and position can be determined fiom Newton’s equations of 
motion (equation 2-12).
Chapter 2 : Theory o f NMR and Simulation methods, 41
V = u + at 
r  = w/ +1 / la t 2 Eqn 2-12
A variety of algorithms have been used to integrate the equations of motion. The 
Verlet^ ** algorithm is the most common and computes the position vectors using 
forces and the previous positions of the atoms. To integiate the equations efficiently 
a small time step is required. The motion of the system can be described by a third 
order Taylor expansion.
r { t  + AG — r(G H-----Nt H—   Eqn 2-13bt 2
-  AG = r (G -  — A^+ Eqn 2-14bt b r  2
Combination of the above equations eliminates odd-order tenus to give Verlet’s 
algorithm for positions (Equation 2-15.). This equation leads to a neglect of higher 
order tenus.
r(t + At) = 2r(t) -  r(t + At) + —y  A^ .^ Eqn 2-15bt
Velocities can be estimated by the Leapfrog Verlet method (equation 2-16). v is the 
average velocity over a time step A t .
r{t + At) -  r{t) + vAt Eqn 2-16
It is assumed that v is approximately equal to the instantaneous velocity at the mid­
point of the time interval.
br AtV — — {t H--------) Eqn 2-17bt 2 ’
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V can be calculated from the mid-point of the previous intei-val and the average 
acceleration between and f+A^ :
v { t  +  a/S.t Eqn 2-18
The time step used for the simulation must be smaller than the highest frequency 
vibration in the system, which is usually the C-H stretch at time lO’ '^^ s. This means 
that a time step of typically 1 femtosecond, lO'^ s^ is used. The molecular dynamics 
time step can be increased by use of the SHAKE^’ algorithm. Here the C-H bond 
lengths in the system are fixed allowing a two-fold increase in the dynamics step size.
To stai-t a moleculai’ dynamics simulation a set of co-ordinates for the system aie 
needed. These are usually provided by a minimised stai ting conformation or a ciystal 
structure. This static structure must be heated computationally to the required 
temperature for the molecular dynamics run. The temperature of the system can be 
calculated from the kinetic energy of all atoms in tlie system.
1 3— imW" =  — NIcbT  Eqn 2-192 ^  2
The temperature of the system is increased giadually over a series of time steps and 
initial velocities are assigned at random fr om a Maxwell-Boltzmami distribution at 
the temperature of interest. This is designed to allow a slow heat build-up. Once the 
system has reached the required temperature, equilibration of the system follows by 
allowing the system to evolve spontaneously over a period of time where the 
equations of motion aie integiated until the average temperature and stmctuie aie 
stable. Velocities aie re-assigned periodically to the desired temperature. Once 
equilibrium is reached, the simulation may take place. This will typically be a 
simulation over a number of picoseconds where co-ordinates and velocities can be 
saved in a dynamics trajectoiy at periodic time steps. This trajectoiy represents the 
motion of the system with time.
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2.4 DETERMINATION OF PEPTIDE CONFORMATIONS
Application of the above methods to determination of peptide conformations can be 
accomplished in a number of different ways. Where experimental results from NMR 
or X-ray ciystallography aie available of sufficient quality these can be used with 
simulation methods to produce a tlnee-dimensional spatial stinicture for a compound.
In the absence of experimental data, it is possible to seai ch for low energy confonners 
of short peptides by simulation methods. For larger stmctures data from previously 
determined structures of proteins can be used to predict unknown confonnations.
2.4.1 Structure Refinement
Simulation techniques can be used in conjunction with experimental data from NMR 
results to build up a tlnee-dimensional spatial stmcture of a compound. Most 
experimental NMR data is in the form of NOE constraints which give rise to 
interatomic distances between different residues in the sequence. To allow for 
experimental eiTor in the evaluation of accurate NOE distances these are usually 
represented between a range of upper and lower bounds. J coupling constants also 
give possible constraints for dihedral angles^ .^ The tiaditional method for refinement 
is distance geometiy (DG)^^ Data is entered into a distance geometiy program as a 
series of distance constraints which are converted to Cartesian co-ordinates that fit the 
experimental data^ "^ . Those stmctures with the best fit of the experimental results are 
assumed to be the best conformations. Values obtained from Distance geometry may 
have high potential energy so the technique is usually applied in conjunction with 
minimisation or molecular dynamics^^.
Other methods include the use of restrained molecular dynamics^^ or simulated 
annealing for stmctuie refinement. NOE constraints aie usually applied by addition 
of a penalty teim in the potential energy function in the form shown in equation
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2-20, where A represents the force constant, Ri the distance in the simulation and R^qe 
the NOE estimated distance.
Epen — HA(Ri — RnoeŸ Eqn 2-20
Molecular dynamics methods may be inefficient because much of the computational 
time is spent evaluating potential energy functions. The use of MD in combination 
with distance geometry allows distance geometiy to produce an approximate stmcture 
that can be further refined by molecular dynamics. In an MD simulation the system 
has kinetic energy that allows energy baniers to be crossed and more conformations 
sampled.
Simulated annealing^ '^^  ^ methods apply NOE constraints to the system at elevated 
temperatures. The high temperatures allow the system more confoiinational freedom 
to move into the best conformation to fit the constraints. The system is then cooled 
slowly to OK using a molecular dynamics or Monte Carlo criteria and the molecule 
becomes ‘locked’ into a low energy conformation.
2.4.2 Location of Low Energy Conformations
Peptides of less than about 25 units long tend to exist under physiological conditions 
as a mixture of interconverting confonners rather than one specific confomiation. 
Techniques such as NMR will give details of an average stmcture that may not exist. 
A number of different methods have been applied to look for low energy 
conformations^^ of linear peptides.
In a systematic search of confonnational space for a molecule, internal variables in 
the system such as torsional angles are systematically varied and the stmcture energy 
minimised at each value to build up the multidimensional potential energy surface for 
that molecule. For small molecules all low energy confonnations can be obtained but 
this is not feasible for peptides except for those of less than around four units long
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because of the lai'ge number of steps in the search. Methods have been developed to 
refine this technique to enable its use with lai'ger peptides. The build-up^° method 
involves use of a smaller sub-unit of the peptide for a systematic search, from which a 
selected number of low energy stmctures aie saved and the rest of the molecule is 
added residue by residue, saving low energy stmctures only at each step. This 
method has the disadvantage that some low energy stmctuies may be discai'ded at 
each step.
Other methods of seai'ching confonnational space include molecular dynamics and 
Monte Carlo simulations. The Monte Carlo (MC) method is based on statistical 
mechanics and the random generation of an ensemble of confonnations^*. The 
Metropolis technique allows biasing of the Monte Caiio sampling to favour low 
energy conformations. Molecular dynamics simulations of up to a few nanoseconds 
can be used to locate low energy confonners for small peptides^^.
Quenched molecular dynamics involves computationally heating up the system to an 
artificially high temperature and mnning moleculai* dynamics at this elevated 
temperature. Structures aie saved at periodic time intervals and subjected to energy 
minimisation. This technique has been used to predict possible constrained 
conformations of biologically active compounds such as tufrsin^  ^ and has also been 
found to show similar* structures to those available from NMR data for the peptide 
bradykinin^"*.
2.4.3 Modelling of Larger Peptides and Proteins
The folded conformation of a protein is thought to be dictated solely by its primai*y 
structure. This opens up the possibility of being able to predict tlnee-dimensional 
structures fr om amino acid sequences alone. Molecular dynamics simulations are not 
available on such a time scale to be able to obsei*ve protein folding. A number of 
predictive teclniiques have been developed for prediction of structure in terms of 
regular secondai*y stmcture units from the protein sequence^^. These are usually at
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best 60% accurate, the best known being that of Chou and Fasman which predicts 
structure based on a-helix, (3-strand and reverse turn preferences of individual amino 
acids. Newer techniques such as those by Lim are based on stereochemical 
considerations of hydiophobic, hydrophilic and electrostatic properties of the side 
chains in the protein in terms of the structural mles of folded proteins. For smaller 
peptides the environment of the peptide, as shown by CD studies^^ will have a laige 
influence on structure.
Although over 15 000 protein sequences are known, tliere aie only around 400 
proteins of known stmcture. These aie contained in the Brookhaven Protein Data 
Bank^^, a database of known X-ray and NMR protein stmctures. Most predictive 
modelling of proteins usually stems from the fact that many sequences contain a high 
degree of similarity to sequences of stmctures whose conformations aie already 
Icnown from experimental techniques. With a good sequence homology (gieater than 
60%) it is possible to build up a good predicted stmcture, although the less the 
sequence homology the less reliable the model obtained. Once a similaiity match is 
found, an alignment procedure is applied to find the best match for the sequence. 
Many sequence aligmnent procedures aie readily available via internet resources. 
Once an alignment is made the sequence is divided into structurally conseiwed regions 
(SCRs) and structurally variable regions (SVRs). Regular stmctural regions are 
copied from the Imown sequences and a number of mles have been developed for 
assigning unknown loop regions'"  ^ which usually contain up to five residues. 
Sidechains are either copied from the model stmcture or can be refined by search 
techniques. Structures usually undergo further refinement by minimisation, 
molecular dynamics and simulated amiealing.
2.5 PRELIMINARY RESULTS FOR MET-ENKEFHALIN
The opoid penta-peptides Leu and Met-Enkephalin are natural peptides that have been 
extensively studied by various experimental and theoretical methods. These are short 
linear peptides known to adopt a large number of low energy confonnations in
Chapter 2 : Theory o f NMR and Simulation methods. 47
solution. In spite of extensive experimental and computational studies on these 
peptides and numerous enkephalin analogues^^ there is still uncertainty concerning 
the biologically active confonnation of the enkephalins and their solution 
conformation.
Met-enkephalin (Tyr-Gly-Gly-Phe-Met) was studied by *H NMR spectroscopy using 
two dimensional COSY and ROESY techniques and the results obtained were 
compared to previous studies. A 2ns molecular dynamics simulation of Met- 
enkephalin was earned out in the absence of solvent to see whether simulation 
techniques could reproduce the NMR results obtained.
2.5.1.1 NMR Results
The *H NMR assignment for Met-enkephalin is given in Table 2-1. The assignment 
was made from the *H spectrum and two dimensional COSY spectrum. The results 
give good agreement with previously reported assignments^**. Unfavourable 
coiTelation times for small lineai* peptides at frequencies of 300-500MHz^* meant that 
ROE interactions were examined because no NOE interactions were obseiwed. A 
schematic of the ROE interactions obtained for Met-enkephalin in H2O is given in 
Figure 2-13.
The results emphasise the flexible nature of Met-enkephalin peptide. ROE 
interactions occur between adjacent residues only, no long range interactions occur. 
This means the NMR results cannot be used to detennine the global minimum 
structure for Met-enkephalin.
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Table 2-1: II NMR Assignment for Met-Ënkephalin.
RESIDUE Chemical Shift (ppm)
aNH aCH pCH OTHER
TYR 4.04(t) 2.93(t) C(3,5)H 6.67(d)
C(2,6)H 6.95(d)
GLY 8.39(t) 3.65(d)
GLY 7.800) 3.69(d)
PHE 7.85(d) 4.44(q) 2.97(d) C(4)H 7.14(t)
2.79(q) C(3,5)H 7.06(t)
C(2,6)H 7.09(d)
MET 7.83(d) 4.07(5) 1.72(11) XCH2  2.24(11)
sCH3 1.84(d)
MET;TYR, PHEj
Figure 2-13 : ROE Interactions for Met-Enkephalin.
2.5.1.2 MD Simulations
Figure 2-14 shows the root mean square deviation of the Met-enkephalin structures 
from a common average structure over the course of the moleculai' dynamics run. 
The graph shows the flexibility of Met-enkephalin over the course of the run. Table
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2 - 2  shows a compaiison of the coupling constants derived from the molecular 
dynamics simulation and those obtained from the *H NMR spectrum. The results 
show good agreement and suggest that the moleculai* dynamics simulation gives a 
good estimation of the solution stmcture of Met-enkephalin.
T in *  ( ib )
Figure 2-14 : RMSD (Â) From Common Frame for 2ns Molecular Dynamics run of Met- 
enkephalin.
Table 2-2 : Calculated and experimental couplings for Met-enkephalin. Calculated constraints 
obtained using equation 2-2. Values were calculated for each value of phi over the trajectory 
and then averaged.
RESIDUE Calculated Couplings Experimental Couplings
GLY2 5.71 5.53
GLY3 5.54 5.88
PHE4 7.46 7.90
MET5 7.65 7.94
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2.5.2 Discussion
Although recent advances in NMR spectroscopy and molecular simulation techniques 
make it possible to examine the three-dimensional structure of a small protein, the 
results illustrated for Met-enkephalin demonstrate the difficulty in obtaining solution 
structures for flexible peptides. Tlie NMR and moleculai* dynamics simulations 
illustrate the flexibility of Met-enkephalin in solution. Other methods have been 
employed over the last 15 years to detei*mine the Met-enkephalin global minimum 
confoi*mation. Met-enkephalin has been studied by Monte Carlo simulations and the 
global minimum has been achieved^^. Other studies have concentrated on finding a 
number of low energy confonners by techniques such as quenched molecular 
dynamics’  ^ and stochastic dynamics^"'. Experimental studies of the enkephalins have 
involved X-ray ci*ystallogi*aphy and NMR spectroscopy. NMR studies have 
suggested the presence of specific structure but usually in the absence of long-range 
NOE effects^^. A number of different structures aie also available from X-ray data.
The flexibility of peptides makes study of their sti*ucture difficult because often no 
specific low energy structure is available.
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3.1 INTRODUCTION
Delicious (umami) Peptide* (Lys-Gly-Asp-Glu-Glu-Ser-Leu-Ala) is an eight residue 
linear food flavour peptide with a savouiy taste similai* to that of beef gravy. The 
peptide was first isolated by Yamasaki and Maekawa by treatment of beef meat with 
papaifr. The chemically synthesised peptide was found to exhibit the same savouiy 
flavour as the extracted compound. Delicious peptide, or BMP (Beefy Meaty 
Peptide) has also been found to occur naturally in aged beef \
In delicious peptide, lysine, a basic amino acid is present at the N terminal, whilst 
acidic amino acids (Asp-Glu-Glu) constitute the middle pait. The taste is thought to 
be produced by the combination of the basic N-terminal region with the acidic middle 
region of the molecule\ If the peptide is hagmented into smaller components, the 
combination of the shorter peptides Lys-Gly, Asp-Glu-Glu and Ser-Leu-Ala gives the 
same taste chaiacteristics as the entire eight residue peptide.
Further studies by Okai et ah'* suggest that the beefy flavour of the peptide stems from 
the presence of the Lys-Gly and Asp-Glu-Glu fragments and that the order of these 
fragments in the sequence is not relevant for the production of flavour. The Ser-Leu- 
Ala fragment appeal's to act only as a spacer between the basic and acidic fragments 
and does not contribute to flavour.
Previous confonnational studies of delicious peptide have been can ied out by Spanier 
and Miller\ The work was based on the assumption that delicious peptide is 
produced in muscle by proteolytic digestion of a parent protein such as papain. 
However a database search found no match for the sequence with muscle proteins, the 
closest match was found for the sweet tasting peptide monellin which contained four 
out of eight matching residues.
In this chapter, delicious peptide was studied initially by NMR spectioscopy to look 
for experimental evidence of a solution conformation. The NMR results reveal the
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flexible nature of the peptide with no single confonnation dominating. Molecular 
dynamics and quenched molecular* dynamics simulations were used to analyse the 
solution confonnations of delicious peptide and to search for possible low energy 
confonners. Further quenched molecular* dynamics studies were carried out on a 
number of delicious peptide analogues to search for similar str*uctur*al char acteristics 
and their* contribution to the savour*y (umami) flavour* of the peptides is discussed.
3.2 NMR STUDIES OF DELICIOUS PEPTIDE
Delicious peptide was studied initially by one-dimensional and NMR. The 
two-dimensional proton COSY and ROESY techniques were used to detennine 
resonance and sequence specific assignments for* the peptide and to look for* evidence 
of secondar*y structure. amide chemical shift values were compared for evidence 
of hydrogen bonding in the system.
3.2.1 Experimental
Samples of Delicious Peptide were obtained from the Institute of Food Research, 
Reading. The NMR spectra were acquired on Bruker Aspect 3000 and AMX- 
500MHz spectrometers. For* each experiment, 10-12mg of solid peptide were 
dissolved in a solvent of either D2O or* a mixture of 90%H20/10%D20. Solvent 
suppression was carried out by pre-saturation of the water* signal.
COSY®’’ spectra were obtained to confirm the resonance assignment of the individual 
residues in the peptide. The ROESY® technique was used for* sequential assignment 
of the residue connectivities and to give secondary structure infor*mation. The two- 
dimensional spectra were recorded with 256 by 4K datasets. The ROESY spectra 
were recorded with a radiofiequency field strength of 2KHz using a mixing time of 
400ms. A temperatur*e of 298K was used throughout.
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Amide temperature coefficients were measured by determination of amide proton 
chemical shift values over a temperature range of 5 to 35°C with values recorded 
every 3°C. The variation of chemical shift with temperature for each residue in the 
sequence was plotted and the gradient of the line gave the temperature coefficients for 
each residue.
3.2.2 Results
3.2.2.1 Proton Assignment
The proton NMR spectrum of delicious peptide in HgO is shown in Figure 3-1. The 
spectrum consists of three main areas; the region 7.8-8.T ppm contains the backbone 
N-H signals, the region 3.7-4.7 ppm contains the backbone a-carbon signals and 0-3.7 
ppm contains side chain signals from aliphatic carbons such as CH3 and CH2 groups. 
The lar ge peak in the centr e of the spectrum stems fi'om the H2O signal, which was 
pre-saturated.
The peptide contains only eight residues so spectral assignment was straightforward. 
Most chemical shifts could be assigned from simple coupling patterns in the 
COSY spectrum (Figure 3-2). Reference chemical shift values^ for amino acids 
were used to aid assignment. Where overlapping values occurred in the one­
dimensional spectrum, the signals were well resolved in the COSY spectrum and 
could be distinguished. Sequential assignments were made fiom the ROESY 
spectrum (Figure 3-3) using cross peaks between adjacent residues. This enabled the 
two Glu residues in the middle of the sequence to be distinguished. Table 3-1 
contains the complete proton resonance assignment for delicious peptide.
coupling constant values are also shown in Table 3-1. In each case a value of 
approximately 7 Hz is obtained. This value is typical for random coil peptide 
conformat ions*^C NMR chemical shifts were assigned from the ^^ C spectrum 
recorded. Reference values were used to aid assignment" and some ambiguities exist 
in the assignment. The values obtained are shown in Table 3-2.
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Figure 3-2 : H COSY Spectrum for Delicious Peptide in H2O. Spectrum shows seven NH-aCH 
interactions.
A
Figure 3-3 : H ROESY Spectrum for delicious peptide showing NH interactions with the rest of 
the peptide.
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Table 3-1 : H NMR Assignment for Delicious Peptide.
RESIDUE Chemical Shift (ppm) ^%H-Ca
NH CaH CPH OTHER (Hz)
L Y Sl 4.03 1.90 %CH2
ÔCH2
sCH2
1.47
1.60
2.98
GLY 2 8.57 4.00 5.00
ASP 3 8.36 4.71 2.88 7.24
GLU 4 8.24 4.30 1.98 xCH2 2.45 6.64
GLU 5 8.18 4.30 1.98 xCH2 2.45 6.60
SER6 8 .1 0 4.40 3.82 6.69
LEU 7 8.04 4.34 1.67 %CH
ÔCH3
1.67
0 .8 8
0.84
8.42
ALA 8 8.06 4.34 1.37 7.78
Table 3-2 : NMR Results for Delicious Peptide.
RESIDUE Ca* c p c% c s Cs c= o *
L Y Sl 53.00 30.25 21.17 26.35 39.70 174.25
GLY 2 42.35 170.76
ASP 3 48.89 35.53 174.25 171.48
GLU 4 53.40 25.81 30.03 177.14 173.30
GLU 5 53.20 25.48 30.03 177.05 173.25
SER6 55.50 60.88 170.31
LEU 7 52.23 39.25 24.22 22.17
20.65
174.13
ALA 8 50.09 16.19 172.54
* Assignment fi'om known resonance values only, some ambiguities may exist.
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3,2,2,2 ROE Interactions
Figure 3-4 shows a diagi'am of the ROE interactions found for delicious peptide. 
ROE patterns are obsei'ved between adjacent residues but there is an absence of long- 
range ROE effects. dc^N(i,i+l) sequential interactions are obtained in most cases but 
no dNN(i,i+l) interactions ai*e obseiwed. This suggests that average backbone angles 
contain (3-sheet rather than a-helical values because no d}^^(i,i+l) interactions, typical 
for torsion angles in the a-helix range, are seen‘^ . The backbone sequential 
comiectivities give an indication of backbone angles but do not give firm evidence of 
secondary stmcture conformation without evidence from other sources. Due to the 
absence of long range ROE interactions it can be assumed that no specific secondary 
structure elements exist in solution for delicious peptide and the stmcture is 
interconverting between a number of different conformations.
GLU 4 GLU 5 ALA,SE R ,GLY, A S P ,LYS
Figure 3-4 : Schematic of ROE Interactions for Delicious Peptide, Solid arrows indicate ROE 
interactions.
3,2.2.3 Amide Chemical Shifts
A  graph of the variation in the amide proton resonance's of the individual residues 
with temperature for delicious peptide gives similar straight lines for each of the 
different residues in the sequence and similar gradients (Figure 3-5). Therefore 
similar* values for temperature coefficient are obtained in each case. The results 
indicate that each of the residues in the peptide is involved in hydr ogen bonding to a
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similai' extent. Most hydi'ogen bond interactions occur between the peptide and 
solvent molecules and the stmctuie is a random coil.
aI
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Figure 3-5 : Graph of variation of H amide chemical shifts with temperature for delicious 
peptide. The gradient obtained in each case is similar for all residues.
3.2.3 Discussion
A complete resonance assigmnent was made for delicious peptide from COSY and 
ROESY spectra in H2O and D2O solution. Peptide conformation in solution was 
determined from the ROESY spectra, coupling constant data, and the change in amide 
chemical shift values with temperature. All results show a lack of specific 
confonnation for delicious peptide and suggest a large number of interconverting low 
energy confonnations exist.
Although it is generally accepted that flexible short linear peptides exist in numerous 
low energy states in solution’^  and that a particular conformation may only be adopted 
when the peptide comes into contact with a specific receptor, a number of exceptions 
are known. Short linear peptides aie present in solution in an ensemble of rapidly 
interconverting confonnations but in favourable cases, the population of one or more
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confonnations in an ensemble may be high enough for detection by NMR methods 
The first short peptide to show specific structure in solution was the ribonuclease A S- 
peptide fiagment'\ Other examples that have been reported more recently include a 
number of short protein fragments studied by Dyson et. al.‘® which show signs of 
secondaiy structure conformation.
Numerous methods have been developed to overcome the problem of peptide 
flexibility in solution. The use of a more polar aprotic solvent facilitates the 
formation of a specific stmcture because the ability of the peptide to hydrogen bond 
with solvent is reduced and therefore the peptide is more likely to hydiogen bond 
internally^’. This however leads to a stmcture that may not exist in aqueous solution 
and results obtained cannot necessaiily be related to the peptide in its natural 
environment. Other methods for determination of peptide stmctui e include foimation 
of cyclic analogues of lineai* peptides'®’*^ to reduce the flexibility of the peptide chain 
in solution.
Most modem biological multidimensional NMR methods for studying peptides and 
proteins work on the assumption that there is only one conformation or a limited 
number of conformations present in solution but this is not always the case and NOE 
constraints may result fr om a number of different confoimations present in solution. 
The use of conventional methods for assignment of constraints may suggest a 
conformation that is an average of a number of different conforaiers^” and therefore 
does not exist. Methods have been developed to account for multiple confoimations 
for peptides in solution^'. For example time-averaged methods apply NOE constraints 
as an average over the course of the moleculai' dynamics simulation to give more 
accurate results for peptide conformations’’"’^ . Where multiple solution 
conformations aie expected a number of methods have been developed for refinement 
by NOE data. Nikiforovich et. al. have studied enkephalin peptides using a 
combination of NMR data, Monte Carlo sampling and statistical evaluations to 
estimate amounts of different confoimers present in solution’'*'’^  Other Monte Cai'lo 
techniques available include confoimation population analysis’^ . Blackledge et. al.
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meanwhile have used multiconformational search teclniiques in conjunction with 
NMR data to propose possible confonners that coexist on tlie NMR timescale” .
3.3 SIMULATIONS OF DELICIOUS PEPTIDE
The NMR data presented previously shows the flexible nature of delicious peptide. 
With this in mind, molecular simulation techniques were used to look for possible low 
energy conformers of delicious peptide. Simulations were cairied out by 
conventional molecular dynamics techniques and also quenched molecular dynamics. 
The results show the flexibility of the system and indicate some of the low energy 
confonnations that may be important for the function of the peptide as a savouiy 
flavour.
3.3.1 Molecular Dynamics of Delicious Peptide
33.1.1 Experimental
Molecular dynamics (MD) simulations were earned out in the absence of solvent 
using a dielectric constant of 80 for 2ns and also in a 30 Â solvent box with periodic 
boundaiy conditions applied. The length of time needed for interactions using 
explicit solvent were such that it was not possible to run MD simulations for greater 
than 60ps and the final stmctures obtained in each case were biased by their staiting 
conformations. The staiting stmcture in each case was an energy minimised extended 
confonnation of the peptide in zwitterionic fomi. Molecular dynamics simulations 
were canied out using a time step of O.OOlps at 300K. The peptide was first heated to 
this temperature duiing 3-6ps of dynamics followed by 3-1 Ops of equilibration before 
the simulations were perfonned.
3.3.1.2 Results for Delicious Peptide
Simulations including explicit solvent show the peptide begin to coil round at the N- 
terminal Lys-Gly residues. The simulation occurs at a much slower rate due to the
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presence of water molecules than where solvent is not included. The course of the 
simulation was too short to show significant changes in stmcture and confonnations 
obtained were biased by the starting conformation.
A 2 ns molecular dynamics mn of delicious peptide was performed in the absence of 
solvent molecules using a dielectric constant of 80. Molecular dynamics trajectories 
were saved eveiy Ips. The results show the flexibility of the peptide in solution. 
During the simulation the straight chained peptide initially coils at the N-terminal 
Lys-Gly region due to the flexibility of the Gly residue. This is followed by coiling 
of the rest of the sequence to begin the foimation of a cyclic structure. Confoimations 
consist of mainly ‘s’ shaped coiled stmctures and cyclic forms over the molecular 
dynamics run. Figure 3-6 shows a schematic of snapshots of the confoimation of 
delicious peptide at eveiy 2 0 0 ps over the course of the molecular dynamics 
simulation.
A large number of interactions occur between the first 5 residues in the sequence. 
The long sidechains mean that there aie a laige number of possible hydiogen bonds 
that can be formed. The N-terminal Lysine residue has the ability to coil round and 
foim hydi ogen bonds with other paits of the molecule. The middle Glu residues also 
contain long sidechains with the ability to hydiogen bond to other parts of the 
sequence. A large number of hydiogen bonds aie foimed between the charged 
peptide gioups and to a lesser extent between other paits of the molecule. This 
suggests that the Ser-Leu-Ala fragment of the peptide is less important for the 
stmcture than the first five residues in the sequence. The results were mn in an 
absence of specific water molecules which means the possibility for interactions with 
solvent are not shown and the peptide is able to move into a number of different 
conformations during the moleculai' dynamics timescale.
Figure 3-7 shows a graph of the variation of N-teiminal Lys to C-teiminal Ala 
distance over time. The short value of this distance indicates the number of cyclic 
conformations formed and the amount of time spent in these cyclic confonnations
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over the course of the MD simulation. A number of sti'aight-chained confonnations 
are also present. Figure 3-8 shows the root mean square deviation of the peptide 
structure from an average conformation over the course of the moleculai' dynamics 
mn. This gives an indication of the flexibility of the system over the time scale of the 
simulation.
The moleculai' dynamics simulation was compaied to the experimental NMR results 
by estimation of ^ cou p l i ng s^ l  Values were obtained from the molecular dynamics 
simulation by calculating the value of the coupling constant fr om a Kaiplus type 
equation (equation 2 -2 ) for each value of the phi torsion angle for each trajectory 
recorded. An average value for the simulation was then calculated from these values. 
The values obtained give good agreement with those derived from experimental 
parameters (Table 3-3).
Table 3-3 : Comparison of calculated and experimental coupling constants for delicious peptide 
2ns molecular dynamics simulation. Couplings calculated from the value of the phi angle at each 
MD time step and then averaged.
RESIDUE MD Estimated 
Couplings 
(Hz)
Experimental
Couplings
(Hz)
Gly 5.40 5.00
Asp 7.28 7.24
Glu 7.87 6.64
Glu 6.80 6.60
Ser 7.04 6.69
Leu 7.41 8.42
Ala 7.29 7.78
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Figure 3-6 : Snapshots of peptide conformation during the 2ns Molecular Dynamics Simulation.
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Figure 3-7 : Graph of Variation of Lys-Ala distance over time for 2ns Molecular Dynamics Run 
of Delicious Peptide.
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Figure 3-8: RMS Deviation from Average Structure for Delicious Peptide during 2ns molecular 
dynamics run.
Chapter 3 : NMR and Modelling of Delicious Peptide 70
3.3.2 Quenched Molecular Dynamics of Delicious Peptide
Many techniques have been developed for the location of low energy confonnations 
of flexible molecules by calculational methods^ .^ Quenched molecular' dynamics^” 
simulations were used to analyse the confoi*mational space available to delicious 
peptide following the method previously outlined for Met-Enkephalin and other short 
lineal’ peptides by Smith et. al.^ *’^  ^ Quenched molecular dynamics involves the 
heating of the peptide computationally to an ai'tificially high temperature, I’unning 
molecular' dynamics at this temperature saving confor-mations to a trajectoi'y file and 
then minimising all the structures recorded during the course of the MD run. The 
high temperature is used to enable the peptide to explore confoi'mational space 
quickly and sample a number of different low energy confonnations. Thus quenched 
molecular dynamics simulations give information on low energy conformations that 
are adopted by the peptide.
3.3,2.1 Experimental
Quenched molecular dynamics calculations were performed as follows. In each case 
the star-ting structure was an initial fully extended conformation of the peptide in 
zwitterionic form. The structure was energy minimised using a combination of 
Steepest Descents and adopted-basis Newton Raphson (ABNR) algorithms to an rms 
deviation of less than O.OOlkcal m ol'\ Quenched Molecular' Dynamics were 
performed by heating the peptide to lOOOK computationally over lOps of dynamics, 
increasing the temperature by 5K every 50 time steps with a molecular dynamics time 
step of O.OOlps. The structure was then allowed to equilibrate at this temperature for 
a further lOps of molecular dynamics simulation. Quenched molecular dynamics 
were canied out for a further 60 Ops at this temperature. The co-ordinates of the 
peptide were saved to a trajectory file evei'y Ips giving a total of 600 conformations 
for further analysis. This method was repeated for delicious peptide at temperatures 
of 600 and 1 2 0 0 K.
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Each of the structures obtained was energy minimised to an rms derivative of less 
than O.OOSkcal mol"  ^using an adopted basis Newton-Raphson algorithm. Constraints 
were placed on all of the go dihedial angles in the molecule with a force constant of 
50kcal mol'^ to prevent the fonnation of cis peptide bond conformations during the 
high temperature quenched molecular" dynamics run.
The results show in all cases a Gaussian distribution of energies with the lowest- 
energy structures being those most likely to exist in solution at 300K (Figure 3-9). 
Low energy conformations were selected that were within 5kcal mol'^ of the lowest 
energy conforaiation. Each of these low energy conformers were categorised in terms 
of backbone dihedral angle ranges and in terms of backbone and sidechain
hydrogen bonds. The str-uctur es were sorted into families using structural similarities 
based on low rms deviations.
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Figure 3-9 : Potential Energy Histogram from Quenched Molecular Dynamics of Delicious 
Peptide.
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33.2.2 Preliminary Results
Quenched molecular dynamics simulations were performed at a series of different 
temperatures in order to establish optimum conditions for the dynamics mn. Table 3- 
4 shows the lowest energy stmctuies obtained at each temperature and the number of 
stmctures within 5kcal mol'^ of the lowest energy structure. It can be seen that the 
lowest energy stmctures were produced from quenched molecular dynamics earned 
out at lOOOK, although simulations at 600K produced a larger number of low energy 
conformations. Simulations at 1200K resulted in a higher value for the lowest energy 
confoimation.
Table 3-4 : Comparison of Quenched Molecular Dynamics at different Temperatures.
Temperature Lowest Energy No of structures
(K) Structure within 5kcal of
(kcal mol"') lowest structure
600 -30.0739 38
1000 -32.3000 28
1200 -29.8559 12
The quenched molecular dynamics mn at lOOOK gave the lowest energy structure and 
these results are expanded in detail in the next section.
3.3.3 Results for Delicious Peptide at lOOOK.
The 600ps molecular dynamics mn at lOOOK resulted in 600 stmctures for further 
analysis by minimisation. Although the initial starting stn.icture for the simulation 
consisted of an extended sti'aight chained peptide, during the quenched dynamics 
process, the stmcture was able to coil round and form a laige number of different 
confonnations. After minimisation, the range in energy of the minimised stmctures 
was -7 to -33 kcal mol ^ Figure 3-9 shows an energy histogram of the 600 minimised 
stmctures considered. The stmctures form a Gaussian type disti'ibution with the
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lowest energy structures being those most likely to exist in solution. Low energy 
stmctures were selected that were within 5kcal mol ' of the lowest energy 
confonnation for further analysis. This resulted in 28 low energy confonnations for 
further consideration.
The conformations obtained were categorised in groups according to the number of 
hydrogen bonds and other secondaiy stmctural elements present. The stmctures 
obtained at first glance can be divided into two broad categories, those with a cyclic 
conformation with hydrogen bonds from the N-teraiinus to the C-terminal of the 
peptide and those with a more coiled 'S' shape confonnation with interactions fiom 
the N-tenninal of the peptide (Lys-Gly) to the middle acidic portion (Asp-Glu-Glu). 
This is important because the flavour action of the peptide is thought to be produced 
from the combination of the initial Lys-Gly basic residues with the middle acidic 
(Asp-Glu-Glu) portion of the peptide. Of the cyclic stmctures, the cyclic forai is 
produced from either the N-tenninal Lysine or Glycine residue. The foimation of 
these cyclic structures gives lysine the ability to interact and foim a large number of 
hydi'ogen bonds with other sidechain and backbone chaiged gi'oups in the molecule. 
Delicious peptide contains a lai'ge number of chaiged gi'oups which means these 
groups can interact to foim hydi ogen bonds between separate portions of the peptide. 
In the conformations selected there are a lai’ge number of hydiogen bonds formed 
between side chain and backbone char ged groups.
3.3.3.1 Families o f Structures
The 28 selected low energy stmctures were sorted into different families of 
conformations according to ims deviations (Figure 3-10). Four families (F1-F4) of 
stmctures were found to exist, which accounts for two-thirds of the stmctures 
examined. No particulai’ trends were found between the non-family stmctures. The 
lowest energy stmctures obtained in each family are shown in Figure 3-11 to 3-14.
Chapter 3 : NMR and Modelling of Delicious Peptide 74
27
23
F4
F3
F2
93 5 71 11 13 15 17 19 21 23 25 27
□ 2-2.5
□ 1,5-2
■ 1-1.5
m0 .5-1
□ 0-0.5
Figure 3-10 : RMS Deviations between the 28 Low Energy Structures and the Families of 
Structures Formed.
Family FI contains the largest series of conformations with 6 low energy structures. 
These consist of cyclic type structures with hydrogen bonds existing in some cases 
between the N-terminal and C-terminal residues. In most cases other hydrogen bonds 
are found between the middle peptide residues. The structures are characterised by 
the existence of a hydrogen bond between the lysine sidechain NH group or the lysine 
backbone NH and the glutamic acid sidechain group at position 5 in the sequence.
Family F2 contains similar cyclic type conformations with more defined cyclic 
hydrogen bonds between the N-terminal Lys and C-terminal Ala, although the 
structures in general are of higher energy than those of FI. This group of structures 
also contain hydrogen bonding interactions between N-terminal Lys and the Glu(5) 
residue.
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Figure 3-11 : Lowest energy conformation for family FI.
Figure 3-12 : Lowest Energy conformation for family F2.
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Figure 3-13 : Lowest Energy Conformation for Family F3.
Figure 3-14 ; Lowest Energy conformation for Family F4.
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Family F3 contains the lowest energy stmcture of the quenched dynamics mn. The 
confonnations consist of 'S' shaped coiled structures with few backbone hydiogen 
bonds, the stmctures being stabilised by sidechain hydiogen bonding. These 
stmctures do not foim cyclic conformations, although the stmctures aie characterised 
by hydrogen bonds between backbone and sidechain groups in the coil.
Family F4 consists of coiled stmctures with hydrogen bond interactions in each case 
between the first five residues in the sequence (Lys-Gly-Asp-Glu-Glu) and in most of 
the confonnations, backbone hydiogen bonds exist to form a cyclic stmcture.
3.3.S.2 Lowest Energy Structure
The lowest energy stmcture is found in family F3 and contains hydrogen bonds 
between the N-teiminal Lys and middle Glu(5) sidechains. This stmcture was 
subjected to a 50ps moleculai* dynamics simulation at 300K (after heating and 
equilibration to temperature). The dynamics tiajectoiy suggests that the stiucture is a 
local minimum and no lower energy conformations were found over the course of the 
simulation.
Although this stmcture is the lowest energy conformation found during the coiuse of 
the quenched molecular' dynamics simulations, it is not possible to confirm that this 
conformation is the global minimum stmcture for delicious peptide. A systematic 
search of all possible torsion angles of delicious peptide would show the lowest 
energy stmcture^^ but this was not canied out here due to the time scales involved for 
the conformational search.
3.3.4 Comparison with NMR Data
Figure 3-15 shows the NOE violations on comparison of the low energy stmctures 
obtained with previous NOE data presented for delicious peptide. The graph suggests 
that most stmctures obtained give a good fit with the NOE data obtained from NMR
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experiments. NOE constraints for a peptide usually represent an average stmcture 
and any specific constraint can be the result of an average between more than one 
type of confonnation. For this reason constraints fiom NMR data are now often 
applied as 'time-averaged'^"'^  ^constraints over the coui*se of a molecular dynamics mn. 
This means that a given low energy conformation may not fit all of the NMR results, 
especially in the case of a flexible molecule.
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Figure 3-15 : NOE Constraint Violations. Clear diamonds represent the number of distance 
violations. Solid squares represent the total amount of violations (Â)
3.3.5 Discussion
Modelling studies suggest that the flexibility of delicious peptide stems in part from 
its ability to foim a laige number of hydrogen bonds between charged side chain 
groups. Both the 2ns molecular dynamics run and the quenched moleculai* dynamics 
results suggest that during the timescale of the simulation an extended confoimation 
of delicious peptide will coil round to foim a large number of cyclic and coiled 
conformations stabilised by hydiogen bonds between the backbone and lengthy 
sidechains present in the sequence. The long sidechain of lysine at the N-tenninal
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means that this residue has the ability to coil round, especially next to the flexible 
glycine residue, to foim hydrogen bonding interactions with all other parts of the 
molecule. The largest number of hydiogen bonds exist between the first five residues 
in the sequence (Lys-Gly-Asp-Glu-Glu) because of the larger number of chaiged 
sidechain groups present in these residues.
The results suggest that the hydrogen bonding ability of the sidechains and their 
ability of foim hydrogen bonds with each other may be the main interaction that 
occurs between these gioups and the flavour receptor to form the delicious peptide 
taste. This is looked at more deeply in the next section.
Quenched moleculai' dynamics simulations were used successfully to search for low 
energy confonnations that contribute to the confonnation of delicious peptide and that 
may be important for stmctural properties. It is not possible to say whetlier die global 
minimum sti'ucture has been reached without comparison with a systematic search of 
all possible conformers for delicious peptide.
3.4 QUENCHED MOLECULAR DYNAMICS OF DELICIOUS 
PEPTIDE ANALOGUES
A new study by Okai et al  ^has suggested that the important factor for production of 
flavour is the combination of the basic (Lys-Gly) and acidic (Asp-Glu-Glu) 
components in delicious peptide. The results suggest that the order of these 
components in the peptide is not always important for flavour, although the intensity 
of the flavour may be affected by the peptide sequence and other flavour 
characteristics may be present. A series of delicious peptide analogues were studied 
by quenched molecular dynamics to suggest stmctural properties to explain the 
production of savoury (umami) flavour char acteristics in these compounds.
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3.4.1 Experimental
Quenched moleculai* dynamics simulations were i*un by the method outlined 
previously (section 3.3.2.1). The peptides studied are listed in Table 3-5 with their 
minimised starting stmcture energy and flavour chaiacteristics (obtained fiom 
reference 5), if known.
Table 3-5 : Starting Structures of Delicious Peptide Analogues. Flavour characteristics obtained 
from reference 4. (Umami indicates a savoury flavour).
Peptide Energy 
(kcal mol'^)
Flavour^
Lys-Gly-Asp-Glu-Glu-Ser-Leu-Ala -19.1156 Umami/Sour
Lys-Gly-Ser-Leu-Ala-Asp-Glu-Glu -16.1820 Sour/Umami/sweet
Ser-Leu-Ala-Asp-Glu-Glu-Lys-Gly -19.6415 Umami/Sour
Ser-Leu-Ala-Lys-Gly-Asp-Glu-Glu -22.0181 Sour/Umami
Asp-Glu-Glu-Lys-Gly-Ser-Leu-Ala -20.0965
Asp-Glu-Glu-Ser-Leu-Ala-Lys-Gly -22.2239
Lys-Glu-Asp-Glu-Glu-Ser-Leu-Ala -25.7456
Lys-Gly-Asp-Glu-Glu-Ser-Leu -16.2038
Lys-Gly-Asp-Glu-Glu -15.6081 Sour/Salty/Sweet
3.4.2 Results
The peptides studied tend to adopt similar confomiations in each case. The main 
stmcture stabilisation element is the formation of hydiogen bonds between the 
backbone and the chaiged side chain groups present. Delicious peptide contains 4 out 
of 8 chai'ged sidechains which aie able to forni hydiogen bonds between other 
charged gioups in the molecule and also with solvent in solution. The results for the 
delicious peptide analogues aie summaiised in Table 3-6. The different peptides 
studied all show the ability to foi*m coiled confoi*mations depending on the sequence 
of their amino acids. The sti'ucture of the eight residue peptides was reliant on the
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order of the residues in the sequence, the main stabilisation factor of the peptides 
being the ability to fonn side chain hydiogen bonding interactions.
Table 3-6 : Results summary for Quenched Molecular Dynamics of Delicious Peptide Analogues.
Peptide Low Energy 
Structure 
(kcal mol' )^
Structures 
within 
5kcal mol^
No of Clusters 
(>3 members)
Structure
Characteristics
KGDEESLA -32.30 28 4 Cyclic and coiled
(iinsd 1.8) structures
KGDEE -16.7853 74 5 Similar pattern of bent
(imsd 1.8) stmctures
KGDEESL -23.7445 93 11 Lai'ge number of low
(4kcal mof^) (nnsd 2.3) energy structures
KEDEESLA -31.9570 47 8 Straight and bent
(rmsd 2.5) structures formed
DEEKGSLA -30.3149 29 5 Cyclic and coiled
(rmsd 2.3) stmctures
KGSLADEE -31.0293 48 7 Coiled, bent and
(nnsd 2.2) straightchain structures
SLAKGDEE -30.9882 33 4 Cyclic and coiled
(nnsd 1.9) sti'uctures
SLADEEKG -30.9116 63 10 Bent structures
The eight residue peptide analogues form similar conformations to delicious peptide 
in each case such that a large number of hydrogen bonded structures are foimed. The 
long sidechains in each of the peptides enable hydrogen bonds to form between 
different residues when a different sequence order is present. The fonnation of 
hydrogen bonds appears to be the most important factor for structural stability.
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Where the order of Üie eight residue peptide is switched at the middle and end 
segments (Lys-Gly-Ser-Leu-Ala-Asp-Glu-Glu) (Figure 3-19) cyclic forms of the 
peptide are no longer seen; the sti'uctures formed aie coiled and bent or are straight- 
chained. However the basic and acidic residues are still able to interact in the coiled 
stmctures by hydrogen bonding.
Peptides starting with the Ser-Leu-Ala hydiophobic fragment show differing 
confonnations. The (Ser-Leu-Ala-Lys-Gly-Asp-Glu-Glu) peptide (Figure 3-17) 
adopts similar' conformations to delicious peptide with cyclic and coiled 
conformations formed and a similar number of low energy conformations seen. 
Meanwhile (Ser-Leu-Ala-Asp-Glu-Glu-Lys-Gly) shows only bent and coiled 
conformations (Figure 3-18). A larger number of low energy conformations are 
found and a much larger number of clusters of similar' conformations exist. The 
energy of the lowest-energy conformers is similar in both cases.
Peptide Asp-Glu-Glu-Lys-Gly-Ser-Leu-Ala (Figure 3-16) shows cyclic and coiled 
str'uctures with coiled helical sti'uctures predominating. The peptide shows hydrogen 
bonding between side chain residues to similar* delicious peptide.
Figure 3-16 : Stereo View of Lowest Energy DEEKGSLA Structure.
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Figure 3-17 : Stereo View of Lowest Energy SLAKGDEE Structure.
Figure 3-18 : Stereo View of Lowest Energy SLADEEKG Structure.
Figure 3-19 Stereo View of Lowest Energy KGSLADEE Structure.
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Figure 3-20 : Stereo View of Lowest Energy KEDEESLA Structure.
Figure 3-21 ; Stereo View of Lowest Energy KGDEE Structure.
Figure 3-22 Stereo View of Lowest Energy KGDEESL Structure.
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The (Lys-Glu-Asp-Glu-Glu-Ser-Leu-Ala) peptide (Figure 3-20) shows much less 
conformational freedom than the other peptides due to the loss of the flexible Gly 
residue in the sequence. This means that the Lys residue loses some of its ability to 
coil round and foim hydrogen bonded structures with other residues in the sequence. 
This results in less hydiogen bonds between sidechain groups in the peptide. The low 
energy confonnations formed consist of bent and straight chained compounds, rather 
than coiled and cyclic confoimations.
The five residue analogue (Lys-Gly-Asp-Glu-Glu) (Figure 3-21) forms a high number 
of low energy structures. The structures tend to adopt similar confoimations in each 
case consisting of cyclic or bent structures. The shorter length of the sequence means 
that the foimation of cyclic structures is less likely and a large number of triangular 
bent structures exist. Most of the confoimations obtained ai e similar in structure.
The 7 residue analogue structure (Lys-Gly-Asp-Glu-Glu-Ser-Leu) (Figure 3-22) 
contains a large number of low energy conformations within 5 kcal m of’ of the 
lowest energy structure. This suggests that the peptide has more conformational 
flexibility than delicious peptide itself. The peptide has the ability to foim similai' 
coiled and cyclic foims to delicious peptide and some straight-chain conformations 
are also present. A large number of different clusters of confoimations aie formed. 
This peptide shows the most flexibility of all the compounds studied.
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Figure 3-23 : Hydrogen Bonding Interactions for Delicious Peptide Analogues. All residues in 
the sequence (all), backbone (bb) hydrogen bonds only, hydrogen bonds between kgdee residues 
(kgdee). Peptides with less than 8 residues (kgdee and kgdeesl) will show less interactions for the 
first two categories.
Figure 3-23 shows the average number of hydrogen bonds observed for the different 
delicious peptide analogue low energy structures. The results show similar backbone 
interactions in most cases with side chain interactions varying with the differing 
sequence of residues. Wliere the Lys-Gly basic dipeptide is present at the beginning 
of the sequence, more interactions are seen because the Gly residue gives these 
residues more conformational freedom. Interactions between the basic and acidic 
residues are similai' in most cases.
3.4.3 Discussion
The results suggest that the most important factor for production of the delicious 
peptide savoury flavour is the ability of delicious peptide and similar peptide 
analogues to form low energy confonnations that enable the basic and acidic regions 
of the peptide to interact. The structure of delicious peptide is such that there me a 
lai'ge number of charged groups present in the sequence which can interact and form
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hydiogen bonds between themselves as well as with water solvent in solution. The 
presence of the Lys-Gly and Asp-Glu-Glu regions in delicious peptide is thought to 
be important for the production of delicious peptide flavom* due to interaction 
between these two peptide fragments. A model of a flavour receptor for savouiy 
compounds involves ‘cationic’ residues interacting with acidic residues and thus with 
the taste receptor. This model agrees with the results obtained. The modelling results 
suggest that the Lys-Gly and Asp-Glu-Glu residues must be present at a distance 
where it is possible for the two groups to interact by hydiogen bonding to foim the 
flavour.
Previous experimental results have shown that peptide analogues of delicious peptide 
with different fragment orders possess some measure of savouiy (umami) flavour. 
This suggests that the spatial structure of the peptide is not important for flavour 
production. However this does not explain why the intensity of the flavours vaiy and 
in some cases other flavour characteristics aie present when the order of the peptide is 
altered. If the flavour was produced only by the interaction of the Lys-Gly (KG) and 
Asp-Glu-Glu (DEE) groups then the penta-peptide KGDEE should show similai’ 
flavour chaiacteristics to delicious peptide, which is not found to be the case. The 
KGDEE peptide contains a predominantly salty flavour, although a slight umami taste 
also exists. This implies that the flavour is induced by more than just the presence of 
basic and acidic residues in the sequence.
The eight residue peptides listed with flavoui* characteristics in Table 3-5 all possess 
the umami flavour to some extent. The SLADEEKG peptide possesses the strongest 
umami flavour where the acid/basic sequence is present in reverse. The 
confoimations of SLADEEKG peptide aie similai’ to those found for delicious 
peptide, although bent rather than cyclic conformations aie formed. This peptide 
possesses a strong umami flavour, similai’ to that found for delicious peptide. The 
SLAKGDEE peptide shows similar confoimations to delicious peptide but does not 
register such a strong umami flavour. The SLADEEKG peptide shows a sti’onger
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umami flavour. This may be due to the Lys-Gly dipeptide being present at the C- 
temiinus.
The quenched molecular dynamics simulations suggest that the peptides foim coiled 
and cyclic foims that stabilise low energy confoimations by hydiogen bonds. Where 
these types of confonnations aie not adopted, e.g. in the peptide KEDEESLA, the 
results suggest that the umami flavour is not present. In this peptide the Lys-Gly 
dipeptide fragment containing a salty flavour is replaced by the Lys-Glu dipeptide 
which possesses a sour flavour. The results obtained here suggest this peptide will 
not adopt the umami flavour. The loss of the Gly residue limits the flexibility of the 
peptide and therefore changes the conformation of this peptide.
The KGDEESL peptide was found to have more confoimational freedom than 
delicious peptide and a lai'ge number of clusters of conformations were foimed. The 
results suggest this peptide will show some measure of umami flavour.
It can be noted from Table 3-6 that for those peptides with the same composition of 
amino acids but different sequences, the lowest energy confoimation obtained was 
that for delicious peptide. This peptide also showed a small number of clusters of 
conformations compaied to other peptide sequences.
Other flavour peptides are known to produce flavour by interaction of different 
groups in the molecule, such as sweet and bitter flavours. For the savoury peptides 
the distance between the main flavour constituents appeal's to be less important than 
for sweet peptides^^ Nakumura and Okai have suggested that the receptor for 
sweetness and bitterness is the same due to the similaiity in models for sweet and 
bitter receptors^’. Spanier et. al. have suggested that savouiy taste can be added to 
this model based on confoimational studies of delicious peptide®. Their model of the 
sti'ucture of delicious peptide based on matching the sequence with protein 
confoimations suggests a straight-chained stmcture. From this it was infeiTed that the 
savouiy taste is recognised at a similar receptor to sweetness and bitterness. The 
results presented here and the previous study by Okai et. al. suggest that the
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perception of savoury flavour however is different to that for sweetness and bitterness 
and the same receptor is not used for each of these flavour perceptions. The distance 
between the two interactions that produce the savouiy flavour (for example the acidic 
and basic fragments of the peptide) is not important for production of flavour.
3.5 CONCLUSIONS
The results outlined in this chapter show the flexible nature of the savoury flavour 
delicious peptide. The NMR results show that no specific solution conformation of 
delicious peptide is present and the peptide in solution adopts a random coil 
confoimation. A simulation of the solution conformation of delicious peptide was 
carried out in vacuo using a dielectric constant of 80 to simulate solvent effects. The 
flexibility of the peptide could be seen from this moleculai* dynamics simulation by 
obseiwation of the change in peptide sti'ucture with time over the course of the MD 
run. Quenched molecular dynamics simulations of delicious peptide suggest that low 
energy conformations aie important for the flavour chai acteristics of the peptide. The 
peptide is found to form clusters that adopt coiled or cyclic conformations. An 
important factor in the foimation of different confoimations is found to be the 
chai'ged sidechain groups present in delicious peptide that may hydrogen bond with 
each other to foim stable stmctures.
Delicious peptide analogues aie shown to adopt similar low energy confoimations to 
delicious peptide when subjected to quenched moleculai' dynamics simulations. The 
results suggest that hydiogen bonding is a key factor for production of the delicious 
peptide flavour and that interaction of basic and acidic gioups is important for 
savoury (umami) taste.
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4.1 ABBREVIATIONS
The following abbreviations aie used in this chapter for protecting groups and 
reagents.
Amino-protecting groups
Boc- f-Butoxycarbonyl Me^C-OCO-
Fmoc- 9-Fluorenylmethoxycarbonyl
Trt Triphenylmethyl (C6H5)3C-
Carbonyl-protecting groups
-OBu/- t-Butoxy, -OCMe^
Other side-chain-protecting groups
Bu'
Mtr
Pmc
-Opfp
-Odlibt
Reagents
ACN
CAPS
DMF
EDT
HOBT
SDS
TFA
TFE
^-butyl- MegC-
4-Methoxy-2,3,6-trimethylbenzene sulphonyl- 
Pentainethylchi'oman sulphonyl- 
Pentafluorophenoxy- (pentafluorophenyl ester ) 
3,4-Dihydi*o-4-oxo-benzotriazine-3-oxy
Acetonitrile
3-cyclohexylamino- 1-propanesulphonic acid
Dimethylformamide
1,2-ethanedithiol
1 -hydi'oxybenzotriazole
Sodium dodecyl sulphate
Trifluoroacetic acid
Trifluoroethanol
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Miscellaneous
CE
Fab-MS
FPLC
HPLC
Capillaiy Electrophoresis 
Fast atom bombardment Mass Spectrometry 
Fast protein liquid chromatogi'aphy 
High-performance liquid chiomatogiaphy
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4.2 INTRODUCTION
This chapter outlines the solid-phase Fmoc-polyamide synthesis and characterisation 
of the antimicrobial peptide Lactoferricin B. The sequence of lactoferricin B is as 
follows (section 1.5.2.2.).
5 10
PHE-LYS-CYS-ARG-ARG-TRP-GLN-TRP-ARG-MET-LYS-LYS-LEU-
15 20 25
GLY-ALA-PRO-SER-ILE-THR-CYS-VAL-ARG-ARG-ALA-PHE
Lactoferricin B was synthesised using standard solid phase Fmoc polyamide 
synthesis. After synthesis the peptide was purified by FPLC and HPLC and 
characterised using amino acid analysis and mass spectrometry. This chapter gives an 
outline of Fmoc-polyamide synthesis designed to give a brief overview of basic 
principles and experimental details, followed by specific information on the synthesis 
and characterisation of lactoferricin B peptide.
4.3 BASIC PRINCIPLES OF SOLID PHASE FMOC POLYAMIDE 
SYNTHESIS
4.3.1 Introduction
Solid phase peptide synthesis techniques were originally developed by Merrifield in 
1963* and have subsequently proven to be the method of choice for production of 
peptides. To form a peptide bond between two structurally similar amino acids, the 
amino gi'oup of one amino acid and the carboxy group of the other must be protected 
to prevent their participation in the reaction and to ensure the formation of only one 
product. Reactive functional groups present in the side chains of some amino acids 
will also need protection to prevent their participation in the reaction. Any protecting 
groups used must be easy to introduce, chemically stable under the conditions of 
peptide synthesis, able to protect the adjacent chiral centre from racemization and
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easily removable under mild conditions at the end or during intermediate phases of 
the synthesis. Permanent protecting groups will be present thioughout the synthesis 
to prevent side-chain reactions. Temporary protecting groups are used for the 
individual step-wise addition of residues and these must have the ability to be 
removed easily in conditions not affecting the permanent protecting groups.
The original method as developed by Merrifield uses tertiary-butoxycarbonyl (Boc) 
gi'oups as temporary protecting groups tliroughout the synthesis. These are removed 
using trifluoroacetic acid (TFA) after each residue addition. Solid phase synthesis 
proceeds from the carboxyl end of the peptide, the opposite end to that used in protein 
biosynthesis. N-a-protected amino acid residues are added sequentially to an 
insoluble polymeric resin. Cleavage of the peptide from the resin at the end of the 
synthesis is carried out using strong acid such as hydr ogen fluoride (HF).
In Boc solid phase peptide synthesis repetitive acidolysis is needed for deprotection 
after addition of each amino acid. This can lead to alteration of sensitive peptide 
bonds and acid catalysed side reactions^. Consequently a new approach to solid- 
phase peptide synthesis was developed, namely ftom the use of a-amino blocking 
groups that can be removed under non-acidic conditions. The 9- 
fluorenylmethoxycarbonyl (Fmoc) group was introduced as an alternative protecting 
group in 1978  ^ since when it has undergone many refinements and Fmoc polyamide 
synthesis has become established as an alternative method to Boc solid phase 
synthesis for the formation of peptides. A description of Fmoc poly-amide synthesis 
follows and more information on this subject can be found in references 2, 4 and 5.
4.3.2 Fmoc Poly-amide Synthesis
Solid phase synthesis proceeds with the amino acids added stepwise to a polymer 
support. In Fmoc poly-amide synthesis this is a polar polyamide support well 
solvated by polar aprotic media such as DMF. The 9-fluorenyl methoxycarbonyl 
(Fmoc) derivatives are used for N-a-protection. These can be easily removed by the
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secondaiy base piperidine to allow the coupling of the next Fmoc protected amino 
acid cai’boxylic group to the a-amino group of the now N-a-deprotected amino acid 
residue. The coupling process for each amino acid is earned out using either a 
coupling reagent or pre-activated species to make the reaction more efficient. The 
synthesised product is obtained after the simultaneous removal of the peptide fi*om 
the resin and deprotection of side-chain groups usually by trifluoroacetic acid (TFA). 
An outline of Fmoc polyamide Synthesis for a simple dipeptide coupling is given in 
Figure 4.1.
Side ciiains protected as acid 
labile t-butyl derivatives Reference amino acid Norleucine
OCHjCO-Nle-NH-PoIyamide resinH,NCHCO-OCH,-CHCHjOCONHCHCO,H
Polar polyamide support 
solvated by dipolar aprotic 
solvents
Reversible 
linkage agentBase-labile Fmoc protecting group
Amino acids activated 
as anhydrides or active 
esters
Figure 4-1 ; Fmoc Polyamide Synthesis - A simple dipeptide coupling''.
The process of polyamide Fmoc synthesis lends itself to automation. It is possible to 
automate the entire process or just the addition of a single residue by interface of the 
synthesis equipment to a computer.
4.3.3 FMOC PROTECTING GROUP
The fluorenylmethoxycarbonyl (Fmoc) strategy for solid phase synthesis uses t-butyl 
based side-chain protecting groups cleavable by a single mildly acidic treatment. 
This combination of side-chain and cai'boxy-terminus permanent protecting groups 
requires temporary protection of the a-amino tenninus with a group of entirely
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different lability (Figure 4-2). The Fmoc amino-protecting group (1) owes its base 
lability to the special characteristics of the dibenzocyclopentadiene structure. 
Resonance stabilisation of the derived cyclopentadienyl anion (2) impai'ts exceptional 
acidity to the 9-hydrogen atom of (1) enabling its removal by bases such as piperidine 
by initiation of a p-elimination reaction.
C CHj-OCO-NH-CHR-CO-CH-CHj-OCO-NH-CHR-CO-
STABILIZED CYCLOPENTADIENYL ION (2)
AMINO
ACID
OR PEPTIDE
FMOC GROUP (I) Elimination
PIPERIDINE
COj+HjN-CHR.CO-+ -OCO-CHR-NH-CO-
CH-CHj DEPROTECTED 
AMINO ACID 
OR PEPTIDE
ADDUCT FORMED WITH PIPERIDINE (5)
Figure 4-2 : Resonance stabilisation of the Fmoc protecting group .
4.3.4 Activation Procedures
The formation of the peptide bond under mild reaction conditions generally requires 
activation of the carboxy group to achieve high coupling efficiency. There aie two 
main methods of activation used, namely the formation of symmetric anhydrides or 
activated esters of the Fmoc amino acids^.
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4.3.4.1 Symmetrical Anhydrides
Symmetrical anhydrides of acylamino acids can be used for the activation of amino 
acids during synthesis. These ai'e relatively stable and can be stored for long periods 
but aie commonly prepared immediately before use. Fmoc amino acids are reacted 
with dicyclohexylcarbodiimide to form the symmetrical anhydiide (Figure 4-3). The 
two reactive caibonyl gioups contained in the symmetiical anhydride are identical 
with the same acylated product being obtained through attack at either gioup.
CHCHjOCO-NHCHRCO-O-COCHRNH-COOCHjCH
Figure 4-3 : Symmetrical Anhydride of an Fmoc amino acid.
4.3.4.2 Activated esters
The alternative to symmetrical anhydrides is to use activated esters for amino acid 
activation. These aie more stable and can be stored for extended periods at low 
temperature and used as required. Although simple alkyl esters of protected amino 
acids undergo aminolysis at too slow a rate to be generally useful for peptide 
synthesis, phenyl esters aie more reactive and if electronegative substituents are 
present in the aromatic ring, may react at rates approaching the symmetrical 
anhydrides. Activated esters are easily prepared and may be stored for long periods 
without decomposition.
The most successful results have been obtained using pentafluorophenyl (Pfp) esters 
(Figure 4-4). Although these react slower than the symmetrical anhydrides, their
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reactivity is increased significantly by use of the catalyst hydi'oxybenzotriazole 
(HOBT).
CHCHjOCO-NHCHRCO-O-/^ %>— F
Figure 4-4 : Fmoc Amino Acid Activated by PFP Ester Group
Preparation of these activated esters is usually straightforward for all amino acids 
except for the very soluble derivatives of Fmoc-O-t-butyl serine and Fmoc-O-t-butyl 
threonine which fail to ci*ystallise. For these amino acids the analogous esters of 3- 
hydroxy-4-oxodihydrobenzotriazine (Dhbt esters ) aie used (Figur e 4-5).
CHCHjOCO-NHCHRCO-O^'
Figure 4-5 : Fmoc amino acid containing Dhbt Ester Group (used for Ser and Thr amino acids).
4.3.5 PERMANENT PROTECTING GROUPS
Although temporai'y Fmoc protecting groups are used during the course of the 
synthesis, side-chain protecting groups ar e also needed because more than half the 
commonly encountered amino acids contain functional side-chains such as acidic 
carboxy groups, basic residues, hydi'oxyamino acids, sulphur containing amino acids 
and heterocyclic rings. The most commonly used side chain protecting groups are t-
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butoxycai'bonyl (Me^C-OCO) or Boc amino acid derivatives. These aie unaffected by 
catalytic hydi'ogenation, but are cleaved completely under relatively mild acidic 
conditions such as Trifluoroacetic acid (TFA) at room temperature.
But OBut BOC
Fmoc * Ser - Asp - Lys -COO CH2- >- OCH, - polyamide
Piperidine TFA
Figure 4-6 : Protecting Groups used in Fmoc Synthesis .
Simple side-chain hydroxy groups (e.g. Ser, Tin) can be easily protected as t-butyl 
ether derivatives. The thiol group of cysteine is a special case which must be 
protected as the thioetlier or the mixed disulphide. The most commonly used 
protecting groups ar e shown in Figure 4-6.
4.3.5.1 Arginine Protecting Groups
Problems occur with the protection of the guanidino gr oup of arginine due to its high 
basicity (pKg 12.5). Boc derivatives of arginine are inadequately protected and may 
be unstable thereby giving unsuccessful results when used as protecting groups in 
synthesis. For this reason alternative protecting groups for arginine have been sought.
The most commonly used arginine protecting gr oups have been the No-arylsulphonyl 
arginines such as the 4-methoxy-2,3,6-trimethyl derivative (Mtr) shown in Figure 4-7. 
The main problem with the Mtr group is the time required for deprotection. For 
peptides containing multiple arginine residues, prolonged treatment in TFA of 
sometimes up to 16 hours or more is necessary for complete cleavage of the peptide.
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This call cause problems for acid-sensitive amino acids in the sequence such as 
tiyptophan and methionine.
Me Me
MeO
Me
Fmoc-NHCHCOjH
Figure 4-7 : Fmoc Arginine Amino Acid protected by Mtr Group.
A new protecting group has been developed where the sulphonyl cation is stabilised 
by addition of a 4-oxygen substituent. The Nq-2,2,5,7,8-Pentamethylchroman-6- 
Sulphonyl-L-Ai'ginine^ (Pmc) protecting group is cleaved in trifluoroacetic acid at a 
much quicker rate (as fast as 20 minutes per residue), avoiding the long deprotection 
times which can adversely affect more sensitive residues in the sequence. The Pmc 
protecting group is shown in Figure 4-8.
Me Me
Me'
SOg-
MeMe
Figure 4-8 : Pmc Arginine Protecting Group.
One significant side reaction has been detected with this protecting group. In 
sequences containing both arginine and tryptophan, the cleaved Pmc group may 
partially substitute into the indole nucleus of a tryptophan residue^’^ . Other aiyl- 
sulphonyl protecting groups are being considered as alternative protecting groups^.
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4.3.6 RESIN CLEAVAGE AND DEPROTECTION
The deprotection of any permanent protecting groups and the removal of the peptide 
from the polyamide resin is performed in a single step after all amino acids in the 
sequence have been added. Problems may occur due to side-reactions between side- 
chain protecting groups that are liberated as stable cations during TFA cleavage and 
deprotection. The majority of these side-reactions involve modifications of acid 
sensitive amino acid residues such as Tip, Met, Tyi' and Cys by TFA-liberated 
protecting groups such as the Mtr and Pmc groups. Deprotection is stiaightfbiwaid in 
TFA if no difficult amino acids aie present in the sequence, otheiivise the 
deprotection may require the use of scavengers to prevent addition reactions 
occuning.
Scavengers are reagents that trap reactive TFA-liberated carbonium ions and thereby 
prevent them from undergoing deleterious side-reactions with sensitive amino acid 
residues. 1,2-Ethanedithiol (EDT) is an efficient scavenger for tBu, Boc and Trt side- 
chain protecting groups. Acid catalysed Met oxidation is suppressed by the presence 
of anisole which is also known to accelerate Aig(Mtr/Pmc) removal in TFA and in 
addition helps to remove a great variety of benzyl-based side-chain protecting groups 
with linkages that aie stable to cleavage in TFA alone. The presence of Phenol aids 
Ai’g(Mtr) removal and offers some protection to Tyr and Tip groups.
4.4 LACTOFERRICIN B SYNTHESIS
Lactoferricin B was synthesised using conventional solid phase Fmoc polyamide 
synthesis. Problems that occuned in the synthesis were due to the five aiginine 
residues in the sequence. Arginine has a high basicity which means that Boc 
protecting groups are not effective and protecting groups such as the Mtr gioup have 
long deprotection times for multiple arginines which may affect more sensitive amino 
acids in the sequence (section 4.2.2.1). These problems were overcome in pai't by 
using the Pmc protecting gioup for all ai*ginine residues.
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4.4.1 Experimental 
4.4J.1 Synthesis
Lactoferricin was synthesised using a semi-automated Pepsynth II continuous flow 
peptide synthesiser (produced by Cambridge Research Biochemicals). This 
instmment canies out all the operations of a single residue addition and deprotection 
under microcomputer control. Liquid flow is controlled by an internal pump and 
electromagnetically operated valves. Individual amino acid derivatives aie 
introduced via a manually filled syringe banel mounted on the fi'ont of the machine. 
A compact vaiiable wavelength spectrometer continuously monitors the reagent 
stieam.
The resin used was Pepsyn KA purchased fi'om Novabiochem with the first amino 
acid to be added (Phe) already attached. Initially the synthesiser resin was placed in a 
sealed column in dimethylfoiTnamide (DMF) solvent. DMF was used as solvent for 
each stage of the synthesis and also to wash and clean out the system after each amino 
acid addition. The first stage of synthesis was the removal of the Fmoc protecting 
group from the first amino acid. This was done by the addition of the secondaiy base 
piperidine (20% v/v, in DMF) through the continuous-flow apparatus.
4.4.L2 Activation
Activated fomis of all of the peptides used were purchased from Novabiochem. The 
method of amino acid activation used was via standaid activated esters in all cases 
except for the addition of the five arginine residues. Standaid Fmoc-amino acid- 
pentafluorophenyl esters were used except for Ser and Thr where 3,4-dihydro-4- 
oxobenzotriazin-3-yl esters were substituted. The activated esters, for each amino 
acid were weighed out to a four molar excess with the appropriate amount of 
hydi'oxybenzotriazole catalyst. This was then dissolved in the minimum possible 
amount of DMF and added to the column. The activated ester derivatives used are 
shown in Table 6-1.
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Table 6-1 : Lactoferricin B Synthesis
Step No Amino Acid Addition Required
(g)
Weighed
(8)
HOBT Notes
(0.060g)
Resin I Fmoc-Phe-Pepsyn KA 1.000 1.016 xxxx
2 Fmoc-Ala-OPFP 0.191 0.210 0.065
3 Fmoc-Arg(Pmc)-OH 0.529 0.540 xxxx symmetlic anhydride
4 Fmoc-Arg(Pinc)-OH 0.529 0.541 xxxx symmetric anhydride
5 Fmoc Val-OPFP 0.202 0.214 0.058
6 Fmoc Cys(Trt)-OPFP 0.301 0.314 0.075
7 Fmoc Tlu(Bu)-ODHBT 0.217 0.238 0.069
8 Fmoc-Ile-OPFP 0.208 0.206 0.067
9 Fmoc Ser(Bu)-ODHBT 0.212 0.212 0.089
10 Fmoc Pro-OPFP 0.201 0.216 0.059
11 Fmoc Ala-OPFP 0.191 0.209 0.068
12 Fmoc Gly-OPFP 0.185 0.191 0.079
13 Fmoc Leu-OPFP 0.208 0.214 0.069
14 Fmoc Lys(Boc)-OPFP 0.253 0.263 0.069
15 Fmoc-Lys(Boc)-OPFP 0.253 0.266 0.080
16 Fmoc Met-OPFP 0.215 0.222 0.075
17 Fmoc-Arg(Pmc)-OH 0.529 0.53 xxxx symmetric anhydiide
18 Fmoc Trp-OPFP 0.237 0.236 0.071
19 Fmoc Gln-OH 0.214 0.216 0.075
20 Fmoc Trp-OPFP 0.237 0.237 0.063
21 Fmoc Arg(Pmc)-OH 0.529 0.532 xxxx symmetric anhydride
22 Fmoc Arg(Pmc)-OH 0.529 0.538 xxxx symmetric anhydride
23 Fmoc Cys(Trt)-OPFP 0.301 0.307 0.061 & 0.303/0.060g
24 Fmoc Lys(Boc)-OPFP 0.253 0.266 0.063 & 0.253/0.076g
25 Fmoc Phe-OPFP 0.221 0.222 0.063 & 0.226/0.061 g
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The Pmc protecting gi'oup employed to protect the ai'ginine sidechains was not 
available in the activated ester foiin and was added via the more reactive symmetrical 
anliydride to optimise the chances of reaction. The symmetrical anliydride was 
prepared just prior to the addition of the residue by the following method. An eight 
molai* excess of the Fmoc-Aig(Pmc)-OH was used (0.8 mmoles). This was dissolved 
in the minimum possible amount of DMF with hydi'oxybenzotriazole (HOBT) added 
to the solution as catalyst. Diisopropylcaibodiimide was then added (0.4 mmoles) to 
the solution and the reactants were mixed for 10 minutes at 4°C before being added to 
the reaction column.
The process used was semi-automated, stopping twice for a Kaiser Test^  ^to be earned 
out to check the extent of reaction by determining the presence of free amino groups. 
The ninliydrin colour (or Kaiser) test is generally canied out at least twice duiing the 
addition of any one residue to ensure complete deprotection has taken place and after 
the addition of each Fmoc amino acid to check a full coupling reaction has occurred.
Ninhydi'in can be used to detect amino acids, peptides and proteins because it reacts 
with the amino groups that are present or that can be generated by hydrolysis of the 
polypeptide chain". The major step is the oxidative deamination of the amino acid to 
CO2, NH3 and an aldehyde containing one less carbon atom than the original amino 
acid. Ninhydi'in is reduced to hydiindantin which then reacts with liberated ammonia 
to give a purple product. This product is intensely coloured with a maximum 
absorbance of 570nm, whereas ninhydi'in is virtually colourless. The presence of the 
intense colour indicates unreacted amino gioups in the sequence and is used to check 
the completion of coupling reactions. The process is shown in Figure 4-9.
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CO,
NH,
HYDRINDANTINNINHYDRIN
(PURPLE PRODUCT)
Figure 4-9 : The Niiihydrin Reaction, used to detect the presence of free amino acid groups.
For residues added early in the sequence, a complete coupling reaction took place on 
a relatively short time scale. For residues added later on in the sequence the reaction 
took much longer and in some cases the amino acid had to be loaded onto the column 
a second time. After the last Fmoc protecting group had been removed from the 
peptide, the resin with peptide attached was removed from the column, washed 
through with t-amyl alcohol and diethyl ether to remove traces of DMF and then left 
to diy under high vacuum.
4.4.1.3 Resin Cleavage and Deprotection
Straightforwai'd deprotection in TFA could not be used because of the presence of 
sensitive amino acids and the five aiginines in the peptide sequence. Standard 
cleavage for peptides containing Ai'g(Pmc) residues with Met, Cys or Trp residues 
was carried out using a mixture of Trifluoroacetic acid, phenol, anisole and 
ethanedithiol in the proportion (94:2:2:2; v/w/v/v). About 50ml of this TFA mixture 
was prepared and added to the peptide in the conical flask to allow swirling of the 
mixture hom time to time to assist the reaction. Actual stiiTing of the mixture may 
damage the resin and therefore affect the yield of peptide obtained.
The deprotection of the peptide was followed by Capillary Electrophoresis^^. 20pl 
aliquots were removed from the deprotection mixture after one hour and every half
Chapter 4: Synthesis and Characterisation of Lactoferricin B Peptide 108
hour thereafter. The TFA was blown off under a gentle nitrogen stieam before adding 
200p.l of 20mM sodium citrate buffer at pH 2.5. This was then analysed using a 
Model 270A Capillary Electrophoresis appaiatus (Applied Biosystems) equilibrated 
with sodium citiate buffer at 30°C and 30kV monitoring the electiophoretic mobility 
at 200nm. The Capillary Electrophoresis data was analysed using the Roseate 
chromatography data analysis package. Initially 30 minute CE mns were performed 
to ensure complete analysis of the reaction mixture. Subsequent mn times were 10 
minutes because no elutions were seen to occur after this time.
The time determining step for the deprotection was the removal of the Pmc arginine 
protecting groups. This can be analysed by CE because the presence of a Pmc group 
will alter the chai'ge of the peptide and therefore the protected product will show a 
different CE elution than the desired peptide.
The CE trace after two hours showed one main peak with a smaller peak attached to it 
which reduced in size during the course of the reaction. After three to four hours 
deprotection there was no change in the CE trace which suggested one major product 
had been obtained from the reaction and full deprotection had taken place. There was 
no change in the results after further time so complete deprotection of the peptide was 
assumed to have occuned.
The resulting mixtuie was filtered to remove the now detached resin leaving the 
peptide present in solution. The peptide was obtained using rotary evaporation to 
remove the TFA solution followed by evaporation with di-ethyl ether to remove the 
organic impurities present and washing with glacial acetic acid.
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4.5 PURIFICATION
4.5.1 Methods of Purification
The following methods were used in the purification of the crude sample of 
lactoferricin B obtained from synthesis.
4.5.1.1 Capillary Electrophoresis (CE)
Electrophoresis enables discrimination between small charge densities of analyte 
molecules. Separ ation is based on different electrophoretic mobilities of the solutes 
which is related to their charge densities. In capillary electrophoresis^^ a buffer-filled 
capillary is suspended between two reservoirs filled with buffer. Samples are 
introduced at one end and under the influence of an applied electric field, migrate 
towards the other end of the capillary. Before leaving the capillary sample zones 
migrate through a detector which senses their passage and records the detector 
response versus time.
4.5.1.2 High Performance Liquid Chromatography
HPLC uses small rigid uniform beads (10-40pm diameter) to produce separations. 
Reverse-phase HPLC^^ uses hydrophobic absorbents such as short-chain aliphatic 
groups attached to a matrix and increasing organic solvent concentration to elute. 
This technique is used mainly for polypeptides and stable small proteins.
Fast Protein Liquid Chromatography^^ (FPLC) is an alternative to HPLC which 
operates under moderate pressure giving higher speed and resolution. Purpose made 
column packing and pre-packed columns are available. Whilst HPLC systems are 
predominantly steel which can be corToded, FPLC uses glass columns.
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4.5.1.3 Mass Spectrometry
Mass specti'ometiy has developed in recent yeai's with the introduction of new 
ionisation techniques that allow ionisation of polai’, labile and involatile species 
The introduction of FAB ionisation by Barber and co-workers allowed the use of 
mass spectrometry as a routine tool. In Fast Atom Bombardment (FAB) Mass 
Spectrometry the peptide is bombarded with excited Argon atoms resulting in 
ionisation and fragmentation of the peptide. New techniques such as electrospray 
ionisation allow compounds with molecular weights of over 1 0  ^ to be determined.
4.5.1.4 Amino Acid Analysis
The amino acid composition of a peptide can be routinely determined by hydr olysing 
the peptide bonds of the polypeptide chain and then determining quantitatively the 
constituent amino acids released. The traditional method for this is to incubate the 
peptide anaerobically in 6 M HCl at approximately 110°C for 24 to 72 hours. Most 
peptide bonds hydrolyse at similar* rates but the peptide bonds between the larger non­
polar* amino acids, especially Val, Leu, and He require longer hydrolysis times or 
addition of organic acids such as TFA. Trp residues ar e usually destroyed completely 
by acid hydr'olysis possibly by reaction with chlorine molecules released from 
oxidation of HCl. This can be prevented by addition of a thiol or sulphonic acid 
compound or phenol to scavenge the chlorine. Tyrosine is also susceptible to 
chlorination but is usually only partially lost. Cysteine is oxidised and partially 
destroyed by acid hydrolysis and is best analysed after performic acid oxidation of the 
peptide to convert all Cys residues to cysteic acid, Cya. Asn and Gin are 
quantitatively hydrolysed to produce Asp and Glu by any chemical procedure used to 
hydrolyse the peptide bonds of the backbone.
4,5.2 Identification of Impurities.
The Capillary Electrophoresis trace of the deprotection of lactoferricin B suggested 
that one main peptide product had been formed during synthesis (although the CE
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pealc was slightly broad). When a sample of the deprotected peptide was analysed on 
a Reverse-Phase HPLC column however, the trace obtained suggested that there were 
a number of different components present (Figure 4-10). The sample was run using a 
gradient of 0% (aqueous TFA (0.1%) to 80% acetonitrile (0.1% TFA). Possible 
impurities present were the scavengers such as phenol added during the deprotection 
stage of the synthesis. The CE results suggested that there were no other peptide 
impurities although the CE trace could have been obtained from two similar peptides 
with similar charges.
The CE trace would not be expected to show up non-peptidic impurities at pH 2.5. A 
CE trace taken using a different buffer system of CAPS buffer at pH 11.0 at 30°C 
however showed a number of impurities present in the system. The different pH 
showed a large number of other peaks present not seen at pH 2.5. This gave an 
indication that scavengers were present in the sample.
The effect of pH on peptide elution has been studied by Grossman et. al.’^  At pH 2,5, 
peptides elute with the most positively charged species first (those with the highest 
measured electrophoretic mobility). At pH 4.0 species that are negatively charged at 
this pH will disappear*. At pH 11.0 the pH is greater than the isoelectric point of most 
peptides and the order of elution is reversed. The peptides migrate as negatively 
char'ged ions concurrently against the electroosmotic flow. At high pH a negative 
peak is seen due to water canied through the capillary by the electroosmotic flow. 
Therefore at high pH non-peptide impurities present in the system acquire a charge 
and proceed to the detector. For this reason non-peptidic impurities are only seen in 
the high pH trace.
For further analysis it was necessary to separate out the different fractions seen in the 
HPLC trace to isolate the peptide from impurities. The fractions were separated by 
FPLC using a gradient of 0 to 60% acetonitrile (in 0.1% TFA). An extract of the 
cnide FPLC trace is shown in Figure 4-11.
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Figure 4-10 ; HPLC Trace of Crude Peptide
Figure 4-11 :The three major peaks from the FPLC Trace of Crude Product.
The FPLC trace indicated three major products present. The fractions corresponding 
to each of these products were collected in acetoniti'ile/water solution during the 
FPLC mn. Acetonitrile was removed under nitrogen and the sample was freeze-dried 
to remove the water layer. When the three separate products had been isolated, the 
three fractions were analysed by Capillary Electrophoresis at pH 2.5 to distinguish 
between peptide and non-peptide products. Of the three products isolated fractions 1 
and 2  were found to contain peptidic material.
Chapter 4: Synthesis and Characterisation of Lactoferricin B Peptide 113
The two peptidic products were further analysed by mass spectrometry and amino 
acid analysis. The amino acid analysis results are shown in Table 6-2 below. Glycine 
was used as a reference amino acid.
The results obtained from amino acid analysis suggested that the two fractions (Frac 1 
and Frac 2) were essentially the same, the only difference being in the cystine and 
cysteine values. The amino acid analysis confirmed that the two compounds contain 
the same amino acid composition.
Table 6-2 ; Amino Acid Analysis of Lactoferricin B
AMINO ACID FRAC 1 
24 Hr 48 Hr Best
FRAC 2 
24 Hr 48 Hr Best Expect
THRI 0.841 0.838 0.841 0.562 0.664 0.664 1
SER 0.918 0.879 0.918 0.725 0.828 0.828 1
GLU 0.909 0.906 0.909 0.958 0.993 0.993 1
PRO(+CYS S-H)2 1.055 1.183 1.055 1.342 1.290 1.290 1
GLY 1.000 1.000 1.000 1.000 1.000 1.000 1
ALA 1.947 1.978 1.978 1.886 2.010 2.010 2
VAL 0.891 0.992 0.992 0.956 1.005 1.005 1
CYSTINE^ (S-S) 0.665 0.626 0.665 0.369 0.306 0.369 2
METHIONINE^ 0.884 0.902 0.902 0.916 0.957 0.957 1
ILE 0.916 0.933 0.933 0.882 0.937 0.937 1
LEU 0.970 0.995 0.995 0.960 1.017 1.017 1
PHE 1.960 1.915 1.960 1.876 2.006 2.006 2
TRp5 1.231 1.279 1.279 0.892 1.432 1.432 2
LYS 2.849 2.968 2.968 2.932 3.123 3.123 3
ARG 4.513 4.682 4.682 4.683 4.959 4.959 5
1,4,5 - Low values expected due to oxidation
2,3 “ Cystine S-S should not exist. This appears to indicate the presence o f a disulphide bond in the 
molecule.
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The similar amino acid analyses obtained for Frac 1 and Frac 2 meant that mass 
spectrometry had to be used to distinguish between the two different forms of the 
peptide. It was found that Frac 1 has a molecular weight of 3124.8, a mass within a 
unit of the theoretical molecular weight and so can be confirmed to be the required 
lactoferi'icin peptide. Frac 2 has a molecular weight of 3390.8, which is 
approximately 265 units above the weight of lactoferricin B and con'esponds to 
lactoferi'icin B with an attached Pmc protecting group.
Further deprotection of Frac 2 was carried out by the same method mentioned 
previously (section 4.4.1.3) but did not produce any further deprotection products 
after four hours. After twenty-four hours there was a slight change in peak ratios with 
a small new peak appearing but no significant change in products. A known problem 
with the arginine Pmc protecting group is the possibility of the Pmc group being 
detached fr om the arginine and substituting into the indole ring of tiyptophan and this 
is probably what has occuiTed here.
4.5.3 Sample Purification
The sample was purified by FPLC using a gradient of 0% (0.1% aqueous TFA) to 
60% acetonitrile (0.1% TFA). The crude product FPLC trace is shown in Figure 4- 
11. Fractions 1 and 2 were isolated from this truce and analysed as indicated in the 
previous section. It was found that tire required product was Frac 1. This product 
was collected in a water/acetonitrile solution by FPLC. Acetonitrile was removed 
under a nitrogen stream and the sample was freeze dried. The sample was then re- 
purified by FPLC by the same method to ensure a high percentage of pine product 
was obtained. An HPLC and Mass Spectrometry trace for the pine compound are 
shown in Figure 4-12 and Figure 4-13.
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Figure 4-12 : Mass Spectrometry Trace for Pure Lactoferricin B compound.
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Figure 4-13 : HPLC Trace purified lactoferricin B.
4.6 CONCLUSIONS
This chapter has outlined the synthesis of lactofemcin B using solid-phase polyamide 
techniques and has also highlighted some of the problems encountered with the 
purification of the peptide. Problems with removal of the Pmc group from the 
arginine residues in the sequence resulted in two main peptide products foimed.
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These were sepaiuted by FPLC. The lactoferricin B peptide obtained was used in 
chapter 6  for studies of the confonnation of lactofemcin B by circular dichroism and 
nuclear magnetic resonance spectroscopy.
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5.1 INTRODUCTION
A major goal in molecular biology is to relate the amino acid sequence of a protein to 
its tliree-dimensional stmcture. The Brookliaven protein database^ contains the X-ray 
crystal stmctmes and NMR sti uctures of the limited number of protein conformations 
that have been detennined. These known stmctui'es have been used to develop mles 
for secondary structure prediction of proteins.
Secondary stmcture in proteins is predicted on the assumption that short similai* 
sequences of amino acids show similar’ secondary sti'ucture tendencies. The aim of 
much research is to go from the amino acid sequence to predict the average atomic 
co-ordinates of a protein. It is believed that the amino acid sequence of a protein 
contains enough information to define its three-dimensional stmcture^.
Other methods for determining stmctures of peptides and proteins use protein 
homology. Proteins descended fiom a common ancestor are said to be homologous. 
These proteins show similarities in amino acid sequence and therefore adopt similar 
conformations. Known crystal str-uctures can be used to predict conformations for 
proteins with similar sequences (or good homology). To find out if a new protein 
sequence is similar to a known protein structure, its sequence is compared to 
str-uctures in the protein database. The reliability of the assigned secondar-y structure 
can be tested using a 3-D profile diagram^.
This chapter reports predicted conformations for the antimicrobial peptides 
lactoferi’icin H (46 residues) and lactoferi'icin B (25 residues). The peptides are 
derived from human and bovine lactoferTin proteins respectively (section 1.4.2). 
Human lactoferi'in is a 691 residue protein whose cr*ystal structure has been 
determined although the crystal structure of bovine lactoferrin is not known. The 
cr-ystal structure of human lactoferrin was used to predict a low energy conformation 
for the lactoferi’icin H peptide. Lactoferricin H and lactoferiicin B show a high 
sequence homology (with 21 out of 25 similar residues) and this similarity in their
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sequences was used to predict a solution confoimation for lactoferricin B peptide. 
The predicted structures obtained were refined by energy minimisation and further 
refined by molecular dynamics simulations under various conditions. Simulations 
included those with and without explicit solvent molecules and for simulations 
without explicit solvent a study of the effect of variation of dielectric constant was 
canied out for lactofenicin B peptide to explain conformational changes in the 
peptide structure in different environmental conditions.
All calculations were canied out using the CHARMm 2.2 force field ninning under 
Quanta 4.1 produced by Molecular Simulations. The Protein Design module was 
used for protein manipulations.
5.2 STRUCTURE PREDICTION FROM AMINO ACID 
SEQUENCE.
Many methods exist for the prediction of protein secondary stnrctures. These work 
on one of two principles, either using the homology of a particular* sequence to known 
protein stnrctures that are present in the Brookhaven Protein Database, or prediction 
based on the amino acid composition alone. The methods provide a mechanism for 
rapid protein structure prediction but only as a guideline and can not be considered 
entirely reliable. If a sequence shows a good homology to a known protein sequence 
it is possible to predict the structure to a reasonable degr ee of accuracy" ,^ but if there is 
less than approximately 50% homology with a known sequence, the accuracy of the 
predicted structure must be called into question.
Techniques used for protein secondary structure prediction are less reliable in general 
for peptides because peptide structure is influenced by environmental conditions, such 
as solvent and peptides are by nature flexible with less well defined structures than 
proteins. Studies carried out on the initiation of protein folding however suggest that 
many larger peptide fragments adopt similar conformations to those found in the 
native protein, although in solution the peptide is often present in more than one
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confoimation. Dyson et. al have been able to detect small populations of P-turn, a- 
helical and nascent helical conformations for peptide fragments derived from proteins 
using NMR and CD spectroscopy^’^ . In many cases helical structures are present as 
only a small part of the population in aqueous studies using Nuclear* Magnetic 
Resonance and Circular* Dichroism and can be obser*ved more clearly in 
water/trifluoroethanol mixtures.
A search of the Brookhaven database for homology to the lactofenicin B sequence 
reveals a homology of greater* than 50% only to the human lactoferrin proteins. The 
antibacterial peptides the defensins, cecropins and magainins show little sequence 
homology to lactoferricin B although all are cationic peptides. These peptides have 
previously shown specific secondary structure in solution by NMR and CD 
techniques. The amino acid sequences and secondary structure of the defensin, 
magainins and cecropins are shown in Table 5-1.
A number* of protein prediction methods ar e available for determination of protein 
structure using interuet resources. These methods use various means such as neural 
network systems and sequence alignment with known protein structures for secondary 
structure prediction. For example the European Molecular* Biology Laboratory 
(EMBL) at Heidelberg runs a secondar*y structure prediction service based on neural 
networks with a greater than 72% accuracy for prediction of a-helix, p-str and and 
loop regions of secondary structure^ in a protein.
Structure prediction methods were applied to the lactoferricin B sequence and the 
results are summarised in Table 5-2. All methods agree that the most likely 
secondar*y structure element for lactofenicin B is a-helical for regions of the 
sequence.
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Table 5-1 : Sequences of Antimicrobial Peptides.
PEPTIDE SEQUENCE KNOWN
STRUCTURE
Defensin
Magainin
Cecropin
5 10 15 20 25 30
DCYCRIPACIAGERRYGTCIYQGRLWAFCC P-sheet^
5 10 15 20
GKFHSAGKRGKAFVGEIMKS a-helix^
5 10 15 20 25 30
KWKLFKKIEKVGQNIRDGIIKAGPAVAWGQ a-helix 
35
ATQIAK
10
Table 5-2 ; Structure Prediction of Lactoferricin B Peptide.
METHOD STRUCTURE PREDICTION
EMBL
NNPREDICT 11
SSPREDICT12
SWISSMOD 13
5 10 20 25
FKCRRWQWRMKKLGAPSITCVRRAF 
HHHHHHHHH HHHHH
FKCRRWQWRMKKLGAPSITCVRRAF 
HHHHHH HHHH
FKCRRWQWRMKKLGAPSITCVRRAF 
EEHHHHHHHHH EEEEEEE 
FKCRRWQWRMKKLGAPSITCVRRAF 
HHHHHHHHHH
H - a-helix
E - Extended confonnation
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5.3 STRUCTURE PREDICTION FROM KNOWN PROTEIN 
STRUCTURES.
5.3.1 Lactoferrin Protein
The ciystal structure of human lactoferrin protein has been solved in a variety of 
forms including with iron bound^ "*, in the apo s t a t eand  in a copper complex foim^ .^ 
Human lactoferrin contains 691 residues and binds to two iron cations and two 
carbonate anions. The iron bound structure consists of two lobes joined by an a- 
helix. (The ciystal structure of the N-terminal lobe is shown in Figure 5-2* ). The two 
lobes have similai* structures and a high level of sequence identity (around 40%^’). 
Each lobe contains a single iron binding site with the iron atoms deeply buried within 
a polar environment in the protein. The structure consists of a number of a-helical 
and P-sheet domains and a Ramachandi*an plot of the backbone phi, psi torsion angles 
of human lactoferrin is shown in Figure 5-1.
180
135 -
Left-handed
lelix
V
'a-hclfi-90  -
-135  -
-180
-180  -135  -90  -45 45 90 135 180
Figure 5-1 : Rainachaiidran plot for Lactoferrin Protein.
Figure 5-2 (overleaf) : N-terminal crystal structure of human lactoferrin. Lactoferricin H 
peptide region is shown in yellow.
r  ./
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In the apo foiin of lactofeirin the N-terminal lobe is open, although there is little 
change in the conformation of the region containing the lactofeuicin peptide. The C- 
temiinal lobe remains closed, possibly due to the presence of an extra disulphide 
bond, not found in the N-terminal region.
5.3.2 Lactoferricin Peptides
The peptides lactofenicin H and lactofenicin B are derived from human and bovine 
lactofenin proteins respectively. The region of the protein containing the peptide is 
near the N-tenninus in both proteins, away from the iron binding sites. The peptides 
are thought to represent loop regions in the proteins that conespond to their 
antimicrobial regions. The two lactofenicin peptides contain a high sequence 
homology in the region between the two Cys residues in lactofenicin B (Table 5-3).
The crystal structure of human lactoferrin was used to predict secondary structure 
confoiinations for the peptides lactofenicin H and lactofenicin B.
5.3.2.1 Lactoferricin H
The sequence for lactofenicin H peptide is given below. The peptide is basic and 
contains forty-six residues including four cysteine residues and four proline residues.
5 10 15
Gly-Ai'g-Ai'g-Ai'g-Ser-Val-Gln-Tip-Cys-Ala-Val-Ser-Asn-Pro-Glu-Ala-Thr-Lys-Cys- 
20 25 30 35
Phe-Gln-Trp-Gln-Arg-Asn-Met-Ai'g-Lys-Val-Arg-Gly-Pro-Pro-Val-Ser-Cys-Ile-Lys- 
40 45
Arg-Asp-Ser-Pro-Ile-Gln-Cys-Ile.
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Table 5-3 : Comparison of Antimicrobial regions of Lactoferricin H (residues 17 to 41) and 
Lactoferricin B.
LACTOFERRICIN H LACTOFERRICIN B
NUMBER RESIDUE NUMBER RESIDUE
17 THR 1 PHE
18 LYS 2 LYS
19 CYS 3 CYS
20 PHE 4 ARG
21 GLN 5 ARG
22 TRP 6 TRP
23 GLN 7 GLN
24 ARG 8 TRP
25 ASN 9 ARG
26 MET 10 MET
27 ARG 11 LYS
28 LYS 12 LYS
29 VAL 13 LEU
30 ARG 14 GLY
31 GLY 15 ALA
32 PRO 16 PRO
33 PRO 17 SER
34 VAL 18 ILE
35 SER 19 THR
36 CYS 20 CYS
37 ILE 21 VAL
38 LYS 22 ARG
39 ARG 23 ARG
40 ASP 24 ALA
41 SER 25 PHE
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In the protein crystal structure of human lactoferrin this segment of the protein 
contains an a-helix. This is illustrated in Figure 5-2. The four cysteine residues in 
the sequence form two disulphide bonds in the protein between residues 9 to 45 and 
residues 19 to 36 respectively. The 19 to 36 disulphide bond occurs in the middle of 
the a-helix region in the peptide. The sequence also contains four proline residues 
which ar e in the trans confoimation in the protein.
A summary of the structure of lactoferricin H found in the human lactoferrin protein 
is shown below.
5 10 15 20 25 30
G R R R S V Q W C A V S N P E A T K C K Q W Q R N M R K V R  
B B B B B  H H H H H H H H H H H H H H H H
35 40 45
G P P V S C I K R N S P I Q C I  
B B H H H H H
H - a-Helix 
B - p-strand
The peptide fragment consists of an a-helical region from residues 13-28 and some 
areas of p-strand. The C-terminal region of the peptide is also found in a helical 
conformation in the protein.
A preliminary conformation for the peptide fragment representing lactoferricin H was 
derived from the protein crystal co-ordinates of the N-terminal human lactoferrin 
protein '^ .^ The structure obtained was energy minimised using the CHARMm force 
field by a combination of steepest descents and adopted basis newton raphson 
(ABNR) methods to relax the peptide fragment and smooth unstable regions caused 
by the absence of the rest of the protein. Hydrogen atoms were added to the stmcture 
to give an all-hydrogen model. A Ramachandran plot showing the backbone phi, psi 
torsion angles for the minimised lactofenicin H stmcture is given in Figure 5-3.
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Figure 5-3 Ramachandran plot for lactoferricin H.
Protein Fragment
Minimized 
Lactoferricin H
Figure 5-4 : Overlay Ca Trace of Lactoferricin H and analogous region in lactoferrin protein.
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Figiu'0  5-3 shows that the backbone torsion angles for lactoferricin H occur in allowed 
regions. Most of the phi, psi backbone angles occur in the a-helix region wliich is 
consistent with the secondary structure, or are in the p-sheet region. Figure 5-4 shows 
an overlay of the minimised lactofenicin H confonnation with the protein crystal 
stmcture of the same region. The secondary stmcture elements ar e conserved during 
the minimisation, although some changes occur in the conformations of the terminal 
residues where these residues relax their stmctures to compensate for the absence of 
the rest of the protein.
5,3.2.2 Lactoferricin B
Table 5-3 shows the analogous regions of lactofenicin B and lactoferTicin H. The 
two regions show a high degree of sequence homology with each other including 21 
out of 25 similar* residues occuning in tire lactoferricin B region. The sequence is 
best preser*ved in the loop region between the cysteine residues in both peptides 
(residues 3 to 19 in lactoferricin B and residues 19 to 36 in lactoferricin H). This 
region is thought to be the antimicrobial domain of the lactoferTicin p e p t i d e s A  
direct comparison between the two peptides can be made with an absence of 
insertions or deletions in the sequence.
A predicted conformation for lactofenicin B was derived from the crystal stmcture of 
human lactofenin. Wlrere residues differed between the two sequences side chains 
were mutated using standard spatial co-ordinates supplied for each residue. The 
derived structure was energy minimised using both steepest descents and the ABNR 
method to relax the entire str*ucture and to account for the effects of changes in side 
chain conformation. Hydrogen atoms were added to the str*ucture to give an all- 
hydr'ogen model. (Lactofenicin H and Lactofenicin B conformations are shown 
overleaf ).
* Figure 5-5 (overleaf) : Derived stmcture of lactofemcin H peptide.
Figure 5-6 (following) : Derived stmcture of lactofemcin B peptide. Basic groups shown in blue.
V ..  y \  J '  * \  1
'►■ '
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The presence of one proline group is preserved in both sequences. The predicted 
lactoferricin B structure contains a smaller a-helical region, from residues 3 to 13. 
The two cysteine residues (residues 3 and 20) in the sequence are close enough in 
space in the energy minimised structure for a possible disulphide bond to form.
A summary of the secondary structure of lactofenicin B as derived from the human 
lactofenin protein is shown.
5 10 15 20
F K C R R W Q W R M K K L G A P S I T C V R R A F  
H H H  H H  H H  H H H  
H - a-helix
A Ramachandran plot for lactofenicin B (Figure 5-7) shows that as expected the a- 
helical region contains the 11 residues shown above. The rest of the torsion angles 
fall in the P-sheet range of the Ramachandran plot or outside allowed regions (7 
residues).
Figure 5-8 shows an overlay of the two energy minimised peptide stnrctures. The 
diagram shows the similarity between the two conformations. Most differences in 
conformation occur due to the changes in amino acid sequence. The a-helical region 
shows good agreement between both stnrctures, this area being well conserved in 
both peptides. The rest of the conformation begins to differ between the two peptides, 
especially at the C-terminus end where most mutations in sequence occur.
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Figure 5-7 : Ramachandran plot for lactoferricin B.
Lactoferricin H
Lactoferricin B
Figure 5-8 : Overlay of Lactoferricin B and Lactoferricin H Structures.
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5.4 MOLECULAR DYNAMICS (MD) SIMULATIONS
The energy minimised predicted stmctures for lactofemcin H and lactofenicin B 
were further refined by molecular dynamics (MD) simulations. MD simulations have 
been shown previously to simulate macromolecular behaviour of lar ger peptides and 
proteins^^’^  ^ and can be used for further refinement of predicted peptide stmctures 
fi’om homologous sequences.
The starting stmctuies for the MD simulations were the energy minimised 
lactofenicin H and lactofenicin B confonnations derived from the X-ray ciystal 
stmcture of lactofenin protein. Simulations were canied out using the CHARMm 
force field, both in the absence of solvent using different values of dielectric constant 
to simulate the electrostatic effects of solvent and with explicit water solvent 
molecules. Simulations were run at 300K using a time step of 0.00Ips. An initial 6 
to lOps of simulation was used to heat up the peptide to the required temperature and 
allow the system to equilibrate. Simulations were canied out on time scales of 
between 50 and 200ps. Van der Waals interactions were switched to give a cut-off at 
15Â. Explicit solvent was simulated using an 8 Â shell of water ai'ound the peptide 
using the TIP3P model for water^ .^ A dielectric constant of 1 was used for 
simulations where explicit solvent was included.
5.4.1 Molecular Dynamics simulations of lactoferricin H.
MD simulations of lactoferricin H were mn for 100 to 15Ops using a dielectric 
constant of 1 for simulations in a vacuum environment, a dielectric constant of 80 to 
simulate water solvent effects by electrostatic methods alone and using explicit water 
solvent.
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5.4,1,1 Results
For the simulations caii'ied out in vacuo (dielectric of 1) lactofemcin H peptide shows 
little change in structure, the a  helical region is conserved over the duration of the 
MD run. The MD simulation shows an initial lowering of potential energy as the 
structure moves into a stable confonnation suitable for the environment away from 
the protein stmcture. The overall secondary stmcture is conseiwed during the 
molecular- dynamics simulation. The stmcture in vacuo is not subject to outside 
forces such as solvent effects and should therefore be stable. The conformation 
adopted does not change much from the initial starting conformation. Main changes 
in stmcture occur at the C-temiinal end of the peptide where the secondary stmcture 
is less well defined in the native protein and residue conformations alter because long 
range interactions no longer occur with other regions in the protein.
Simulations carried out in vacuo using a dielectric of 80 mimic solvent effects using 
electrostatic means alone by including a dielectric constant of 80 in the calculations. 
These simulations will be perfonned at a quicker rate than if explicit solvent is used, 
although simulations ar e limited because for example solvent solute interactions will 
not be taken into corrsideration. In these conditions the peptide shows more flexibility 
and illustrates the ability to move away from its low energy a-helical starting 
conformation. The simulation results suggest that the predicted peptide conformation 
coexists with other conformers in solution. This is normally expected in peptides 
because more than one conformation is generally found in solution^^. Some 
alterations in the a-helical region takes place and the conformation of the peptide 
begins to become globular due to the absence of outside forces affecting the peptide, 
such as hydr ogen bonds between peptide and solvent.
Simulations including explicit solvent molecules show much less flexibility than 
simulations under other conditions. This is because the peptide conformation is held 
rigidly in place by a shell of solvent molecules. Over the duration of the molecular- 
dynamics simulation in solution the predicted structure remains stable. The a-helical 
region is well preser-ved in this environment with not much change in helical
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backbone torsion angles. The a-Helical backbone confonnation is clearly visible 
throughout the course of the run.
The flexibility of lactoferricin H peptide is best illustrated in Figure 5-9. The graph 
shows the root mean square deviation of the peptide from a common average 
structure. The most flexibility is seen for the peptide where a dielectric of 80 is used. 
The secondary structure is best conserved over the course of the molecular dynamics 
nin where explicit solvent is included in the simulation. The graph shows how the 
chain moves out of its starting stmcture to adopt a more stable confonnation in all 
cases.
Figure 5-10 shows the average phi and psi torsion angles obtained over the course of 
the different molecular- dynamics simulations. In all cases the average values 
obtained show that for residues in the a-helical region, backbone torsion angles occur 
at expected values. Some variation can be seen between the different simulation 
conditions used. The backbone torsion angles are best conser-ved in the simulations 
with explicit solvent, although all simulations show compar able values.
Figures 5-11 and 5-12 show the changes in the two disulphide distances in the peptide 
over the course of the molecular- dynamics run. In all cases one disulphide bond 
distance, positioned in the middle of the a-helical region (between residues CYS 19 
to CYS 36) is conserved at a distance possible for a disulphide bridge to form for a 
significant period of time (Figure 5-11). This bond is conser-ved without specific 
inclusion of a disulphide bond in the molecular dynamics simulation. The presence or 
absence of a disulphide bridge in the loop region of lactoferricin H and lactoferTicin B 
is not thought to affect the antimicrobial properties of the lactoferricin peptides '^* and 
this was illustrated here by the conser-vation of the disulphide bond distance in the 
simulation where no specific disulphide bond was assigned. In the simulation with 
explicit solvent the two disulphide distances are well conserved with little change in 
values for the duration of the molecular dynamics run. This illustrates that little 
change in confonnation takes place on the time scale of the MD simulation.
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Simulations with a dielectric constant of 80 show most change in disulphide values. 
The helical stmcture is still mostly conseiwed throughout the MD mn but the 
disulphide distance between the Cys residues in the middle of the helix is not well 
defined. The second disulphide bond describes an interaction between residues 9 and 
45 and these end residues can be seen to move apart in the first two simulations, 
although less change occurs in simulations in explicit water. For simulations in vacuo 
changes occui’ in the second disulphide distance because the confonnation of this 
region of the peptide relies on interactions with other residues in the protein. The 
giaphs showing the change in disulphide distance over the course of the MD 
simulations give a good indication of the change in confonnation taking place over 
the course of the molecular' dynamics run.
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 H20
vO vO VO vO
Time (ps)
Figure 5-9 : Graph showing RMSD from a Common Frame for lactoferricin H in different 
environments. Dielectric constant of 1 (El), dielectric of 80 (E80) and with explicit water solvent 
(H20).
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Figure 5-10 ; Average phi and psi angles (°) for lactoferricin H Molecular Dynamics Runs, (s 
represents dielectric constant.)
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Figure 5-11 : Disulphide distance from residues 9 to 45 for lactoferricin H simulations with 
dielectric constant of 1 (El), dielectric constant of 80 (ESQ) and with explicit water solvent (H20)
25
20
15
t o
5
0
-El
-E80
H20
— ^ 0 ' o o f ^ ' 0 « n < t f ' i r 4 * - ^ o p 0 \ o o r ^ > o w ^ ^
— — — < N < N < N f * r r ^
Time (PS)
Figure 5-12 : Disulphide distance from residues 19 to 36 for lactoferricin H simulations with 
dielectric constant of 1 (El), dielectric constant of 80 (E80) and with explicit water solvent (H20)
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5.4.2 MD simulations of Lactoferricin B
A series of molecular dynamics simulations were perfonned on the lactoferricin B 
peptide. These included molecular' dynamics simulations in vacuo (dielectric constant 
of 1), simulations at a series of dielectric values to mimic effects of different solvent 
conditions and simulations using explicit water molecules. All simulations were i*un 
for 1 0 0  to 2 0 0 ps.
5.4.2.1 Results
The predicted lactoferricin B peptide secondai'y sti'ucture is less well maintained over 
the MD simulations than that for lactoferTicin H peptide. Simulations using a 
dielectric constant of 1 show conser-vation of the a-helix region over the course of the 
MD simulation although the rest of the peptide structure undergoes some change in 
confor-mation because there are no regular’ secondar-y sti’ucture elements present. The 
results suggest an initial relaxation of the sti’ucture dming the MD simulation as the 
peptide moves into a more stable conformation and this stmcture is maintained over 
the rest of the MD simulation.
Simulations using a dielectric constant of 80 suggest a high degree of mobility exists 
in the peptide stmcture because the peptide begins to move out of the a-helical 
predicted sti'ucture into confor-mations with less well defined secondary sti'ucture. 
The peptide is known to show a high degree of flexibility in solution and this is 
observed by the MD simulations with a dielectric constant of 80. The derived 
sti'ucture for lactoferi’icin B peptide is less stable than the corresponding lactoferricin 
H peptide stmcture because there is a shorter a-helical domain present. This results 
in less stability for this conformation in solution.
Simulations including explicit water suggest the predicted peptide stmcture is well 
conserved over the time scale of the molecular' dynamics mn. Backbone sti'ucture 
undergoes little change over the MD simulation, altliough some side chain
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interactions with solvent occur. Overall the secondary structure is conserved over the 
course of the MD simulation.
Figure 5-15 shows the average values of the phi and psi backbone torsion angles for 
lactofenicin B over the cour se of the different MD simulations. The values obtained 
are comparable in each case. All values suggest the conservation of the a-helical 
region for a large portion of the MD simulation. The rest of the peptide adopts p- 
strand or extended backbone torsion values over the MD run. The torsion angles ar e 
best conserved in simulations with explicit water. Values obtained here are close to 
those of the starting structure.
Figure 5-14 shows tire change in tire cysteine disulphide distance (residues 3 to 19) 
over the MD simulation. The disulphide bond is well conserved in the simulation 
including explicit water, for the simulation with a dielectric of 80, the cysteine 
residues begin to move away from each other as the peptide moves out of the a-helix 
conformation. Here the disulphide distance is not important in the formation of the a- 
helix structure and this suggests that the presence or absence of a disulphide bond is 
not important for the preservation of the a-helical region in the peptide. This agrees 
with previous experimental results where the presence of a disulphide bond does not 
affect the activity of lactofen icin B peptide.
Figure 5-13 shows the root mean square deviation for lactoferTicin B peptide from the 
average stnicture obtained over the MD simulations. During the MD simulations the 
peptide relaxes and moves into a more stable confonnation. The molecular dynamics 
simulation removes unstable sidechain conformations occuning in the predicted 
sti'ucture of lactofenicin B. The peptide is most flexible in simulations with a 
dielectric constant of 80. The peptide shows much less change in conformation in 
simulations with explicit solvent where the predicted structure is maintained 
throughout the MD run.
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Figure 5-13 : RMSD From Common Frame for Lactoferricin B in different environments. 
Dielectric constant of 1 (El), dielectric constant of 80 (ESC) and in explicit water solvent (H20).
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Figure 5-14 : Graph of Disulphide Distance over Molecular Dynamics run of lactoferricin B in 
different environments : dielectric constant of 1 (El), dielectric constant of 80 (E80) and explicit 
solvent (H20).
Chapter 5: Modelling of Lactoferricin Peptides 143
180.00
144.00-
100.00  -
72.00 —
36.00 -  
0.00  —
-36.00 -  
-72.00“  
-108.00 -  
-144.00—  
-180.00 “
2 4 6 8 10 12 14 16 18 20 22 24 26
R e s id u e  N um ber  
Phi Angies for Lactoferricin B at 8=1
180.00
144.00-
108.00 
72.00 -
36.00 -  
0.00 
-36.00 
-72.00 
- 1 0 0 .0 0  
-144.00 
-180.00
2 4 6 0 10 12 14 16 18 20 22 24 26
R e s id u e  N um ber
Psi Angles for Lactofemcin B at 8=1
180.00
144.00-
108.00
72.00 -
36.00 
0.00  -
-36.00
-72.00“
-108.00
-144.00“
-180.00
I ll II I I I i l l l l 1
I ' I ' i ' I ' I ' I ' I
2 4 6 8 10 12 14 16 18 20 22 24 26
R e sid u e  Num ber
Phi Angles for LactofeiTicin B at 8=80
180.00
144.00“
108.00 -
72.00
36.00 -  
0 .0 0  ' 
-36.00 
-72.00 
-108.00 
-144.00 
-180.00
2 4 6 8 10 12 14 16 10 20 22 24 26
R esid u e N um ber
Psi Angles for Lactoferricin B at 8=80
180.00 
144.00' 
108.00 
72.00 -
36.00 -  
0 .0 0  ' 
-36.00 
-72.00 
-108.08 
-144.00 
-180.00
1 11 1 l l [. Ill
I ' I ' I ' I ' I ' I ' I
2 4 6 8 10 12 14 16 18 20 22 24 26
R e sid u e  N um ber
Phi Angles for Lactoferricin B at 8=H20
180.00
144.00“
108.00
72.00“
36.00 -  
0.00 
-36.00 
-72.00 
-108.00 
-144.00 
-180.00
10 12 14 16 10 20 22 24 26
R e sid u e  N um ber
Psi Angles for Lactoferricin B at s= H2O 
Figure 5-15 : Average phi psi angles (®) for lactoferricin B. 8 = dielectric constant.
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S.4.2.2 MD Simulation o f Lactoferricin B using different dielectric constants. 
Circular Diclu'oism results for lactofenicin B peptide suggest that the secondary 
stmcture of the peptide is dependent on environmental conditions (Chapter 6 ). 
Molecular dynamics simulations of 5Ops were earned out on lactofenicin B peptide 
using a series of dielectric constants to simulate changes in solvent conditions. 
Dielectric constants of 1,4, 10, 20, 30, 40 and 80 were used to represent different 
environmental conditions.
A dielectric constant of 1 represents the peptide environment in a vacuum where no 
outside forces are present. The interior of protein structures ar e generally simulated 
in the CHARMm force field by a dielectric of 2 to 10, although these simulations do 
not consider neighbouring effects^ .^ Membrane environments have been represented 
by Salvino et. al.^  ^using a dielectric constant of 4 for simulations of the nonapeptide 
bradykinin. A value of 20 represents vaiiations in dielectric constant in differing 
membrane environments. A dielectiic constant of 26 (approximately 30) gives the 
value for trifluoroethanol, and a dielectric of 80 simulates a water environment as has 
been shown previously. Moleculai* simulations carried out under these conditions aie 
unlikely to give accurate results for specific values because only electiostatic effects 
aie accounted for. Therefore a range of dielectric values were examined to look for 
trends in the peptide stability in different environments.
The root mean square deviation (RMSD) from an average conformation for 
lactofenicin B peptide for different dielectric constants aie shown in Figure 5-16 and 
Figure 5-17. The simulations with the most flexibility are those where a high 
dielectiic constant is used. A dielectric constant of 80 is close to the value for water. 
The peptide shows most flexibility in this environment and does not exist in one 
specific secondary stmcture confoimation but is present in a number of low energy 
conforaiations. Using a dielectric of 1 gives a simulation in a vacuum and the 
stmcture shows a high degree of stability here because it is not subject to outside 
forces. The most stable simulation (after the vacuum environment) was found to 
occur for a dielectric constant value of 20. This is close to the value for a membrane
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environment and for tiifluoroethanol (26.5) and suggests that the a-helical region of 
the peptide is stable in this environment. This has been confinned by experimental 
results. The peptide is also stable for dielectric constants of 4 and 10.
A graph of the variation in disulphide distance (residues 3 to 20) over the course of 
the run (Figure 5-18 and Figure 5-19) shows similai* changes in distance values in 
most cases. The dielectric of 20 simulation shows the most movement from the 
starting value. The results suggest that the presence or absence of a disulphide bond 
is not important for adoption of an a-helical confoimation in all environments. This 
agrees with results for the antimicrobial activity of lactoferricin B.
5.5 DISCUSSION
Secondary structure prediction methods for lactofenicin B peptide suggest that the 
peptide is most likely to adopt an a-helical confoimation. The lactofenicin H peptide 
sequence is found in the protein human lactoferrin where the peptide region is mainly 
a-helical, similar to the predicted confoimation for lactofenicin B peptide.
Although both lactofenicin peptides aie thought to adopt an a-helical structure, the 
confoimation of lactofenicin H peptide is more stable in molecular dynamics 
simulations than that of lactofenicin B peptide. The smaller size of lactofenicin B 
peptide increases the peptide flexibility as illustrated by the molecular dynamics 
simulations. This gives the peptide the ability to move out of confoimation. The 
shorter length of the a-helical region in lactoferricin B peptide also makes the region 
less stable.
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Figure 5-16 : RMSD For Dielectric constants 80 (E80), 40 (E40) and 30 (E30).
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Figure 5-17 : RMSD From Common Frame for different Dielectric constants 20 (E20), 10 (ElO), 
4 (E4) and 1 (El).
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Figure 5-18 : Disulphide Distances for Dielectric Constants of 80 (E80) , 40 (E40) and 20 (E20)
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Figure 5-19 : Disulphide Distance for different dielectric constants of 20 (E20), 10 (ElO), 4 (E4) 
and 1 (El).
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Predictive modelling techniques indicate that a-helices aie unstable in peptides in 
aqueous solution. However a number of peptides have been found to adopt stable a- 
helical conformations by experimental methods"^. Moleculai* dynamics simulations 
by DiCapua et. al have been used to probe the stability of helices in solution and 
destabilisation of the a-helix is thought to occur due to insertion of water molecules 
in the helix^^’^ .^ The effects on stability of a-helices due to temperature^^ and pH^  ^
have also been examined by molecular dynamics.
Molecular dynamics simulations of the a-helical Ribonuclease A S-peptide in 
aqueous solution shows the stability of the peptide in this environment and its 
unfolding at high temperature^^. This peptide is known to adopt an a-helical 
confonnation in solution^^. The results presented here suggest that lactoferricin B 
peptide does not simply adopt an a-helical confonnation in aqueous solution but that 
an ensemble of conformations are present.
Where explicit water is included in the model, solvent effects aie simulated explicitly, 
not just by electrostatic means. Inclusion of explicit waters mean that hydiogen 
bonding between water and the peptide can be simulated. Ideally water should be 
included in periodic boundaiy conditions so that bulk water properties can be 
simulated^" .^ Increasingly periodic boundaiy conditions are used for simulations of 
bulk properties of other solvents such as DMSO^^’^  ^and chlorofoim^^. Using a shell 
of water limits the time required because eventually the water will drift away from the 
peptide. Other methods of water simulation include Langevin stochastic dynamics 
which has been used effectively to solvate the active site, for example in a protein^^.
5.6 CONCLUSIONS
The derived structures for the peptide fiagments lactofenicin H and lactofenicin B 
suggest an a-helical confonnation in each case. These confonnations were 
detennined from the known stmctuie of human lactofenin protein, where 
Lactofenicin H is found directly in the protein sequence. Circulai* dichioism studies
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of lactofeii'icin B indicate no specific secondaiy stmcture is present in water and 
secondaiy stmctural elements ai'e present only in more hydrogen bonding inducing 
solvents such as trifluoroethanol (TFE). The predicted a-helical stmcture agrees with 
the results obtained for lactofenicin B peptide in trifluoroethanol solution.
Molecular* dynamics simulations of lactofenicin H suggest that the a-helical 
conformation is a stable stmcture in all conditions used. During the course of the 
molecular dynamics simulation, the stmcture remains close to the confoi*mation 
predicted from lactofenin protein.
Over the simulations time scale the a-helical stmcture predicted for lactofenicin B 
was found to be a stable confoi*mation. Using a dielectric constant of 80 for 
simulations in the absence of water, the peptide has a tendency to move out of the 
starting confonnation much more and shows a high degree of flexibility in solution. 
This result agrees with experimental CD results obtained so far which suggest that 
lactofeiTicin B shows no specific secondaiy stmcture in solution (Chapter 6 ). 
Moleculai* dynamics simulations canied out in explicit water suggest that the a- 
helical stmcture of lactoferricin’s H and B aie stable over the time scale of the mn. 
Therefore Lactofenicin B is present in solution in an ensemble of conformations
Effects of different solvent conditions were examined for lactofenicin B peptide by 
variation of the dielectiic constant in the simulations. The peptide was found to show 
the most flexibility at high dielectric constant where the dielectric constant is close to 
that for water and least flexibility in vacuo with a dielectric constant of 1. The a- 
helical conformation was best consei*ved for a value of dielectric constant of aiound 
20. This value is close to that for tiifluoroethanol and a membrane environment.
The moleculai* dynamics simulations show tliat the a-helical stmcture predicted is a 
possible stable sti*ucture for lactofemcin B in solvents such as trifluoroethanol. 
Experimental results suggest that a single confonnation is not present for lactofenicin 
B in water and simulation studies agree with this.
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6.1 INTRODUCTION
Predictive modelling of lactofemcin B as outlined in Chapter 5 suggests that 
lactofemcin B adopts an a-helical confonnation at the receptor site. Structural 
information was obtained from the previously derived ciystal structure of human 
lactofenin protein. Moleculai* dynamics simulations emphasise the flexible nature of 
the peptide in aqueous solution.
Although the conformations of numerous small proteins have been determined 
successfully by NMR spectroscopy^'^, most lineai* peptides possess little conformation 
in solution^ unless stmctui'e stabilising factors (such as disulphide bridges or a cyclic 
conformation) are present. For example Seville et. al analysed the 27 residue peptide 
oo-Conotoxin GVIA '^ and found evidence of specific secondaiy structure. The 
globular folding pattern stays rigidly in place due to the presence of three disulphide 
bridges in the peptide. Many cyclic peptide foims show a more rigid conformation 
than for that found in the conesponding linear peptide^, although these cyclic forms 
aie not always successful at reproducing the peptide activity^. Linear peptides show 
more flexibility but many protein fragments adopt regular structure elements in 
solution^. Where the peptide confoimation is less well defined, the use of molecular 
modelling methods in conjunction with NMR and CD results becomes less reliable 
because more than one conformation may be adopted that contributes to the NMR 
data obtained.
Lactofemcin B is a 25 residue linear peptide and such peptides are generally flexible 
in solution, existing in a number of low energy confoimations. Using NMR 
spectroscopy it is sometimes possible to distinguish elements of régulai* stmcture that 
the lineal* peptide adopts in a reasonable percentage of conformations. Circular 
dichioism (CD) spectroscopy is sensitive to slight deviations from regular stmcture 
and only gives results for well-reproduced secondaiy stmctural elements^ NMR 
spectroscopy is more sensitive to deviations in secondaiy structure where the peptide 
shows small populations of régulai* secondary structure in solution. This chapter
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contains the experimental Circular dichioism and NMR spectroscopy results obtained 
for tlie lactofenicin B peptide. Details of the synthesis of lactofemcin B were given 
in Chapter 4. CD experiments were canied out using a number of different solvents 
including water and trifluoroethanol (TFE) to look for evidence of specific secondaiy 
stmcture for the peptide. NMR spectroscopy techniques were canied out in aqueous 
solution to study the solution conformation of lactofenicin B peptide.
6.2 CD RESULTS FOR LACTOFERRICIN B
6.2.1 Background
Circulai' dichioism is used to measure the optical activity of asymmetric molecules in 
solution. CD gives infonnation about tlie unequal absoiption of left and right handed 
circulaily polarised light by optically active molecules. CD signals are found in the 
same spectral regions where the absoiption bands of a paiticulai* compound aie found, 
provided the respective chiomophore or its molecular environment aie asymmetric.
CD bands of proteins occur in two spectral regions. The fai-UV or amide region 
(170-250nm) is dominated by contributions from the peptide bonds and contains 
infonnation about the secondaiy stmcture of a protein. In particular the a-helix 
displays a strong and characteristic spectmm in the far-UV region. The spectral 
contribution of other elements of secondaiy structure aie less well defined.
CD bands in the near-UV region (250-300nm) originate from the aromatic amino 
acids tyrosine, tryptophan and phenylalanine. Phenylalanine has a molai* absoiption 
smaller by an order of magnitude than that of tyiosine and tryptophan, with 
tryptophan being the most strongly absorbing amino acid. This ai ea of the spectmm 
is therefore dominated by tyrosine and tryptophan residues. Disulphide bonds also 
give rise to minor CD bands around 250mn.
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Modern CD spectl'opolarimeters use a high-frequency photoelectric modulator to 
generate alternately the two circulaily polaiised components of light^. This leads to 
an alternating cuiTent contribution to the photomultiplier signal that is proportional to 
the CD of the sample. The instrument is normally calibrated using d-10- 
camphorsulphonic acid. The measured CD bands are generally veiy small so a high 
stability of CD signal is required. The slit width and time constant aie the two major 
instmmental vai iables that determine the signal to noise ratio (S/N) of the CD signal. 
An increase in slit width will improve the S/N. The upper limit is set by the 
requirement that the fine structure of the spectmm is not averaged out. Most modem 
CD instruments include repetitive scanning to improve the S/N ratio of the spectrum. 
A fused quai'tz cuvette cell is preferably used. CD cells aie usually circulai* and are 
available in a vai iety of path lengths. The choice of solvent used is important because 
ideally a solvent should be used with low absorbance values in tlie fai-UV region, 
limiting solvent effects occumng in the specti*um*°.
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Figure 6-1 : Standard CD Spectra for Regular Secondary Structural Elements.
Characteristic spectra are obtained for the main secondai*y structural elements of 
proteins such as alpha-helix, beta-sheet and random coil confomiations^^ (Figure 6-1). 
Proteins are normally made up of a combination of different secondary stmctural
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elements and the percentage of each is usually found by employing fitting procedures 
using spectra of model peptides.
6.2.2 Experimental
The spectra were obtained on a Jobin CD6  circulai* dichioism spectrometer. Samples 
were scanned four times over the range 180 to 250mn sampled at 0.5nm increments 
and also from 250 to 300nm sampled at Inm increments. Solvent blank spectra were 
subtiacted from all data presented. Peptide solutions were at concentrations of 
approximately 1 mg/ml and housed in a 0.1mm cell. The instmment was calibrated 
using d-lO-camphorsulphonic acid. All spectra presented have not been subject to 
smoothing operations.
Solvents used included water at 20°C and 0°C. A high pH of 11.0 was achieved using 
a 20mM solution of CAPS buffer and also using NaOH solution. These spectra were 
mn at 20°C. Other solvents used were 100% TFE and a 2mM solution of SDS 
micelles, also mn at 20°C.
6.2.3 CD Spectra for pure Lactoferricin B
6.23.1 CD spectra in aqueous solution at different pH.
The CD spectra for lactoferricin B in water at both 0°C and 20°C produced a 
spectmm indicative of a random coil confoimation with a minimum at 200nm. The 
CD spectmm is shown for the peptide at 20°C in Figure 6-2.
The spectmm obtained in CAPS buffer at pH 11.0 (Figure 6-3) shows some change 
fi’om a random coil conformation for lactofenicin B peptide but this result was not 
repeated when an NaOH solution at pH 11.0 was used as solvent, where results for a 
random coil conformation were obtained (Figuie 6-3). However no specific 
secondary stmcture elements are indicated for the peptide in CAPS buffer. This 
suggests a modification of the peptide stmcture has taken place in the presence of the
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buffer solution, or interference effects are occuning (although these should be 
removed by the recording of a spectmm blank).
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Figure 6-2 : CD spectrum of lactoferricin B in water at 20°C. A random coil conformation is 
indicated by a minimnm at 200nm.
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Figure 6-3 : CD spectrum for lactoferricin B in CAPS buffer at pH 11.0. The results differ from 
that of the conventional random coil spectmm.
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Figiire 6-4 : CD Spectrum of lactoferricin B in NaOH solution at pH 11.0. The results suggest a 
random coil conformation with a minimum at 200nm.
6.2,3.2 CD results fo r lactoferricin B in other solvents
Lactofemcin B peptide was found to adopt a typical a-helical conformation in 100% 
TFE solution (Figure 6-5). This is illustrated by a double minimum at 212 and 22Inm 
and a positive band at 19Inm. However, using SDS micelles in low concentrations a 
p-strand confonnation was obtained typified by a positive peak at 2 0 0 nm and a 
negative peak at 220nm (Figure 6 -6 ). Similar results have been previously obtained
for other peptide fragments 12,13
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Figure 6-5 : CD spectrum of lactoferricin B in 100% TFE Solution. The results show an alpha- 
helix conformation.
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Figure 6-6 : CD spectrum of lactoferricin B in 2mM SDS Micelle Solution. Results suggest a 
beta-strand conformation.
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6.2.4 CD Results for Lactoferricin B containing the Pmc protecting group
The CD results obtained for this sample differ from those for pure lactofenicin B. 
The CD spectmm suggests that some a-helical confoimation is present for the sample 
at pH 11.0 (Figure 6-7). This suggests some stabilisation occurs due to the presence 
of the Pmc protecting gi’oup. This result is found for the peptide both in CAPS buffer 
solution and in NaOH solution at pH 11.0. No evidence of stmcture is found at pH
7.0 or pH 2.5, although there is some indication of a change in stmctuie at pH 9.0.
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Figure 6-7 : CD Spectrum of Lactoferricin B with protecting group attached at pH 11.0 in NaOH 
solution Spectrum suggests some degree of a-helical conformation is present.
6.2.5 Discussion
CD spectroscopy is used routinely to study proteins which adopt ordered structures. 
Peptides are more flexible than proteins and are therefore less likely to adopt regular 
secondary stmcture units. An a-helix stmcture in a peptide may not be stable in
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water because it is exposed to solvent interactions. Some examples have been found 
however, particulai'ly for synthetically designed peptides
The results suggest the absence of an ordered secondary stmctui'e for lactoferricin B 
peptide in aqueous solution. In the presence of TFE however an a-helical 
conformation is obtained. TFE is often used in studies of peptides to simulate 
membrane effects of the active sample in contact with a receptor. The accuracy of 
this technique is unclear- however in that the peptide conformation is clearly 
dependent on the solvent environment. The results obtained in TFE agree with the 
predicted structure of lactofeiTicin B from secondary str*ucture prediction methods 
(Section 5.2) and this is often found to be the case for peptides of similar* size^ .^ The 
fact that the addition of SDS micelles in small quantities can be used to produce a 13- 
strand environment shows the sensitivity of the lactofeiTicin B peptide conformation 
to local environment. This suggests that protein prediction techniques are unlikely to 
be accurate for this peptide because the str*ucture obtained is too dependent on 
solvation factors. Although TFE is assumed to enhance specifically a-helical 
conformations, (3-strand conformations have also been found to maintain their 
str-ucture in TFE*  ^ and stability of helical conformations in aqueous solution is not 
always increased by addition of TFE^ .^ Therefore the a-helical conformation found 
for lactofeiTicin B peptide in TFE could be similar- to the conformation the peptide 
adopts at a receptor site.
A pH effect is found for lactoferricin B containing a Pmc sulphonyl group indicating 
the impure peptide conformation is stabilised by interaction with the Pmc protecting 
group at high pH.
CD studies canied out on the antimicrobial peptide cecropin A^  ^ show that whilst the 
peptide is disordered in water, the presence of TFE can be used to induce an a-helical 
conformation in the N-terminal region of the peptide. It is found that the addition of 
helix-breaking residues at key points in the sequence correspond to a decrease in 
antimicrobial activity. This gives a clear indication linking peptide activity with
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peptide conformation. Studies of peptide hagments fi'om proteins in general show 
that addition of TFE can be used to stabilise stmcture chaiacteristics and mimic the 
secondary stmcture found in the protein environment^^. Other studies have used 
methanol to stimulate receptor conditions'^, such as studies carried out on heparin 
peptide fragments^ \
6.3 NMR RESULTS FOR LACTOFERRICIN B PEPTIDE
6.3.1 Experimental
The Lactofenicin B sample was obtained from synthesis as outlined in Chapter 4 and 
a fiirther sample was obtained from Genosys Biotechnologies Ltd. NMR samples 
were prepared fr om lyophilised peptide by dissolving 1 0  to 2 0  mg of peptide into 
0.5ml of 90% H2O/D2O solution. Phase sensitive COSY, HOHAHA, NOES Y and 
ROESY spectra were recorded. A mixing time of 400ms was used for the NOESY 
and ROESY experiments. NMR spectra were recorded on a Bmker AMX 500MHz 
spectrometer and time-proportion phase incrementation was used in all cases. Spectra 
were mn at a temperature of 298K. Interference from the strong solvent resonance 
was minimised by presaturation during the preparation period (and mixing time for 
NOESY). The time domain data size was typically 2K points in the t2 domain with 
512 points in t}. TOCS Y spectra were recorded using the MLEV-17 sequence to 
create a spin-lock with a total mixing time of 75ms. A spectral width of 5680Hz was 
used.
Problems occuned in mnning the NMR spectra of lactofenicin B peptide because the 
peptide is found to be unstable in solution. NMR data are obtained using two 
different samples and these give slightly differing results. Sample 1 represents the 
original sample obtained from synthesis as outlined in Chapter 4. Two-dimensional 
NMR techniques of COSY, HOHAHA and ROESY were obtained for this sample in 
H2O solution. Sample 2  represents the sample obtained from Genesys 
Biotechnologies Ltd. Two-dimensional NMR techniques of COSY, HOHAHA,
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NOESY and ROESY were earned out for this sample in H2O solution. NMR 
results for these two samples aie presented separately in the order that the spectra 
were recorded to avoid confusion between the two different sets of results. 
Conclusions di awn from both sets of samples ar e then given.
6.3.2 Results
6.3.2.1 Sample 1
The fingerprint region of the two-dimensional COSY spectrum of lactoferricin B is 
shown in Figure 6 -8 . The spectmm shows the good resolution of the NH-CaH cross 
peaks with 21 distinguishable signals present. The expected number of cross peaks is 
23 because the Pro possesses no N-H signal and the N-terminus Phe signal is not 
found. This implies that either some degeneracy in chemical shift values is occurring 
and some cross peaks are indistinguishable in the spectmm under the conditions used 
or that cross peaks ai e lost during pre-saturation of the water signal where the values 
of the cross peaks ai e close to that of the saturated water signal.
Figure 6-9 shows part of the HOHAHA spectmm for lactoferricin B. Cross peaks aie 
seen between the N-H signals in the spectmm and resonance’s fi'om 0 to 5 ppm. The 
HOHAHA spectrum shows long range interactions that spread out through the 
individual residues. For example for alanine, Haitmann Hahn interactions can be 
seen fr om the N-H signal to the aC-H tlnough to the PCH3 signal. The limit of 
sensitivity of the spectrum is uncoupled signals 3 to 4 atoms apart in an individual 
residue. This spectmm was used for resonance assignment of the peptide.
63.2.2 Sample 2
The fingeiprint region of the two-dimensional COSY spectrum of sample 2 is shown 
in Figure 6-9. Here it can be seen that there aie some differences in the number of 
cross peaks seen compaied to sample 1, and some changes in the NH-aCH 
connectivities. The spectrum indicates the presence of some peptidic impurities. The
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COSY spectmm of the upper field region (0-4.7ppm) shows good agreement between 
samples 1 and 2. For the rest of the spectmm more spreading out of NH~aCH cross 
peaks is seen compared to sample 1. For example for the first NH signal it can be 
seen that the two COSY cross peaks are better resolved in the second spectmm. The 
sensitivity of sample 2  is less than that of sample 1 because the concentration of the 
sample used was less. Most changes in cross peak values are present due to different 
conditions and different measuies of purity.
Figure 6-10 show the HOHAHA spectrum used for specti'al assignment of sample 2. 
The region shown contains cross peaks between N-H signals and resonance’s at 0- 
5ppm. This specti um was used for resonance assignment of the peptide.
6.3.2,3 Resonance Assignments
Resonance assignments of lactofenicin B are canied out using known spectral 
patterns for the individual amino acid residues in the COSY and HOHAHA spectra^^. 
The results obtained are presented in Table 6-1.
The first residue assigned was the single Gly residue in the sequence which had the 
lowest fi'equency cross pealc in the COSY spectmm. The coupling of the cross peak 
between the NH and CH2 signals had twice the splitting of the other cross peaks in the 
spectmm in sample 1 because Gly contains an aCH2 instead of an aCH group. For 
sample 2 only a weak signal for the Gly residue is obseiwed.
The Ala and Thi* residues were distinguished due to the direct connectivities of the 
aCH of Ala and P-CH2 of Tin to a methyl carbon in the COSY spectmm. These fall 
in the same place for Ala and Thi* and can be distinguished fiom other signals. Three 
such signals aie obseiwed in the spectmm indicating two Ala and one Thr residue 
present in the sequence as expected. These signals can be traced thiough to their aC- 
H and N-H connectivities.
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The aliphatic amino acid residues He, Leu and Val are distinguishable as the 
remaining signals in the methyl region of the spectrum. Val connectivities in the 
HOHAHA spectrum could be traced from the methyl groups to the aC-H and aN-H 
signals. The He methyl signal was traced through to its’ aC-H signal. The Leu aC-H 
was harder to distinguish due to overlap with other residues (specifically the Lys and 
Arg residues) in the sequence.
Of the residues left not assigned the Ser, Cys, Tip and Phe residues show similar 
connectivity patterns of NH to aC-H to P-CH2 in the HOHAHA spectmm. These 
residues suggest no further interactions in the HOHAHA spectmm because for the 
aromatic residues no further HOHAHA cross peaks occur to the aromatic region and 
the SH signal in Cys and OH signal in Ser are exchanging and therefore do not appear 
clearly in the spectrum. The Ser residue was distinguishable from the other resonance 
values due to the P-CH2 resonance occumng at a lower field to tlie other amino acid 
residues. The other three amino acids (which represent six signals in the spectrum) 
were indistinguishable from each other in the HOHAHA spectmm. The aiomatic 
residues can be distinguished from the Cys residues however by identification of 
aiomatic cross peaks from the NH and aC-H resonance’s to the aiomatic region in the 
ROESY and NOESY spectra.
Resonance values for the Met, Pro and Gin amino acids in the aC-H region are 
distinguished by their individual chemical shift values and connectivities in the 
HOHAHA spectmm.
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Figure 6-8 : COSY Spectrum of Lactoferriciu B sample 1.
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Figure 6-9 : H HOHAHA Spectrum of Lactoferricin B sample 1.
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Figure 6-10 : *H COSY Spectrum for Lactoferricin B sample 2.
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Figure 6-11 ; H HOHAHA Spectrum for Lactoferricin B sample 2.
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Table 6-1 : H NMR Resonance’s for Lactoferricin B.(Values calibrated to H^O at 4.7ppm). 
(Where individual values could not be assigned a range of values is given.)
Amino
Acid
aNH aCH PCH OTHER
PHE (1) 4.051 2.928 C(4)H 7.362
0(3,5)H 7.013
0(2,6 )H 7.013
LYS (2) 838 4.16 1.537 yOH2 1.254
Ô0H2 1.425
sOH2 3.024
CYS (3) 8 .2 0 4.18 2.726
ARC (4) 8.40 4.07 1.471 yOH2 1 .1 1 1
50H2 2.938
NH 6.5-7.0
ARG(5) 8 .1 2 2 4.045 1.510 yOH2 1.438
Ô0H2 2.725
NH 6.5-7.0
T R P (6 ) 7.933 4.394 2.974 0(2)H 7.119
0(4)H 7.302
0(5)H 7.179
0(6)H 7.013
0(7)H 7.223
N(1)H 1 0 .1 0 2
GLN(7) 8 .2 0 0 4.275 1.716 yOH2 2.098
T R P (8 ) 7.70 4.320 3.041 0(2)H 7.119
0(4)H 7.302
0(5)H 7.179
0(6)H 7.013
0(7)H 7.223
N(1)H 10.159
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Amino
Acid
aNH aCH pCH OTHER
ARG(9) 8.158 4.095 1.492 yCH2 1.166
ÔCH2 2.708
NH 6.5-7.0
MET (10) 7.865 4.140 1.806 yCH2 2.345
sCH3 1.954
LYS (11) 7.70 3.983 1.178 yCH2 1.254
ÔCH2 1,425
sCH2 3.024
LYS (12) 7.70 3.983 1.178 yCH2 1.254
ÔCH2 1.425
sCH2 3.024
LEU (13) 8 .2 0 4.16 1.559 yCH2 1.537
Ô1CH3 0.751
Ô1CH3 0.693
GLY (14) 8.18 3.69
ALA (15) 7.90 4.41 1.178
PRO(16) 4.275 2.098 yCH2 1.716
ÔCH2 3.512
SER (17) 8 .2 0 4.16 3.69
ILE (18) 8.050 4.163 1.716 yCH2 1.267
0.998
yCH3 0.761
5CH3 0.683
THR (19) 8.091 4.208 4.028 yCH3 0.988
CYS (20) 8.158 4.365 2.726
VAL (21) 8.068 3.893 1.873 yCH3 0.751
0.729
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Amino
Acid
aNH aCH pCH OTHER
ARG (22) 7.998 3.925 1.469 yCH2 1.393
ÔCH2 2.936
NH 6.5-7.0
ARG (23) 8.045 4.073 1.469 yCH2 1.393
SCH2 2.938
NH 6.5-7.0
ALA (24) 8.098 4.118 1.155
PHE (25) 7.933 4.395 C(4)H 7.362
C(3,5)H 7.013
C(2,6)H 7.013
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The remaining signals to assign in the sequence aie from the Ai'g and Lys basic 
residues. These two amino acids give similar signal patterns in the NMR spectra and 
are therefore difficult to distinguish. These amino acids account for 8 out of 25 
residues in the sequence (five arginine residues and thi'ee lysine residues). In addition 
the Leu P-CH2 signal is difficult to distinguish from the P-CH2 Lys/Ai'g resonance’s 
with all the signals occuiTing in the same region in the spectmm. One distinguishing 
feature between the Lys and Arg residues is that the Lys residues contain an extra 
CH2 group and should therefore show one exti'a connectivity in the HOHAHA 
spectrum. This was used where possible to distinguish between the two residues. For 
assignment of the individual Lys and Ai'g residues in the sequence, NOE 
comiectivities to neighbouring residues were used to determine the individual 
resonance’s in the sequence.
6.3.2.4 Sequence Specific Assignments
NOE and ROE interactions for lactofemcin B peptide were examined by taldng cross 
sections tlnough the spectra for individual cross peaks. The ROES Y spectmm of 
sample 1 (Figure 6-11) shows few interactions occurring between adjoining residues 
and not enough for a full sequence specific assignment of lactofenicin B. The 
NOES Y spectrum of sample 2 (Figure 6-12) shows more interactions including a 
number of inter-residue NH-aCH (Figure 6-14) and NH-NH (Figure 6-15) signals 
which enabled a partial sequence specific assignment to be obtained.
After the individual amino acid sequences for the peptide had been established, 
residue specific assignments for NH and CaH protons aie caiTied out for lactoferricin 
B using sequential assignment techniques^^’^ "^. The sequential assigmnent process 
enabled the identification of individual Lys and Ai'g residues in the sequence 
according to interactions with adjacent residues. The NOE interactions also allow the 
identification of the aromatic residues in the sequence and N-H signal positions can 
be defined for all residues..
Chapter 6: Experimental Results for Lactoferricin B Peptide 172
rJor
I! L
Figure 6-12 : ROESY spectrum of Lactoferricin B sample 1.
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Figure 6-13 : NOESY spectrum of Lactoferricin B sample 2.
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Figure 6-14 : NH-CH (d^ N) Interactions for Lactoferricin B Peptide.
Figure 6-15 : NH-NH (d^ iy) NOE interactions for Lactoferricin B Peptide.
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6.3.3 Peptide Conformation
The NMR results acquired suggest that lactofeiTicin B peptide is predominantly 
flexible in aqueous solution. There is an absence of long range NOE interactions that 
give indications of secondaiy stmcture folding such as a-helix, (3-strand and turn 
conformations or indicate a specific spatial structure. However, a number of d ,^  ^
(NH, to NHj+i connectivities )and d^ N (aCH; to NHj+J interactions exist for the 
peptide (for notation see Figure 2-9). This suggests that the local stiucture exists at 
least for a period of time in a specific confonnation rather tlian just a random coil. 
Nucleai" Overhauser enhancements occur for atoms that aie close in space at a 
distance of aiound 3À apai't. This means that the NH-NH residues concerned must be 
at a distance of aiound 3Â for a reasonable length of time for the interaction to appear 
in the spectrum and therefore the stmcture of the peptide cannot be completely 
random^^. Few d^ N interactions aie seen although these signals may be obscured by 
strong intra-residue interactions.
The d^N aiid d^ N connnectivities for adjacent residues in lactofenicin B peptide are 
listed in Figure 6-16.
5 10 15 20 25
F K C R R W Q W R M K K L G A F S I T C V R R A F
d ^ N  -  -  -  -
Figure 6-16 : Sequential Connectivities derived from NOESY cross peaks.
The d^N interactions by themselves do not constitute enough evidence for a folded 
peptide structure. Additional infomiation is needed ideally from medium range 
di^(i,i+3) or d^.^(i,i+4) NOE interactions^^. The dNN(i,i+l) NOE 
connectivities indicate the local dihedi'al angle populations only at each residue and 
these are indicative of a-helical torsion angles.
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The values of the J coupling constants were between 5.5 and 8.5Hz in all cases 
derived from the 2D COSY spectmm and no structural significance can be infeiTed 
fi'om these values. The J coupling constant values obtained indicate a random coil 
confonnation. Strong NOE interactions between the CaH of Ala and the C5Hs of Pro 
suggest that the major Pro residue conformation is in the trans configuration^^.
6.3.4 Discussion
The results presented show that lactofenicin B adopts little régulai' stmcture in 
solution. NOE effects obtained include NH-NH interactions which suggest that the 
peptide is present in a specific confonnation for a period of time such that an NOE 
effect is seen in the average stmcture which suggests some local dihedral angles are in 
the a-helical range. The NOE results come fiom an averaging of all conformations 
obtained^^.
Although small sequences of ordered structure are suggested by the peptide 
connectivities, the overall peptide stmcture in aqueous solution must be considered 
flexible due to the absence of medium and long range NOE interactions. Small 
regions of backbone conformations show d^N interactions only.
The presence of strong sequential NOE interactions has previously been used to 
distinguish between flexible and ordered backbone stmctures for a number of 
peptides^' of similai* length to lactofenicin B. Dyson et al. found evidence of a 
nascent helix confonnation from protein fragments of myohemeiytlnin^^. These 
fragments showed stiong sequential d^N interactions in aqueous solution as well as 
medium range NOE effects and the helical confonnations obseiwed were further 
stabilised in TEE solution.
In most cases of lineai* peptides where evidence of specific stmcture has been 
detennined there is more than one confonnation present. Blanco et. al. found 
evidence of low concentrations of turn confonnations for Tendamistat fragments in
Chapter 6; Experimental Results for Lactoferricin B Peptide 176
aqueous solution^ \  In many cases where some evidence of helical conformation has 
been found in water solution, TFE is added to the solution to maximise the helical 
content of the peptide^^. Amyloid-p Peptide shows no stmcture in water^^, although 
the CD spectmm examined in TFE/H2O solution and in sodium doceyl sulphate 
micelles was found to be identical in both cases and the confoimation in TFE was 
used to give an indication of receptor conformation. The 39 residue peptide y- 
interferon studied by Sakai et. al. showed some suggestion of helical content in H2 0 ^^  
using CD experiments, and the peptide was studied in TFE to maximise the helical 
content in solution.
6.4 CONCLUSIONS
Both the CD and NMR results presented indicate the flexibility of lactofenicin B 
peptide in aqueous solution. The CD results indicate no specific secondary structure 
is present for this peptide in solution. The NMR results indicate some helical torsion 
angles are adopted by lactofenicin B peptide but no clear indication of specific 
confoimation can be derived. Previous experimental work, by many authors, has 
used NMR results carried out in trifluoroethanol to give indications of receptor bound 
conformations. CD results in trifluoroethanol show that the peptide adopts a helical 
conformation in this environment. However, the peptide adopts a (3-stiand stmcture 
in low concentrations of SDS micelles. This illustrates the problems of caiTying out 
peptide solution studies in different solvents. The results obtained are dependent on 
the solvent and conditions used.
One method that overcomes the flexibility of peptides in solution uses NMR studies 
of the peptide in a model membra 
peptide in its active environment.
rane environment^^’^ .^ This gives the structure of the
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7.1 INTRODUCTION
This chapter outlines the main conclusions drawn from the preceding chapters and 
gives some suggestions for future work to follow on from the results outlined here. 
The work studied in this thesis consists of two main sections. Chapter 3 outlines 
work carried out on delicious peptide, a savoury food flavour. Chapters 4, 5 and 6  
give details on the synthesis, modelling, CD and NMR results for the antimicrobial 
peptide lactofenicin B.
The results presented emphasise many of the problems occuiTing in the determination 
of peptide conformation in solution. As illustrated, many peptides ar e flexible in 
solution and may only adopt a specific conformation on interaction with a receptor. 
Combined experimental and modelling studies aid in the determination of the mode of 
action of these compounds.
7.2 ACHIEVEMENTS
7.2.1 Delicious Peptide
The conformation of delicious peptide in aqueous solution was examined by NMR 
spectroscopy. A full resonance assignment for the peptide in water was possible from 
COSY and ROESY spectra. Conformational details of the peptide structure in 
solution were obtained fr om ROE interactions, J coupling constants and dependence 
of *H amide chemical shift values on temperature. All of the information indicates a 
random coil conformation is adopted by the peptide in solution. Molecular dynamics 
simulations of delicious peptide give good agreement with the experimental NMR 
results according to the calculation of homonuclear coupling constants. 
Quenched molecular- dynamics simulations were used to find a number of low energy 
confoimers for delicious peptide that contribute to the flavour characteristics of the 
peptide in solution. These conformers were clustered into families of similar
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structures and used to derive infoimation on the flavour action of delicious peptide. 
The results obtained agree with previous hypotheses that the flavour of the peptide is 
produced by the interaction of basic and acidic fr agments in the peptide\
The study of delicious peptide was extended to look at analogues of delicious peptide 
with similar* flavour characteristics according to a study by Okai et a f . A series of 
peptides were examined for structure characteristics similar* to tliose of delicious 
peptide. Tlie results obtained suggest that the interaction of the basic and acidic 
regions in the peptides are the most important factors for flavour production and that 
both the length and sequence of the peptide ar e important for production of flavour. 
The model for savour*y peptide flavour production is thought to be more complex than 
previously suggested by Spanier et. al. .^
7.2.2 Lactoferricin B Peptide
The antimicrobial peptide lactoferricin B is studied in chapters 4, 5 and 6 . Chapter 4 
outlines the synthesis of the 25 residue peptide by solid-phase poly-amide Fmoc 
synthesis. The Pmc protecting group used for arginine residues in the sequence is 
known to produce shorter deprotection times than other ai'ginine protecting groups. 
Problems with the synthesis occuned because the Pmc protecting group when 
removed from arginine was able to react with the peptide at the Trp residues'* in the 
sequence. This resulted in a 50% loss of product during synthesis. The peptide was 
purified by FPLC and the purified peptide was tested for purity by HPLC, mass 
spectrometry and amino acid analysis.
Chapter 5 presents predictive modelling results obtained for the antimicrobial 
peptides lactofenicin B and lactofenicin H. These peptides are derived from the 
proteins bovine and human lactoferTin respectively. Lactoferricin H peptide is found 
in human lactofenin protein where the peptide adopts a mainly a-helical 
conformation. The known crystal stmcture for human lactofenin in the apo state was 
used to predict secondai*y stmcture confomiations for lactoferricin H and lactofenicin
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B peptides due to the good sequence homology between the two peptides. Predictive 
methods also suggest that the most likely secondaiy stmcture for lactofemcin B 
peptide is in the a-helical fomi for regions of the peptide. Moleculai* dynamics 
simulations of the two peptides in a number of different environments suggest that 
whilst lactoferricin H peptide adopts a similar* a-helical conformation over the course 
of the molecular* dynamics simulation, lactoferr icin B peptide is able to explore more 
conformational space and move away from the a-helical starting confor*niation. The 
results suggest that lactofen icin B peptide is present in an ensemble of conformations 
in solution.
Studies were carried out in order* to simulate the sti*ucture of the lactofenicin B 
peptide in a number of different environments such as in trifluoroethanol and in a 
membrane environment. These studies indicate tliat the peptide is likely to adopt an 
ordered str*ucture in trifluoroethanol and in a membrane environment and the 
predicted a-helical conformation is more stable in these environments than in 
aqueous solution.
Chapter* 6  preseirts experimental data obtained for lactofemcin B. Circular* diclrroism 
results indicate that the peptide does not adopt an ordered secondary structure 
conformation in aqueous solution. The effect of pH on the peptide was also examined 
by CD and was found not to affect the random coil conformation obtained. 
Conversely, the impure peptide with a Pmc protecting group attached adopted an a- 
helical conformation in solution at a high pH value only, probably due to an 
interaction with the Pmc protecting group present in the peptide.
The CD results indicate that lactofenicin B peptide forms an a-helical conformation 
in TFE solution. The dependence of the peptide conformation on environment is 
shown because the peptide is also found to adopt a p-strand confonnation in low 
concentrations of SDS micelle solution. This indicates the difficulty in determining 
peptide confonnation based on environmental conditions alone^.
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*H NMR results for the lactoferricin B peptide were carried out using two- 
dimensional NMR techniques. The peptide shows flexibility in solution and 
assignment of the different peptide residues in the sequence was complicated due to 
the presence of 5 ai'ginine and 3 lysine residues with similar resonance assignments. 
These residues were assigned by d^^ d^ N NOE connectivities to neighbouring 
residues'". The peptide does not show much sign of specific secondaiy stmcture in 
solution although some indication of what has been called a ‘nascent helix’ 
confonnation is suggested^. No confirmatory experimental data such as long-range 
NOE interactions are found to confirm this.
Compar ison of the experimental and modelling results for the peptide gives good 
agi'eement. Modelling studies indicate that the most stable conformation for the 
peptide is a-helical for parts of the peptide. NMR studies show the flexibility of the 
peptide in solution but suggest that a likely low energy conformation for the peptide is 
a-helical. The stmcture of the peptide in trifluoroethanol solution is found to be a- 
helical.
7.3 FUTURE WORK
7.3.1 Delicious Peptide
Further NMR studies on delicious peptide are unlikely to lead to more information on 
its conformation. One method to overcome the flexibility of the peptide chain is by 
formation of a cyclic form of the peptide, although the conformations adopted by 
short linear peptides are often influenced by the cyclic process^ or do not show the 
same activity^ and therefore may not help to establish more information on the lowest 
energy conformation of the peptide. The main difficulty for food flavour peptides is 
determination of the site of action for the peptide because flavour intensity is a 
combination of different factors. Better molecular* dynamics simulations results for* 
delicious peptide need longer* simulations in aqueous solution with periodic boundary 
conditions applied*^, although for the determination of low energy conformations the
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time scale of the simulations needed is too long to be realistic for most modern 
systems of computer hardware. Other methods of solvent simulation include use of 
langevin dynamics, which include friction effects, and more reliably simulate charge 
interactions**. Further work on delicious peptide analogues, such as the flavour 
characteristics of different analogues would give more credence to the reliability of 
modelling studies on the peptide. Other methods to find the global minimum 
conformation of delicious peptide include use of build-up methods for which long 
cornputatiorral times are necessary*^.
7.3.2 Lactoferricin B peptide
NMR results for lactoferricin B peptide show the flexibility of the peptide in solution. 
CD results show that the peptide adopts an a-helical conformation in TFE solution. 
NMR studies of peptides in TFE are often cited as evidence of membrane 
environment for peptides that show flexibility in solution. Therefore NMR studies in 
low concentrations of TFE may be helpful for determining the structure of 
lactoferricin B at the active site. Using modelling studies with NOE constraints as 
input*  ^ this would enable a direct compar ison of the structure of the peptide fragment 
as derived from the protein and the conformation of the peptide in low concentrations 
of TFE, although the reliability of such results needs to be tested by obtaining further 
information on the active conformation of lactoferTicin B.
NMR studies on the rnagairrin 2 peptide, which is known to be flexible in solution, 
were canted out for the peptide in a membrane environment using solid state NMR*'* 
and numerous other studies of peptides and proteins in a membrane environment have 
been reported*^. Similar studies canted out on lactofenicin B would enable the 
conformation of the peptide to be recorded at the site of its specific mode of action.
Useful modelling studies for lactoferricin B require the inclusion of periodic 
boundary conditions for simulations of the peptide in aqueous solution, also 
simulations on a longer time scale than were previously able to be canted out would
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be helpful. Further synthesis methods for deteraiination of the key residues in the 
sequence include synthesis of lactofenicin B with key residues removed (such as Pro, 
Ai'g, Lys and Cys) to test the effect of the removal of these residues on activity. The 
choice of peptides synthesised can be nanowed down by molecular modelling 
techniques.
7.4 FUTURE TRENDS
Biological NMR spectroscopy is an area that has increased in importance 
significantly during the past ten to fifteen years. Numerous new NMR experiments 
have been designed that aid in NMR assignment of peptides and proteins. These 
include the combination of coupling and Overhauser experiments (For example 
NOESY-TOCSY*^) that aid assignment of NOE cross peaks in the spectrum*^. 
Heteronucleai" techniques are increasingly used for protein assignments*^’*^ . New 
developments in this field include the use of isotope labelling in conjunction with 
thi'ee and four dimensional techniques to enable NMR to be used for the 
determination of conformations of larger proteins^ **. 3D and 4D NMR enable cross 
peaks to be further resolved using *^ C or *^ N isotope labelling. Extra NOE restraints 
can be found from additional coupling constant data^*. Resonance assignments of 
proteins can be automated^^ to give improved times for structure determination.
Relaxation times in NMR give information on mobility of peptides and proteins in 
solution and ai*e being used increasingly for the deteimination of NMR flexibility in 
solution^^. Relaxation times can also be predicted from moleculai' dynamics 
simulations '^*. Use of Transfened NOE effects enables studies of peptides bound to 
membranes^^ or in other environments^^ to be perfoi'med.
Molecular simulations of peptides and proteins continue to be caii'ied out for larger 
systems with better simulation of solvation conditions. In addition, improved 
har dware facilities enable simulations of larger systems to be carried out. With an 
increase in the speed of the hardware, it is possible to determine larger moleculai'
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systems such as proteins and water interactions simulated using periodic boundary 
conditions. Simulations can also be carried out on a faster time scale by increasing 
the time step in the simulations^^ and due to the development of more efficient 
software codes.
In conclusion improved experimental and computational techniques for NMR 
spectroscopy and faster computing facilities for moleculai* simulations will lead to 
more accurate methods for peptide and protein structur e determination.
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ERRATUM
P(") dependant should read dependent
p8 paragi';i[)h 2 complimentary should read complementary
p i 4 paragraph .1 effect should read affect
p25 line 2 correlation’s should read correlations
P28 hue J ’mutual ring flip’ should read ’mutual spin flip’
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resonance’s should read resonances
P3 1 ’creating NOE curves' should read 'measuring NOE curves'
p34 line ! effect should read affect
p38 section 2.3.2.3 'These method should read 'This method
p46 section 2.5 opoidshoul read opioid
p36 'fragment appears to act as a spacer’ is incorrect
p57 hxpci imcnial pH should have been recorded
p79 paragi apii 2 'of form’ should read 'to form’
p79 section 3.4 reference 5 should be reference 4
pl29  sectik)n 5..).2.2 residues 3 to 19 in lactoferricin B’ should read 'residues 3 to 20’
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p8 paragraph 2 
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effect should read affect
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effect should read affect
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reference 5 should be reference 4
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